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ABSTRACT 
 
Manganese (Mn2+) has recently gained acceptance as a magnetic resonance imaging (MRI) 
contrast agent useful for generating contrast in the functioning brain. The paramagnetic properties of 
Mn2+, combined with the cell’s affinity for Mn2+ via voltage-gated calcium channels, makes Mn2+ 
sensitive to cellular activity in the brain. Compared with indirect measures of brain function, such as 
blood oxygenation level dependent (BOLD) functional MRI, manganese-enhanced MRI (MEMRI) 
can provide a direct means to visualize brain activity. 
 
MEMRI of the brain typically involves osmotic opening of the blood-brain barrier (BBB) to 
deliver Mn2+ into the interstitial space prior to initiation of a specific neuronal stimulus.  This 
method assumes that the BBB-disruption process itself does not induce any apparent stimuli or cause 
tissue damage that might obscure any subsequent experimental observations.  However, this 
assumption is often incorrect and can lead to misleading results for particular types of MRI 
applications. 
 
 One aspect of these studies focused on characterizing the confounding effects of the BBB-
opening process on MRI measurements typically employed to characterize functional activity or 
disease in the brain (Chapters 4 and 5).  The apparent diffusion coefficient (ADC) of tissue water 
was found to decrease (relative to the undisrupted contralateral hemisphere) following BBB opening, 
obscuring similar ADC changes associated with ischemic brain tissue following stroke.  Brain 
regions exhibiting reduced ADC values following osmotic BBB disruption also experienced 
permanent tissue damage, as validated by histological measures in the same vicinity of the brain.  
Non-specific MEMRI-signal enhancement was also observed under similar conditions and was 
found to be correlated to regions with BBB opening as verified by Evans Blue histological staining.  
   vi  
  
In this case, MEMRI may prove to be a useful alternative for monitoring BBB-permeability changes 
in vivo. 
 
MEMRI was also investigated as a method for visualizing regions of BBB damage following 
ischemic brain injury (Chapter 6).  BBB disruption following stroke has been investigated using 
gadolinium-based MRI contrast agents (e.g., Gd-DTPA).  However, as an extracellular MRI contrast 
agent, Gd-DTPA is not expected to provide information regarding cell viability or function as part of 
MR image contrast enhancement. By comparison, brain regions with ischemia-induced BBB 
damage, and blood-flow levels sufficient to deliver Mn2+, show MEMRI-signal enhancement that 
correlates to regions with tissue damage as verified by histological staining.  This approach should 
allow us to better understand the factors responsible for ischemia-induced BBB damage.  
Furthermore, MEMRI should be a useful tool for monitoring therapeutic interventions that might 
mitigate the damage associated with BBB disruption following stroke.
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1.0 Basic Physical Principles of Nuclear Magnetic Resonance  
 
1.1 Introduction 
 
 This chapter is an introduction to the basic theory of magnetic resonance imaging (MRI). The 
topics covered include the MR theory and methods that pertain specifically to the research described 
in this dissertation. The MR theory is discussed at a depth that should provide a basic understanding 
of spin-echo, gradient echo, echo-planar and diffusion-weighted MR imaging.   
 
1.2 Electromagnetic Wave Theory 
The electromagnetic wave is of fundamental importance for the generation of a magnetic resonance 
image. A brief discussion of the basic components of an electromagnetic wave, the electric and 
magnetic field, and what portions of the wave are important to magnetic resonance imaging (MRI) 
are presented here.  
 
1.2.1 The Electric and Magnetic Field 
Generation of the electric and magnetic field by charged particles 
The concept of a ‘field’ can be described with a common force that surrounds us: gravity. To every 
point in space we can assign a vector g that represents the force F exerted on some mass m by earth’s 
gravity. The gravitational field is then written as g =  F/m. In a similar fashion we can talk of a 
vector E that represents the force F that a positive electric charge q experiences when placed near a 
charged rod. The electric field is then described as E = F/q. The direction of the vector E is the same 
as F; it is the direction the stationary positively-charged particle would accelerate towards the rod. 
The electric field, therefore, is representing the force of one electrically-charged particle on another. 
Can it then be said that the magnetic field is a representation of a magnetically-charged particle on 
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another? The answer to date is no, i.e., there are no known magnetic charges. It is the moving 
electrical charge that generates a magnetic field.  
 
Properties of the Magnetic Field 
A charged particle moving in the presence of a magnetic field B does not experience acceleration but 
can have its direction changed. The magnetic field deflects a moving charge by a force FB
 maximally 
when the charged particle is moving perpendicular to the direction of the magnetic field: FB = 
qvBsin(θ) where θ is the angle between the direction of the moving particle and the direction of the 
magnetic field, q is the measure of electric charge, and v is the velocity of the charge. The measure 
of magnetic field strength is the newton / (ampere * meter) or more simply and more commonly 
referred to as the Tesla (1 T = 1 N/(A * M) ) (1). As reference a small toy magnet (refrigerator 
magnet) has a magnetic field strength of ~ 10-2 T, the magnetic field at the surface of the earth is ~ 
10-4 T and a clinical MRI scanner is at 1.5 T.  Figure 1.1 shows an example of the magnetic-field 
profile of a bar magnet.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1: Magnetic field lines for a typical bar magnet. Note the linearity of the field in the middle of the magnet; this 
is an important characteristic of magnets for magnetic resonance imaging and will be discussed later.  
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1.2.2 Generation of an Electromagnetic Wave 
Electric and magnetic fields can be generated by point charges and bar magnets, respectively, as 
discussed in the previous section. What is required to generate a magnetic resonance image is a 
propagating magnetic field (which moves in a direction perpendicular to the main magnetic field of 
the MRI scanner). A convenient way to generate a relatively small and switchable magnetic field is 
by passing an electric current through a small loop of wire that surrounds the sample we are 
interested in imaging. The small loop of wire and the circuit that completes it is referred to as a LC 
oscillator.  
 
 
 
 
 
Induced Magnetic Field in Wire Loop 
 
For a single loop of wire carrying a current I, a fairly homogenous magnetic field is generated near 
the center of the loop as shown in Figure 1-2: 
 
Figure 1-2: Current flow in single loop of wire (A) and a side view of resultant magnetic field lines (B).  
 
 
Current (I) flow 
x
y 
z +Z 
A B 
Basic Principles of MRI    4 
 
 
The LC Oscillator 
 
The electric charge and current in the LC oscillator circuit fluctuates at a particular frequency given 
by ω = 1/√LC where L and C are the inductance and capacitance values in the circuit. The oscillation 
frequency of the LC circuit is more commonly named the resonant frequency. For MRI applications 
the frequency of oscillation of the magnetic field needed for MR signal generation is in the radio-
frequency (RF) range. Therefore, the ‘coil’ (or coils) used to generate MR images are commonly 
referred to as RF coils. When an LC oscillator (or resonator) is used to acquire images in a 2 Tesla 
MR scanner, the resonant frequency of the LC circuit must be tuned to 2 Tesla * 42.57 MegaHertz/ 
Tesla (MHz/T) or ~ 85 MHz. The special constant, 42.57 MHz/T, will be discussed later in this 
chapter.    
 
 
 
 
 
 
The single loop of wire shown in Figure 1-3 is one of many ways of generating a resonating 
magnetic field within a tissue of interest. Multiple loops of wire wound tightly together (solenoid) 
are also commonly used with the advantage of a highly homogeneous magnetic field produced 
Capacitor (C) 
Inductor (L) 
Sample for imaging 
(water phantom, tumor 
tissue, etc…) 
MR signal to and 
from MR scanner 
Figure 1-3: LC oscillator circuit. The capacitor shown is adjustable to allow the user to tune the coil to an exact 
frequency (the resonant frequency of the coil can change due to stray capacitance values in the sample among 
several other variables). The inductor shown is a single loop of copper wire. In this form the RF coil is referred to as 
a ‘surface coil’.  
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within the diameter of the coil. The transfer of energy from the coil to the tissue (sample) of interest 
(via the magnetic field produced by the coil) is the primary goal of the LC oscillator and all RF coils 
used for MRI. Water molecules within the tissue of interest become ‘excited’ by the magnetic energy 
produced by the coil. The means by which the tissue becomes excited is the subject of the next 
section.  
 
1.3 Nuclear Energy States 
 
Atomic structure and angular momentum 
Atomic structure is defined by an atom’s nuclear configuration and its orbiting electron(s). The 
nucleus of the atom consists of protons (charge = +e, where e is the charge of an electron: -1.60 x 10-
19 Coulomb) and neutrons (charge = 0); both of which are referred to as nucleons. The electron(s) 
that orbit(s) the nucleus are each negatively charged and possess both spin and orbital angular 
momentum.  The angular momentum associated with a charged particle generates a magnetic field 
(referred to as the magnetic dipole moment or MDM) which is a vector quantity with both 
magnitude and direction.  The magnetic field associated with electrons is referred to as the electron 
MDM.  Since nuclei can also possess spin and orbital angular momentum and are positively charged, 
the associated magnetic field is referred to as the nuclear MDM.  For MRI, the MDM of the 1H 
isotope of hydrogen is simply that associated with the single proton in the nucleus (Figure 1-4).  The 
proton MDM is the fundamental physical property that is exploited to generate an MR image.   
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Figure 1-4: Single proton (1H isotope of hydrogen) showing the angular momentum vector (P) and the antiparallel 
nuclear MDM (µ) vector that is created by the moving positive charge associated with the proton.  
 
A convenient way to represent the relationship between the nuclear MDM and its angular 
momentum is to consider the ratio of the two quantities. This ratio is referred to as the magnetogyric 
(or gyromagnetic) ratio and is written as γ = µ/P = -(e/2me), where  e and me are the charge and mass 
of the proton, respectively, when considering the 1H isotope of hydrogen.  
 
The ‘spin’ of a nucleus 
The laws of quantum mechanics require that the angular momentum of the proton shown in Figure 
1-4 be quantized, i.e., the magnitude of the nuclear spin angular momentum can only be represented 
by specific discrete values: 
2/1)]1([ += IIP η
ρ
 
 
(1.1) 
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6 Protons 
7 Neutrons 
Spin Pairs 
Resulting 
Spin (I) 
0 
1/2 
13C  
Nuclear  
Config. 
)2/( 0 πγhBmE ii −=
where π2/h=η (h = Planck’s constant = 6.63 x 10-34 kgּmּs-1) and I is the nuclear spin quantum 
number. The value of I depends on the structure of the nucleus; specifically, the number of protons 
and neutrons. Each proton and neutron has an associated spin of ½. In the nucleus, the pairing of two 
protons (or two neutrons) results in a cancellation of the spin from each partner.  Consequently, the 
net spin of a particular nucleus is determined by the number of unpaired protons and/or neutrons in 
the nucleus. For example, the 13C nucleus has six protons and seven neutrons. The six protons form 
three pairs whose spins cancel.  The seven neutrons form three spin pairs and with one neutron 
remaining unpaired.  As a result, the net spin associated with the 13C isotope is simply that 
contributed by the single unpaired neutron (i.e., I = ½), as shown in Figure 1.5.  
 
  
 
 
 
 
 
Figure 1-5: Spin pairs for the 13C nucleus. Paired protons and neutrons result in a net zero spin for each pair. It is the 
unpaired neutron that gives 13C a spin of I = ½.  
 
Nuclei in an external magnetic field 
     For nuclei with a non-zero value of I, the nuclear MDM can adopt certain orientations with 
respect to the direction of an applied external magnetic field.   For spin-½ nuclei, such as 1H or 13C, 
the nuclear MDM can be oriented in a ‘spin-up’ or ‘spin-down’ state which corresponds to the 
nuclear MDM being either parallel or antiparallel to the external magnetic field, respectively. In the 
absence of an applied external magnetic field, the two spin states have the same energy (i.e., they are 
said to be degenerate). However, in the presence of an applied external magnetic field – usually 
designated as Bo – the energy associated with each state is different and given by:   
 
    (1.2) 
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0 
Bo ON 
m+1/2 (spin up) 
m-1/2 (spin down) 
∆E = γhBo/2π 
Bo OFF 
E 
where γ is the magnetogyric ratio, h is Planck’s constant, Bo is the external magnetic field strength, 
and i is the particular spin state (either +½ or -½ in the case of 1H).  Equation 1.2 indicates that the 
energy of the proton MDM is quantized in units of γhBo/2π and varies with the external magnetic 
field strength Bo. Figure 1-6 shows the two energy levels associated with the proton MDM in the 
absence and presence of the Bo field.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6: Energy of the proton (1H) MDM in the absence and presence of an external magnetic field Bo. The 
quantization of the proton MDM implies that the MDM can occupy only one of two possible energy states.  
 
 When a sample containing spin-½ nuclei is placed into an external magnetic field, the nuclei will 
distribute themselves between the two energy states according to the Boltzmann distribution. The 
number of nuclei in a particular energy state, NI, is given by: 
 
      KT
E
I
I
eN
−
=  
where EI is the energy of state I, K is the Boltzmann constant (1.38 x 10
-23 Joules/Kelvin), and T is 
temperature (Kelvin scale).  The ratio of nuclei in each state is given by: 
 
KTE
KTE
KTE
e
e
e
NN /
/
/
2/12/1
2/1
2/1
/ ∆−
−
−
− ==
−
, 
 
where N-1/2 and N1/2 are the populations of nuclei in the upper and lower states, respectively, and ∆E 
is the energy difference between the two states. Writing the total population of nuclei as NT = N-1/2 + 
(1.3) 
(1.4) 
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N1/2, the difference in population between the two states as ∆N = N1/2 - N-1/2 , and using the Taylor 
series approximation KTEe /2/1−− ~ 1 -  ∆E/KT, the difference in population between the two energy 
states, ∆N, can be written as: 
KT
EN
N T
2
∆
=∆ . 
For an MRI experiment, the MR signal is directly proportional to the population difference, 
∆N, between the two states. The population difference can be expressed in terms of the net nuclear 
magnetization vector, M, which is defined as the sum of all the individual nuclear magnetic 
moments, µ:  
∑ −==
I
Im zmm
NM µ , 
where Nm is the number of nuclei in state m and µzm is the z-component of all the nuclear magnetic 
moments in state I.  If the system is at the Boltzmann equilibrium, then the net nuclear magnetization 
vector is designated as Mo, where the subscript denotes the equilibrium condition. 
     From a quantum-mechanical point of view, the MRI experiment involves transitions between 
energy states.  For spin-½ nuclei, transitions from the lower to the higher energy state are induced by 
applying energy [in the form of radiofrequency (RF) radiation] that exactly equals the difference in 
energy between the two states (i.e.,  ∆E = γhBo/2π). Since the difference in energy between the two 
states is also given by ∆E = hυ, where υ is the frequency of electromagnetic radiation (in this case 
RF), then the RF frequency that satisfies the “resonance” condition is given by: 
 
υ = γBo/2π. 
 
Equation 1.7 can be thought of as the quantum-mechanical version of the magnetic resonance 
equation. 
 
Classical Description of MR 
The net nuclear magnetization, M (from Eq. 1.6), can be depicted in the classical sense using 
vector diagrams. Figure 1-7 shows a vector diagram for a single nuclear MDM and a diagram for a 
collection of nuclear MDMs that give rise to the net magnetization vector, M, in the laboratory frame 
of reference. If the system is at the Boltzmann equilibrium, then the net nuclear magnetization vector 
is designated as Mo, where the subscript denotes the equilibrium condition. 
(1.5) 
(1.6) 
(1.7) 
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Figure 1-7: a) A single nuclear magnetic dipole moment (MDM), µ, in the presence of the external magnetic field, Bo.  
The Bo field exerts a force on µ, resulting in a precessional motion of µ about Bo. b)  A collection of nuclear MDMs 
precessing about Bo with an excess population (of two) oriented in the Bo direction.  Although the transverse (x-y) 
components of the MDMs cancel each other out, there is a net z-component of magnetization, Mo (if the system is at the 
Boltzmann equilibrium), which corresponds to the population difference between the two orientations. The Cartesian-
coordinate system is defined in this case as the ‘laboratory’ frame of reference.  
 
In the presence of an external magnetic field, Bo, aligned along the z-direction of a Cartesian 
coordinate reference frame, individual nuclear MDMs will precess about Bo as a result of the force 
exerted on them by Bo. The precessional frequency, ω (in rad/s), is given by the Larmor equation: 
ω = γBo. 
 
Notice that the Larmor equation has a form analogous to the resonance equation (Eq. 1.7) derived 
from the quantum-mechanical model.    
In the presence of a radiofrequency field, B1, that is perpendicular to the main magnetic field, 
Bo, and to M, the motion of M in the laboratory frame of reference (a fixed frame of reference with 
respect to the laboratory surroundings) can be described by a set of differential equations known as 
(1.8) 
Basic Principles of MRI    11 
 
the Bloch equations (2). The Bloch equations also include the relaxation parameters T1 and T2 (more 
on these parameters in Section 1.4) which account for the motion of the Mz and Mxy components of 
M, respectively, during their return to the Boltzmann equilibrium (after the RF field is turned off). 
By considering first the single magnetic moment (Figure 1-7a), the rate of change of µ with respect 
to time is given by:  
)( 0xB
dt
d
µγ
µ
= , 
which describes the precessional motion of µ around Bo. An analogous Bloch equation can also be 
written for the net magnetization vector M as: 
)( 0xBM
dt
Md
γ=  
By adding the contributions that describe the behavior of the magnetization under the influence of 
the B1 field as well as relaxation, the full Bloch equations for each component of M are summarized 
as follows:  
2
10 sin
T
M
tMBMB
dt
dM x
zy
x −+= ωγγ  
2
10 cos
T
M
tMBMB
dt
dM y
zx
y −+−= ωγγ  
1
0
1
)(
)cos(sin
T
MM
tMtMB
dt
dM z
yx
z −−+−= ωωγ  
In this form the Bloch equations are tedious to solve.  However, the task is made easier by a 
coordinate system transformation into a frame of reference that is rotating at the precessional 
frequency of the nuclei (i.e., a rotating reference frame).  For example, consider a spinning merry-
go-round with several children aboard. To the observer standing next to the merry-go-round, the 
children would appear to be spinning at the rotational frequency of the ride.  However, if the 
observer were to then jump on the merry-go-round with the children, the children would not appear 
to be moving (i.e., they would appear to be stationary) in that frame of reference.  Similarly, if the 
magnetization vector M is observed from a frame of reference rotating at the precessional frequency 
of the nuclei, then M will also appear to be stationary in that rotating frame of reference.  In other 
words, observing M in the rotating reference frame effectively removes the contribution of the 
precessional term (i.e., γBoMy or –γBoMx) from the Bloch equations (e.g., Eqs. 1.11 and 1.12, 
(1.9) 
(1.10) 
(1.12) 
(1.11) 
(1.13) 
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respectively).  Transforming to the rotating frame of reference (x′, y′, z′) from the fixed laboratory 
frame of reference (x, y, z) requires the following definitions for the Cartesian components of 
magnetization in the rotating reference frame: 
Mx′ = Mxcos(ωt) - Mysin(ωt) 
My′ = Mxsin(ωt) + Mycos(ωt) 
Mz′= Mz. 
The Bloch equations can then be re-written as: 
2
'
'0
' )(
T
M
M
dt
dM x
y
x −−= ωω  
z
y
x
y
MB
T
M
M
dt
dM
1
2
'
'0
' )( γωω +−−−=  
'1
1
0 )( y
zz MB
T
MM
dt
dM
γ−
−
−= , 
and solved in this form to predict how the different components of magnetization behave under a 
particular set of experimental conditions. 
Figure 1-8 shows the observed path of M in the presence of an RF magnetic field, B1, 
oscillating at the Larmor frequency for an observer in the laboratory frame of reference (Figure 1-8a) 
and in the rotating frame of reference (Figure 1-8b). The RF coil in Figure 1-8 is positioned such that 
when alternating current is passed through the coil, an oscillating magnetic field, B1, is generated 
according to Ampere’s law.  The B1 field is perpendicular to Bo and to M and exerts a torque on M 
such that M tips away from Bo. The ‘tip angle’ θ can be adjusted by controlling the amplitude of the 
B1 field and the duration, t, of the RF pulse that is applied to the coil. For a nucleus with a 
gyromagnetic ratio γn, the flip angle θ is given by: 
  
tBn 1γθ = . 
 
The purpose of the B1 field then is to convert the z-component of magnetization (Mz), which is not 
directly observable, into detectable transverse components of magnetization (i.e., Mxy).  As shown in 
Figure 1-8b, a 90o RF pulse creates the maximum transverse component of magnetization which in 
turn yields the largest MR signal intensity. 
 
(1.17) 
(1.18) 
(1.19) 
(1.20) 
(1.14) 
(1.15) 
(1.16) 
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Figure 1-8: a) The RF magnetic field B1 and M in the fixed or laboratory frame of reference containing Bo. In this frame 
of reference, the B1 field rotates at the Larmor precessional frequency of M.  The effect of B1 and Bo together forces M to 
tip away from the z-axis as well as precess about Bo at the same time (resulting in the complex spiral motion indicated in 
the figure).  At the time point shown in the figure, M has two nonzero components; Mz (longitudinal) and Mxy 
(transverse) magnetization. b) The RF magnetic field B1 and M in the rotating frame of reference. In this frame of 
reference, the B1 field now appears stationary and the effect of the Bo field on M is effectively removed.  Consequently, 
in the rotating reference frame, M only experiences the effect of the B1 field and is confined to rotate about B1 in the x′, 
z′ plane. At the time point shown in the figure, M has rotated through 90o and thus has only a transverse component, Mxy.      
 
1.4 The Free Induction Decay Signal 
 As long as the external magnetic field B1 is applied, the net magnetization vector M will continue 
to precess about the B1 axis (in the rotating frame of reference). When the B1 field is removed (or no 
longer oscillates at the Larmor frequency), M begins to return to the Boltzmann equilibrium state. 
The MR signal can then be detected during this period. From Faraday’s law of induction, an 
oscillating magnetic field – in this case Mxy – generates (or induces) an electromotive force (emf) in 
the RF coil (that has a geometry and orientation to specifically detect transverse components of 
magnetization). The small emf oscillating in the RF coil is referred to as the free induction decay 
(FID).  ‘Free’ refers to the process being free of any applied forces, ‘induction’ refers to the emf 
induced in the coil, and ‘decay’ refers to the fact that the amplitude of the induced emf decays over 
time. The FID is amplified and then digitized for subsequent signal processing (e.g., Fourier 
transformation) to extract the frequency components of the signal. A typical FID and the 
corresponding RF detection coil arrangement in the laboratory frame of reference are shown in 
Figure 1-9. 
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Figure 1-9: Detection of transverse magnetization, Mxy. The Cartesian coordinate systems depict Mxy vectors at different 
time points in the absence (A) or presence (B) of transverse magnetization decay. The graphs depict the corresponding 
amplitude of Mxy (in terms of signal intensity) as a function of time. The phase of the signal depicted by numbered points 
on graphs depends on the initial position of the Mxy vector in the transverse plane relative to the position of the RF 
detection coil. The decaying Mxy signal is referred to as the free induction decay (FID). The FID shape is the result of a 
sinusoid multiplied by an exponential.  The decay rate is dependent on T2
* relaxation (more on T2
* relaxation in Section 
1.4.1). 
 
1.4.1 Sampling the MR Signal 
The MR signal is a continuous signal (i.e., analog) while signals that computers deal with are 
discrete or digital signals. Therefore, MR signals must be sampled and stored digitally (i.e., 
digitized) before the FT can be applied to generate a MR image. A minimum sampling rate is 
necessary for correct digitization of the MR signal (and any time-domain signal) and is determined 
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according to the Nyquist Sampling Theorem. The Nyquist Sampling Theorem states that to correctly 
digitize a signal the sampling rate must be twice the highest frequency contained within the signal. 
This concept is shown graphically in Figure 1-10: 
 
  
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
Figure 1-10: Examples of correct and incorrect sampling of a time domain signal. Sample rate in A) is greater than twice 
the highest frequency component in the signal and the resulting reconstruction (digitization) of the signal is accurate. 
Sample rate in B) is less than twice the highest frequency component in the signal and the resulting digitization of the 
signal does not accurately represent the original signal. In this example (B), the frequency of the reconstructed signal is 
exactly half of the sampled signal.  
 
 
 
 A) Correct Sampling Rate (> 2*max freq.) Correct Reconstruction 
B) Incorrect Sampling Rate (< 2*max freq.) Incorrect Reconstruction 
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1.5 Relaxation in the MR Experiment 
A complete description of the Bloch equations includes a basic understanding of the MR 
relaxation parameters T1 (spin-lattice relaxation) and T2 (spin-spin relaxation). T1 and T2 depend on 
the biological sample and the magnitude of the main magnetic field (Bo) and are the primary 
contributing factors to the contrast seen in most magnetic resonance images. 
 
1.5.1 Mechanism of Spin-Lattice (T1) and Spin-Spin (T2) Relaxation 
 To perturb the equilibrium nuclear magnetization vector Mo towards the transverse plane 
(i.e., which is equivalent to exciting the nuclei from the ground state to the excited state) requires RF 
stimulation supplied by the RF transmitter (via the RF coil) of the spectrometer. Similarly, recovery 
of the longitudinal component of magnetization (i.e., Mz) back to the Boltzmann equilibrium state 
(or, from a quantum-mechanical point of view, nuclei in the excited state to returning to ground 
state) also involves RF stimulation; albeit from a very different source: the nuclei’s surroundings or 
‘lattice’. Each water molecule contains two protons, each with their own individual nuclear MDM.  
Given the magnitude of the proton MDM and the close proximity of the water protons to each other, 
each proton experiences the dipolar field of its neighbor – the so-called lattice field – in addition to 
the main magnetic field Bo. As the water molecule rotates and/or translates, the local magnetic field 
experienced by each proton then fluctuates at the rotational/translational frequency of the water 
molecule. Water molecules rotating and/or translating at a frequency that is at or near the Larmor 
frequency create effective coupling between the nuclei and the lattice.  Under these circumstances, 
energy can be efficiently dissipated from the nuclei to the lattice which in turn allows excited nuclei 
to return to the lower (ground) energy state. 
 For example, bulk water has a relatively long spin-lattice (T1) relaxation time since the 
rotational frequency of the water molecules is much faster than the Larmor frequency; resulting in 
poor coupling between the molecules and the lattice and thus inefficient energy dissipation.  On the 
other hand, water in biological tissues has T1 relaxation times on the order of hundreds of 
milliseconds. In this case, a fraction of the water molecules are bound to macromolecules and 
membranes in the tissue, reducing their rotational frequency in the bound state to that of the slower-
moving macromolecules.  Since water molecules are in fast exchange between the bulk phase and 
the bound state, the average rotational frequency of the tissue water molecules are reduced.  As the 
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average rotational frequency of the water molecules approaches the Larmor frequency, the 
molecules will couple more effectively to the lattice; resulting in more efficient energy transfer from 
the excited protons to their surroundings and thus reduced T1 relaxation times. The rotational rate 
and, therefore, the T1 relaxation time of bound water depends on the size of the macromolecule 
involved as shown in Figure 1-11.  
 The theory of Bloembergen, Purcel, and Pound (3) provides a quantitative estimate of T1 and T2 
relaxation times based on the correlation time (τc) of the molecule.  The correlation time is defined 
as the time required for a molecule to rotate though 1/2π of a cycle (i.e., 1 radian or 57.3o) or the 
“average” time between molecular collisions.  The R1 (1/T1) and R2 (1/T2) relaxation rates also 
depend on the Larmor resonant frequency (ω0) of the nuclei as well as a number of other nuclear 
parameters as given by:  
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where 
62
422
160
3
r
K
π
γµ η
= , µ = the MDM of the particular nucleus, ћ = h/2π = Planck’s constant divided 
by 2π, γ = the gyromagnetic ratio of the nuclear species, and r = the separation between the protons 
in the water molecule (i.e., the dipole-dipole separation). 
Figure 1-11 shows the relationship between molecular correlation times and T1 and T2 
relaxation times for various sized molecules. Note that as the molecular size increases (i.e., 
decreasing τc) the T1 relaxation time decreases and attains a minimum where the average 
rotational/translational frequency of the molecules (1/τc) matches the Larmor frequency.  As the 
molecular size increases further, the T1 relaxation time also increases due to the increasing mismatch 
between the average molecular rotational/translational frequency and the Larmor frequency. In the 
case of the transverse relaxation time, T2 also decreases with increasing molecular size.  However, 
the additional 3τc term in Eq. 1.22 (as compared to Eq. 1.21 for T1) causes the T2 relaxation time to 
continue to decrease (rather than increase as seen for T1) as the molecular size continues to increase.  
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Figure 1-11: Plot of T1 and T2 relaxation times versus molecular correlation time (τc) (from Eqs. 1.21 and 1.22). Note 
that for bulk water the T1 and T2 relaxation times are nearly identical (this is the so-called ‘extreme narrowing’ regime) 
while for larger molecules, such as lipids and proteins, T1 and T2 differ significantly. The dependency of T1 on the main 
magnetic field strength, Bo, is clearly demonstrated for medium-sized and large molecules.  The minimum in the T1 
curves is the point at which the rotational frequency of the molecules (i.e,, 1/τc) equals the Larmor frequency.    
 
 The transverse or spin-spin relaxation time, T2, characterizes the rate of decay of the Mxy 
magnetization that is created following the rotation of Mz magnetization into the transverse plane 
following the application of an RF pulse.  In the case of an FID, the time constant associated with 
the decay of the transverse magnetization is denoted by T2
*, which contains contributions from a 
variety of sources.  The R2
* relaxation rate (i.e., 1/ T2
*) is given by: 
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In addition to the intrinsic fields that contribute to T2, inhomogeneities in the main magnetic field Bo, 
local magnetic field inhomogeneities arising from differences in magnetic susceptibility (e.g., at air-
tissue interfaces), and molecular diffusion in the presence of magnetic field inhomogeneities all 
result in loss of phase coherence among the individual nuclear MDMs as they precess in the 
transverse plane.  Ideally, it would be desirable to have T2
* dominated by intrinsic field effects (i.e., 
only the first term on the right-hand side of Eq. 1.23).  Although the other terms in Eq. 1.23 can 
often contribute significantly to the decay of the transverse magnetization, there are compensatory 
measures that can be taken to mitigate their effects (discussed in the next section). The effect of T2
* 
on the FID signal is shown in Figure 1-12.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-12: Two FID envelopes, one with a decay envelope dominated by T2 effects (spin-spin interactions) only, the 
other dominated by T2
* effects (spin-spin interactions, magnetic field inhomogeneities, susceptibility, and diffusion).  
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1.5.2 The Spin-Echo RF Pulse Sequence 
There are no experimental methods for removing the intrinsic-field effects from the decay of the 
transverse magnetization.  However, magnetic field inhomogeneities can be corrected using the spin-
echo RF pulse sequence. Magnetic field inhomogeneities arise from imperfections in the main Bo 
field as well as local (within the sample) magnetic field inhomogeneities that are due to differences 
in magnetic susceptibility at the interface of two dissimilar materials (e.g., at air/tissue interfaces). 
 To understand how the spin-echo RF pulse sequence works, consider a race-track analogy 
with four runners of varying abilities (Runner #4 > #3 > #2 > #1). Before the start of the race, the 
runners position themselves at the appropriate starting positions and can be considered to be ‘in 
phase’ with each other. At the sound of the starter’s gun the runners are off.  After 15 seconds, the 
runners are given a signal to turn around and head back to the starting line, running at the same 
speed as they were during the first 15-second interval. After another 15 seconds, the runners return 
to exactly the same starting positions (i.e., they return to their ‘in phase’ positions). This mock race 
is depicted in Figure 1-13: 
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Figure 1-13: Mock foot race of four runners of varying abilities (Runner #4>#3>#2> #1). The runners are “in phase” 
with each other at the start of the race. Fifteen seconds into the race, the runners are given a signal to turn around and 
head back to the starting line. Fifteen seconds later, the runners are back “in phase” with each other at their original 
starting positions.  
 
The mock foot race depicted in Figure 1-13 can be extended to the transverse magnetization vector 
created after a 90° pulse is applied to Mo (i.e., Mz is moved completely into the transverse plane 
leaving only Mxy) in the rotating frame of reference. Following the 90
° pulse, the in-phase Mxy 
magnetization vector begins to precess in the transverse plane. As individual nuclear MDMs within 
the spin ensemble experience small magnetic field differences, some precess faster than others 
resulting in a loss of phase coherence due to T2
* effects. After a time (TE/2), the analogous foot race 
‘turn around!’ signal is given to the dephasing nuclear MDMs in the form of a 180° RF pulse. The 
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RF pulse rotates each nuclear MDM 180° about the x′ axis, effectively reversing the relative 
positions of the nuclear MDMs.  After another TE/2 time period, all of the nuclear MDMs come 
back into phase producing a ‘spin-echo’ signal. The spin-echo signal looks similar to two FIDs back 
to back. At this point, the transverse magnetization vector is only attenuated by the intrinsic T2 
relaxation effects.  The process of spin-echo formation is shown graphically in Figure 1-14 using 
vectors in the rotating frame of reference: 
 
Figure 1-14: Formation of the spin-echo by a sequence of 90° - 180° RF pulses. This experiment was first performed by 
Hahn and colleagues in 1950 (4). 
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1.6 Measurement of Relaxation Times 
Measurement of T1 and T2 relaxation times can be accomplished using several methods. Inversion 
recovery and the Carr-Purcell-Meiboom-Gill pulse sequence for T1 and T2 measurements, 
respectively, are very robust and commonly used methods for relaxation measurements. 
 
1.6.1 T1 Relaxation Measurement Techniques 
Measurement of the T1 relaxation time requires that a series of data is acquired at various time 
intervals and then fitted to a model equation to estimate the T1 relaxation time constant.  The model 
fitting equation can be derived by solving the Bloch equation for the longitudinal (Mz) component of 
magnetization under a particular set of experimental conditions.  For example, recall that the Bloch 
equation describing the T1 relaxation time (Eq. 1.19) is as follows:                                            
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Solving this equation for the case where the Mz magnetization recovers from zero (i.e., immediately 
following a 90o RF pulse) for a system that was initially at the Boltzmann equilibrium yields the 
following expression: 
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where Mz(t) is the magnitude of the longitudinal magnetization at some time, t, following the 
application of the 90o RF pulse, Mo is the Boltzmann equilibrium magnetization, and T1 is the 
longitudinal relaxation time constant. The recovery of the longitudinal magnetization is a first-order 
rate process and thus is well-modeled by an exponential function. Consequently, one way to think of 
T1 is that it is the time required for the longitudinal magnetization to recover 63% of its original 
equilibrium value after perturbation by an RF pulse. A plot of the longitudinal magnetization as a 
function of time under these experimental conditions is shown in Figure 1-15. 
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Figure 1-15: Recovery of longitudinal magnetization after the rotation of Mo into the xy plane by a 90
o RF pulse as 
modeled by Eq. 1.24. The T1 ‘time’ is the time at which longitudinal magnetization recovers to 63% of its original value. 
  
Alternatively, if Eq. 1.19 is solved for the case where the Mz magnetization recovers from -Mo (i.e., 
immediately following a 180o inversion RF pulse) for a system that was initially at the Boltzmann 
equilibrium, then the model equation is slightly different from that in Eq. 1.24.  In this case, an 
additional factor of 2 precedes the exponential term as shown in the following expression: 
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−= .     (1.25) 
A plot of the longitudinal magnetization as a function of time under these experimental conditions is 
shown in Figure 1-16. 
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Figure 1-16: Recovery of longitudinal magnetization after rotation by a 180o RF pulse onto the –z axis as modeled by 
Eq. 1.25. In this case, the 180o RF pulse ‘inverts’ the magnetization; hence the term ‘inversion recovery’.  
 
1.6.2 T2 Relaxation Measurement by Carr-Purcell-Meiboom-Gill Pulse Sequence 
Application of successive 180° RF pulses following a 90°-180° pulse sequence will result in a train 
of spin-echoes whose amplitudes decay exponentially after each 180° RF pulse. The decay rate of 
each individual echo is governed by T2
* effects while the decrease in amplitude of each successive 
echo is governed by intrinsic T2 effects. The echo train depicted in Figure 1-17 was first 
demonstrated by Carr and Purcell in 1954  (5).  
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Figure 1-17: After an initial 90° and 180° RF pulse one spin-echo is formed at time TE after the 90° pulse. Continued 
application of successive 180° pulses, at time intervals equal to TE after the initial 180° pulse, results in a train of spin-
echoes each of which reforms and decays according to the T2
* of the sample. The decrease in amplitude in each 
successive spin-echo is attributable to the intrinsic T2 relaxation and, in some cases, to T2 relaxation combined with 
molecular diffusion effects.  
 
The echo train length in a Carr-Purcell echo train is determined by the T2 of the sample and the 
magnitude of the signal is given by: 
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where G(t) is any magnetic field gradient that affects the nuclear magnetic moments in the sample, D 
is the self-diffusion coefficient of the sample, and τ = TE/2 (as shown in Figure 1-17). To reduce the 
effects of diffusion (more on this topic in Section 2.7), the time τ should be minimized (on the order 
of 500-1000 µsec) to ensure the decaying signal amplitude of each echo in a Carr-Purcell echo train 
is due mostly to the intrinsic T2 relaxation time. 
One disadvantage of the Carr-Purcell sequence is that imperfections in the applied 180° RF 
pulses can give erroneous estimates for the T2 relaxation time.  This issue was addressed by Carr and 
Purcell in 1958, however, a more elegant solution was proposed by Meiboom and Gill in the same 
year (6). By changing the phase of the 180o RF pulse so that the B1 field is oriented along the y-axis 
(1.26) 
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(rather than the x-axis as shown in Figure 1-17), flip-angle errors associated with imperfections in 
the 180o RF pulses are compensated for by the even-order echoes.  Consequently, the Carr-Purcell 
Meiboom-Gill (CPMG) pulse sequence is the preferred method for accurately measuring the 
intrinsic T2 relaxation times.  
 
2.0 Magnetic Resonance Imaging 
2.1 Spatial Localization of a MR Signal 
 To obtain an MR image from biological samples requires encoding of the spatial information into 
the MR signal. Within the plane of the image, spatial encoding in two dimensions is required.  The 
two most common methods of spatially encoding the MR signal are the so-called frequency-
encoding and phase-encoding schemes. Frequency- and phase-encoding in MRI requires the 
application of linear magnetic field gradients across a particular region of interest (or field of view) 
within the sample. The linear magnetic field gradients allow the spatial location of nuclei in the 
sample to be uniquely encoded into the frequency and phase of the measured MRI signal.   
 
2.1.1 Magnetic Field Gradients for MRI 
 The magnetic field gradients used for MR imaging are created by unique sets of copper coils 
mounted on a former within the bore of a (typically) superconducting MRI magnet. MR images can 
be generated in any plane of a 3-D sample by separately controlling currents in each of the X,Y, or Z 
gradient coils. The typical geometries of the gradient coils are shown in Figure 1-18:  
 
 
 
 
 
   
 
Figure 1-18: Typical geometries and orientations of copper conducting bands (or ‘coils’) that, when energized, produce 
linear magnetic field gradients in the X,Y, and Z directions, respectively. Depending on the imaging sequence used, 
electric current in the gradient coils can be (for very short periods of time) as high as 30 Amperes (and higher for echo-
planar imaging applications) in order to create linear gradients with strengths of approximately 10-30 mT/m.   
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The magnetic field gradient produced by each of the gradient coils shown in Figure 1-18 is 
superimposed on the main Bo field to create a magnetic field that varies linearly in strength as a 
function of distance from the center of the magnet. Consequently, in the presence of a magnetic field 
gradient, the nuclei placed within the bore of the magnet will have precessional frequencies that vary 
linearly with respect to their position within the magnet. A ‘steeper’ gradient will allow for a greater 
difference in precessional frequencies for nuclei that are closely spaced; allowing for higher spatial 
resolution in MR images. In addition to encoding spatial information in the phase and frequency of 
the MR signal, RF pulses – applied in concert with magnetic field gradients – can be used to 
selectively excite nuclei within a particular region of the sample. This approach essentially provides 
the 3rd dimension of spatial localization for the MR image (with frequency and phase encoding 
providing spatial localization in the 2-dimensional plane of the image).  “Slice selection” is achieved 
by applying amplitude-modulated RF pulses in conjunction with a linear magnetic field gradient. 
The ‘bandwidth’ (BW) of the RF pulse together with the slope of the gradient determines the 
thickness of the desired MR image ‘slice’. The co-dependency of MR image slice thickness, gradient 
slope, and RF BW is shown in Figure 1-19.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-19: The MR slice thickness can be adjusted by varying the slope (i.e., strength) of the magnetic field gradient 
(blue lines) for a given RF excitation bandwidth (BW).  Adjustment of ωo, the resonant (Larmor) frequency, controls the 
position of the slice.  The slice thicknesses that arise from the two different gradient strengths are given by ∆x1 and ∆x2, 
respectively. Note that slice thickness is also dependent on RF pulse bandwidth (BW).  
x (or y or z) coordinate of slice 
ωo BW 
 gradient slope for slice 1 
∆x1 
∆x2 
 gradient slope for slice 2 
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As can be seen in Figure 1-19, the slice profiles defined by ∆x1 and ∆x2 are rectangular in 
shape.  To excite a rectangular bandwidth in the “frequency domain” requires that the RF pulse be 
amplitude modulated based on the Fourier equivalent in the “time domain” (where the RF pulse is 
generated). In this case, the Fourier transformation can be used to determine the specific functional 
form of the RF amplitude modulation needed to excite the desired bandwidth of frequencies.  
 
2.1.2 The Fourier Transform 
The Fourier transform (FT), named after the French mathematician Jean Baptiste Joseph Fourier 
(1768-1830), is a mathematical operation that transforms a time-domain signal into its equivalent 
frequency-domain representation. Consider a signal in the time domain oscillating at only one 
frequency; the FT of this signal has a peak at that particular frequency. If a time-domain signal 
oscillates at two or more frequencies, the FT of the signal will have peaks at the unique frequencies 
in the signal. The amplitude of the FT peaks provides information about the strength of the time-
domain signal at that particular frequency. Figure 1-20 and 1-21 show examples of the FT of two 
basic time-domain signals (sinusoids). 
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Figure 1-20: Oscillating time domain signal with a period of 25 ms and its corresponding Fourier transform 
(FT). 
 
 
 
 
 
 
 
 
 
 
Figure 1-21: Combination (multiplication) of two oscillating time-domain signals with periods of 10 ms and 100 ms. The 
signal with the dark line is the combined signal for which the FT is shown in the adjacent figure. Note the difference in 
amplitude in the two peaks of the FT and the difference in amplitude of the two time-domain signals (the amplitudes of 
the FT representation are not exact but are qualitative for display purposes). 
 
The FT is used in a wide array of signal processing applications, but, for the purposes of this thesis 
(and for basic MR theory), it is sufficient to look at a limited number of FT properties. The interested 
reader is referred to Oppenheimer and Schafer (7) for a more detailed description of the FT (DFT, 
FFT) and its properties and applications to digital signal processing.  
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2.1.3 Basic Properties of the Fourier Transform 
Consider the function f(t) and its FT F(k). The two functions f(t) and F(k) are referred to as FT pairs. 
The term ‘pair’ is appropriate because the function f(t) can be retrieved from the function F(k) by 
using the inverse FT (IFT). In other words, the IFT undoes the operation of the FT as follows: 
)()))((( tftfFTIFT =  
   
A FT pair that is very important for the understanding of MR image formation is the FT pair that 
relates a rectangular (RECT) function in the time domain to its frequency-domain equivalent, the sin 
x/x (SINC) function as shown in Figure 1-22: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-22: A generalized view of the relationship between a rectangular function in the time-domain and its frequency-
domain counterpart. The time waveform in A) and B) is commonly referred to as a RECT function and the frequency-
domain waveform is referred to as a SINC function. Note that the relationships shown above hold if the RECT function 
is in the frequency domain and if the SINC function is in the time domain. A time-domain SINC function is used in MR 
for rectangular frequency-domain excitation. 
Based on the FT properties discussed above, to excite a rectangular region of frequency space 
requires that a SINC-shaped RF pulse be applied in the time domain together with a linear magnetic 
FT 
f t Time Frequency 
A) 
B) 
IFT 
t Time Frequency f 
(1.27) 
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Time  0  t  
field gradient of the appropriate strength. MR hardware can approximate the SINC function in the 
time domain by using a series of short ‘hard’ or rectangular pulses as shown in Figure 1-23: 
Figure 1-23: Narrow rectangular pulses of varying 
amplitude and polarity can be combined to approximate 
a SINC function in the time-domain. A perfect 
rectangular pulse in the frequency-domain is not possible 
because a SINC pulse in the time domain must be 
truncated to a finite length.  
 
 
 
2.1.4 Slice Select Gradients and the RF Excitation Pulse 
The function of slice-select gradients is to change the Larmor frequency of spins across the sample 
in a position dependent manner as shown in Figure 1-24. Slice-select gradients change the Larmor 
frequency of spins across the sample to allow a RF excitation pulse to transfer energy to one 
particular slice. The slice-select gradient and RF excitation pulse are typically applied 
simultaneously during slice selection. 
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 A) Selection of one slice of a particular thickness in a hypothetical human head. 
 
 
 
 
 
 
 
 
 
  
   
  
 
 
 
 
 
2.1.4.1 Slice Dephasing 
Ideally, after application of a 90° RF excitation pulse, all nuclear MDMs are precessing at the same 
frequency in the transverse plane and are in phase with each other. In the case of a slice selection 
pulse, however, this is not true. As the 90° RF excitation pulse begins to rotate magnetization into 
the transverse plane, the nuclei experience a large magnetic field inhomogeneity from the slice 
selection gradient since it is being applied at the same time.  The result is that the nuclear MDMs 
quickly dephase; significantly reducing the amount of transverse magnetization available for 
subsequent spatial encoding and signal detection. Fortunately, the dephasing effect of the slice-
selection gradient can be reversed by applying an additional magnetic field gradient pulse 
immediately following the 90° RF excitation pulse. In order to rephase all of the nuclei within the 
z1 z2 z3 
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B) Typical pulse sequence diagram for slice selection and excitation. 
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Figure 1-24: A) Schematic of slice-select gradient and RF 
excitation pulse in hypothetical human head. When the RF 
excitation pulse is generated with a center frequency at ω3 ± 
BW/2, the spins within a slice at a particular location along the 
z-axis are excited. B) A pulse-sequence diagram indicating the 
timing of the RF pulse and the slice-select gradient. The need 
for a ‘re-phasing’ gradient is discussed in Section 2.1.4.1.  
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slice, the ‘re-phasing’ gradient must be of opposite polarity and have an area equal to half of that of 
the slice-selection gradient. Figure 1-25 demonstrates the idea of slice dephasing. 
 
  
 
 
 
 
 
 
 
 
 
Figure 1-25: De-phasing within a slice (within a hypothetical human head) during application of a 90° slice-selective RF 
excitation pulse. The dephasing of all nuclear MDMs within the slice can be rephased after the RF excitation by 
application of a re-phasing gradient (Figure 1-26).  
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Figure 1-26: Slice-selection re-phasing gradient used to restore the phase coherence of the transverse magnetization 
following de-phasing due to the slice-selective RF pulse. For complete restoration of phase coherence, the re-phasing 
gradient must have an amplitude-duration product (area under curve) equal to half that of the slice-selective RF 
excitation pulse. Note that the re-phasing gradient can have any shape (not necessarily rectangular) as long as the 
amplitude-duration product is equal to the amplitude-duration product of half of the slice-selective RF pulse. 
 
2.2 Spatial Encoding of the MR Signal 
The MR signal received by the RF coil includes the vector sum of all signals from all voxels within a 
particular FOV. The problem arises then as to how to make the signal from each voxel spatially 
distinct in order to create a two-dimensional image. Considering that all time-domain signals have 
associated amplitude, frequency, and phase, a means of encoding spatial information into some of 
these parameters is needed for MRI.  Since the amplitude of the signal is used to create signal-
intensity contrast between different regions of the image, only the frequency and phase of the MR 
signal are available for spatial encoding.  
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2.2.1 Phase-Encoding 
After slice-selective excitation and re-phasing of nuclei within a particular slice, the phase and 
frequency of the transverse magnetization can then be used to encode the 2-dimensional spatial 
information in the plane of the slice. If a magnetic field gradient is applied for a short period of time 
in a different direction (relative to that of the slice-selection gradient), the nuclei will begin to 
precess at different rates depending on their position along that gradient direction. When the gradient 
is turned off, the nuclei will return to their original precession frequency. However, the relative 
phase between the precessing nuclei will be different, depending upon their relative position along 
the phase-encoding-gradient direction. Consider a hypothetical slice through a human head 
immediately following slice selection perpendicular to the z-gradient direction. The plane of the slice 
is divided into rows and columns which represent individual volume elements (or voxels) within the 
plane of the image. At Time 1 in Figure 1-27, all spins are in-phase and are precessing (or are about 
to precess) at the same frequency. At Time 2, a phase-encoding gradient is applied along the y-axis 
for a finite period of time, producing a phase shift among the nuclei in various voxels, the magnitude 
of which depends upon their relative position along the phase-encoding gradient direction. At Time 
3, immediately after the phase-encoding gradient has been turned off, the spins resume the same 
precessional frequency they had at Time 1, however, the phase imparted to the nuclei by the phase-
encoding gradient is retained and measured during the detection period.   
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Figure 1-27: Phase-encoding of nuclei in a sample based on position along a gradient in the y-direction. A phase-
encoding gradient is applied for a finite time period, causing the nuclei to acquire a phase-shift that is unique to their 
particular position along the magnetic field gradient direction (Time Point 2). At Time Point 3, the phase-encoding 
gradient is turned off, however, the nuclei retain their respective phase shifts acquired during the second time period.  
 
2.2.2 Frequency-Encoding 
Just as the y-gradient was used for phase-encoding in the previous section, the x-gradient can be 
used to spatially encode the remaining dimension of information. The concept of frequency-
encoding is similar to phase-encoding and can be demonstrated again using Figure 1-27. Observation 
of Time Point 2 in Figure 1-27 reveals a difference in spin frequency between rows as a result of the 
brief y-gradient. To make each voxel unique in phase and frequency it is clear that a gradient along 
the x-axis (Figure 1-27) will also change the frequency of precession within each voxel as a function 
of position along the x-gradient axis. For generation of an MR image, the frequency-encoding 
gradient must be 1) applied in a direction perpendicular to the phase-encoding gradient and 2) 
applied in concert with the acquisition (digitization) of the MR signal (the frequency-encode 
gradient is therefore sometimes referred to as the read or readout gradient). To generate a MR 
image, phase- and frequency-encoding can be used together with slice-selective RF pulses in a 
carefully timed manner. The timing of the slice-selective RF pulses and the phase and frequency-
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encoding gradients can be diagrammed using a so-called pulse sequence. The spin-echo pulse 
sequence is described in the next section.    
 
2.3 Spin-Echo MRI  
The MR spin-echo method is one of the most commonly-used methods for generating MR 
images. The RF and gradient pulses needed to create the spin-echo are played out at specific time 
intervals diagrammed by a pulse sequence. The MR signals generated and acquired during the 
execution of the pulse sequence are stored in a 2-dimensional matrix commonly referred to as the k-
space (or time-domain) representation of the raw data.  
 
2.3.1 Spin-Echo MRI Pulse Sequence 
The spin-echo pulse sequence shown in Figure 1-28 represents the timing diagram necessary to 
generate a MR signal that will be stored in one ‘row’ in ‘k-space,’ which is the time-domain 
representation of the image data. Most of the components of Figure 1-28 are those discussed in 
previous sections. The portions of Figure 1-28 that have not been mentioned are 1) the gradient 
representation along the ‘GY’ axis and 2) the positive gradient pulse applied along the x direction 
before the 180° refocusing pulse. The amplitude of the phase-encoding gradient pulse shown along 
the ‘GY’ axis changes each time the pulse sequence is repeated (typically 128 or 256 times for an 
image with 128x128 or 256x256 matrix size, respectively). The positive GX gradient pulse in Figure 
1-28A serves the same function as the re-phasing portion of the slice-selection gradient.  In this case, 
however, the re-phasing gradient compensates for de-phasing that will occur during the subsequent 
acquisition of the signal during the frequency-encoding (i.e., readout) period; when the frequency-
encoding gradient is being applied.  The polarity of the de-phasing gradient is the same as that of the 
frequency-encoding gradient when the de-phasing gradient precedes the 180° refocusing pulse (since 
the 180o pulse effectively reverses the precessional direction of the de-phasing gradient), as shown in 
Figure 1-28A.  If the de-phasing gradient pulse immediately precedes the frequency-encoding period 
(as shown in Figure 1-28B), then its polarity is opposite that of the gradient applied during the 
frequency-encoding period. When the area under the de-phasing gradient pulse is half that of the 
frequency-encoding-gradient pulse, the nuclei will come back into phase (i.e., refocus) resulting in a 
gradient-echo (which is also the same point at which the RF spin-echo is formed). The MR signal 
receiver is turned on at the beginning of the readout-gradient period in order to acquire the entire  
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Figure 1-28: A) Timing diagram of the spin-echo MR pulse sequence.  A slice-selective 90o RF pulse creates transverse 
magnetization within the selected slice.  The amplitude of the phase-encoding gradient (GY in this case) is varied 
incrementally between successive repetition time (TR) intervals as a part of creating a 2-dimensional k-space 
representation of the raw time-domain data (one row at a time).  The second dimension of spatial information in the 
plane of the image is obtained by acquiring the spin-echo signal in the presence of a frequency-encoding gradient.  In A), 
the de-phasing gradient for the frequency-encoding period is applied before the 180° refocusing pulse. Note that the FID 
generated after the slice rephase gradient (GZ) is not measured at that point so as to allow for subsequent phase- and 
frequency-encoding of the measured spin-echo signal.  The time between the middle of the 90o slice-selective RF pulse 
and the apex of the spin-echo signal is referred to as the time to echo or TE time.  EAOS = Equal Area Opposite Sign, 
EA = Equal Area. B) The spin-echo pulse sequence can also be implemented by applying a de-phasing gradient just prior 
to the frequency-encoding period; however, in this case, the polarity must be opposite to that of the readout gradient. 
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echo.  The digitized spin-echo signal for a particular value of the phase-encoding gradient is used to 
fill one row of k-space.  The sequence is then repeated, incrementally varying the amplitude of the 
phase-encoding gradient, until the desired number of k-space rows has been acquired. 
To better understand how the entire k-space acquisition process works; consider the series of 
spin-echo pulse sequences in Figure 1-29. The time between each 90o RF pulse is referred to as the 
repetition time or TR. Each new TR period begins with a 90o RF pulse and the only difference from 
one TR interval to the next is a change in the amplitude of the phase-encoding gradient (e.g., GY in 
Figure 1-29). For the first TR period in the series, the phase-encoding gradient amplitude is typically 
at its most extreme (negative or positive) value.  At the end of the first TR interval, the data acquired 
during the readout-gradient period is stored as the outer-most (in this case ‘bottom’) row or line of k-
space.  During each subsequent TR interval, a new line of k-space is filled which corresponds to the 
particular value of the phase-encoding-gradient amplitude during that interval. This process 
continues until the desired image resolution in the phase-encoding direction has been achieved. For 
example, a spin-echo image with a 256x256 matrix will have 256 different phase-encoding steps 
(requiring 256 TR intervals), with the spin-echo signal being digitized with 256 points during the 
frequency-encoding period of each TR interval. Note in Figure 1-29 that the amplitude of the 
received MR signal increases as the phase-encoding-gradient amplitude decreases. This is because 
the phase-encoding-gradient pulse, just like any other gradient, causes de-phasing of the signal 
(proportional to the area of the pulse) and a concomitant reduction in signal amplitude. The outer 
lines of k-space contain the high-spatial-frequency information (e.g., sharp edges) in the image.  The 
center lines of k-space contain the low-spatial-frequency and signal-intensity information within the 
image (e.g., general shapes in the image (8)).  
 
 
 
 
 
 
 
 
 
 
Basic Principles of MRI    41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RF 
GZ 
GX 
Signal 
GY 
TR 
90° 180° 90° 180° 90° 180° 90° 180° 90° 180° 
Figure 1-29: Spin-echo MRI pulse sequence and placement of raw-data into k-space as a function of the phase-encoding-
gradient amplitude. Each line (row) of k-space corresponds to a particular value of the phase-encoding-gradient amplitude 
during the respective TR interval. Large phase-encoding-gradient amplitudes result in progressively smaller MR signals 
due to the increased de-phasing of the transverse magnetization during the phase-encoding period. Consequently, the center 
lines of k-space, where the phase-encoding-gradient is low, contain the low-spatial-frequency and signal-intensity 
information in the image whereas the high-spatial-frequency information is contained in the outer lines of k-space.   
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The MR data acquired in k-space are the 2-dimensional time-domain representation of the 
data.  The k-space data are then converted into the spatial (i.e., frequency) domain via a 2-
dimensional Fourier transformation in order to create the MR image.  The k-space data acquired in a 
typical MRI experiment can be represented as shown Figure 1-30. Raw data acquired during each 
step of the phase-encoding process (e.g., during the acquisition/readout period of a TR interval) 
comprise a row of complex data points from the digitized spin-echo signal.  The real (‘Re’) and 
(‘Im’) part of each complex data point arise from the fact that the signal is measured in quadrature; 
using two channels that are 90o out of phase with each other.  
 
 
 
 
 
 
 
 
 
 
Figure 1-30: Raw MR data storage format typically used during the acquisition of 2-dimensional k-space data for a 
128X128 image.  Each data point is acquired using quadrature detection (i.e., two receiver channels that are 90o out of 
phase with each other) and stored as a complex (real and imaginary) pair.  A complex 2-dimensional Fourier transform is 
then used to convert the k-space data into the spatial (i.e., frequency) domain.  
 
Following a complex 2-dimensional Fourier transformation, each point in the MR image is still 
represented as a complex pair.  However, for display purposes, the real and imaginary parts of the 
data are separated and only the real part is used for image display.  
 
2.4 The Gradient-Echo and Gradient-Echo (GRE) MRI 
The gradient-echo (GRE) method is frequently used for MRI applications that require fast 
imaging times. Formation of a GRE has already been discussed to some extent (e.g., in the context 
of Figure 1-28B), but will be revisited here for clarity.  Consider Figure 1-31, where an echo is 
shown forming after de-phasing and re-phasing of nuclei using a magnetic field gradient. Note that 
the echo is formed at the point where the duration-amplitude product (area) of the de-phasing 
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gradient pulse is equal to the duration-amplitude product (area) of the first half of the readout (or, in 
this case, re-phasing) gradient pulse.  
 
 
 
 
 
  
 
 
 
Figure 1-31: Formation of a gradient echo (GRE) by reversing the gradient polarity. A GRE is formed when the 
duration-amplitude product of the de-phasing gradient is equal to the duration-amplitude product of the first half of the 
readout gradient pulse. 
 
Since the GRE imaging pulse sequence does not use a 180° RF pulse to refocus transverse 
magnetization, the echo time (i.e., TE) of the imaging sequence can be significantly reduced. To 
further minimize the TE time, the re-phasing gradient pulses for both slice-selection and frequency-
encoding can be applied simultaneously in the phase-encoding-gradient period. To reduce the 
imaging time by decreasing the repetition time (TR), the RF pulses used for GRE imaging typically 
do not rotate longitudinal magnetization completely into the transverse plane (i.e., the flip angle – α 
in Figure 1.32 – is generally much less than 90o). As a result, a substantial fraction of the 
longitudinal magnetization remains along the z-axis.  In this case, the longitudinal magnetization 
does not require as much time to recover to the Boltzmann equilibrium (relative to a 90o RF pulse) 
and successive applications of the reduced-tip-angle pulse can be applied more frequently. 
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Figure 1-32: The flip angle ‘α’ of the RF pulse in a GRE imaging pulse sequence is usually less than 90° to allow for 
significant magnetization to be available following each repetition time (TR) interval.  
 
Selection of the optimal flip angle for a GRE excitation pulse is commonly based on the ratio 
of the repetition time (TR) to the T1 relaxation time.  The flip angle that maximizes the MR signal 
[for sequences that do not establish a steady-state transverse magnetization (9)] is given the Ernst-
angle, αE, equation: 
1)cos( T
TR
E e
−
=α . 
 
A typical pulse sequence for GRE imaging is shown in Figure 1-33. Note that the re-phasing 
gradient pulses for both slice-selection and frequency-encoding are applied simultaneously in the 
phase-encoding-gradient period.  This is possible since each gradient has a separate effect on the 
transverse magnetization which can be distinguished from those of the other gradients.  Although 
these spatial-encoding gradients could also be applied sequentially, the TE time would be increased 
unnecessarily. 
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Figure 1-33: Gradient-echo (GRE) MRI pulse sequence. The flip angle, α, of the slice-selective RF pulse is typically less 
than 90o so that the residual longitudinal magnetization can recover to the Boltzmann equilibrium in a shorter period of 
time.  As a result, the repetition time (TR) can be shortened, significantly reducing the total imaging time.  
 
2.5 Image Contrast Based on Tissue T1 and T2 Relaxation Times 
Most tissue contrast in MR images is derived from differences in tissue proton density 
(N(H)) and the T1 and T2 relaxation times. MR images with tissue contrast (i.e., signal-intensity 
differences) based on relative differences in N(H), T1, or T2 are referred to as N(H)-weighted, T1-
weighted, or T2-weighted images, respectively. For spin-echo MRI, the signal intensity in a voxel, 
S(TE, TR) in Eq. 1.32, is dependent on the user-adjustable MRI parameters TE and TR as well as 
tissue N(H), T1 and T2 (10):  
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T1- and T2-weighted spin-echo imaging is commonly used for neurological applications in the brain 
due to the large differences among T1 and T2 relaxation times between tissues. For example, the T1 
value of white matter, gray matter and cerebrospinal fluid (CSF) in the brain is ~780 ms, ~920 ms, 
and ~4000 ms, respectively, at 1.5T (11,12). The significant difference in T1 relaxation times 
between brain white and gray matter makes it possible to differentiate between these tissues in a T1-
weighted MR image. Consider the T1 recovery curves in Figure 1-34. To optimize the T1-weighted 
MRI contrast between the two tissues, a TR value is chosen that maximizes the signal-intensity 
difference between the two curves. For the case shown in Figure 1-34 the optimal TR time is 850 ms 
based on the TR that coincides with the apex of the signal-intensity difference curve. The optimal 
TR, in this case, is also equal to the average of the tissue T1 values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-34: T1 recovery for white and gray matter in the human brain and difference in signal intensity between white 
matter and gray matter as a function of TR. To produce the highest contrast between white and gray matter in a MR 
image, a TR is chosen that maximizes the signal intensity difference between the two tissues. In this case, the TR that 
maximizes the signal intensity difference  between white and gray matter is also equal to the average value of the tissue 
T1 values (850 ms). 
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For a visual example, consider the images of human brain in Figure 1-35. In this case the TR values 
were varied from 400 ms (leftmost image) to 6000 ms (rightmost image) while the TE value was 
held constant at 20 ms. Contrast between white and gray matter is evident at TR/TE = 800/20 ms. At 
TR/TE = 6000/20 ms the white/gray matter contrast appears reversed compared to the white/gray 
matter contrast at TR/TE = 800/20 ms. MR images of brain acquired at TR/TE = 800/20 ms (and 
400/20 ms) are primarily T1-weighted and at TR/TE = 6000/20 ms MR images are primarily N(H)-
weighted. 
 
 
 
 
Figure 1-35: Series of adult human brain images to demonstrate changes in contrast between white and gray matter (and 
CSF) as TR is changed (TE constant at 20 ms). The leftmost image (TR/TE = 400/20 ms) is primarily T1-weighted while 
the rightmost image (TR/TE = 6000/20 ms) is primarily N(H)-weighted. In T1-weighted adult human brain images white 
matter appears white (or relatively bright) and gray matter appears gray (or relatively dark). There is considerable 
contrast between white and gray matter (as well as CSF) in the rightmost image due to differences in proton density 
between the two tissue brain tissues as well as CSF. Images here were acquired using a 1.5T clinical scanner and have 
resolution of approximately 940 µm. 
 
To acquire T2-weighted spin-echo images, it is important to use long TR values to minimize the 
effect of T1-weighting on the image. For example, notice that as the TR value approaches a value on 
the order of 5T1, the “T1 factor” term in Eq. 1.32 approaches one. In that case, the MR signal 
intensity within each voxel will depend primarily on the N(H) and T2 relaxation time of the tissue as 
well as the TE value used in the spin-echo MRI pulse sequence as:  
    
      .  
TR/TE = 400/20 ms 
(1.33) 
TR/TE = 800/20 ms TR/TE = 1600/20 ms TR/TE = 6000/20 ms 
white 
matter 
gray 
matter 
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Inspection of Eq. 1.33 also reveals that a N(H)-weighted spin-echo MR can be acquired by 
maximizing TR (~4-5T1) and minimizing  the TE value (e.g., 5-10 ms); the right-most image in 
Figure 1-35 being a good example. 
For T2-weighted spin-echo MRI, TE is typically long (on the order of 80-100 ms). The T2-
relaxation-time values for white matter, gray matter and cerebrospinal fluid (CSF) in the human 
brain are 67, 77, and 180 ms, respectively.  The N(H) values are 0.61, 0.69 and 1.00, respectively 
(11), normalized relative to CSF, which has the maximum value. By minimizing T1-relaxation-time 
effects (i.e., using Eq. 1.33), the MRI signal-intensity-decay curves, as a function of the TE value, 
are as shown in Figure 1-36. 
As with T1-relaxation-time recovery curves, the T2-relaxation-time decay curves indicates 
that for optimal contrast between tissues based on differences in the T2 relaxation times, a TE value 
is chosen that maximizes the MRI signal-intensity differences between the respective tissues and/or 
CSF.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-36: T2 decay curves for cerebral spinal fluid (CSF), and white and gray matter in the human brain. The long T2 
relaxation time of CSF, relative to those of white and gray matter, results in higher CSF signal intensity relative to white 
and gray matter on T2-weighted brain MR images. The optimal TE time to maximize contrast between white and gray 
matter and CSF is the TE time that maximizes the signal intensity difference between white matter  and gray matter and 
CSF (~51 ms and ~65 ms respectively as indicated on the graph). In this case the TE times that maximize contrast 
Signal intensity difference curve for:  
CSF and white matter 
CSF and gray matter 
max 
max 
~ avg T2 
value of CSF and  
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between white and gray matter and CSF do not coincide with the average T2 value (~125 ms) of CSF and white (or gray) 
matter.  
 
For a visual example, consider the human brain images in Figure 1-37. Here, the TE values 
were varied from 50 ms to 200 ms while TR was held constant at 3000 ms. In Figure 1-37 the 
change in contrast between white (and gray) matter and CSF is apparent as TE increases. As TE 
increases signal from CSF is stronger relative to surrounding brain matter as predicted by the T2 
decay curves in Fig. 1-36. 
 
 
 
Figure 1-37: Series of adult human brain images to demonstrate changes in contrast between CSF and white and gray 
matter as TE is changed (TR constant at 3000 ms). The leftmost image (TR/TE = 3000/50 ms) is primarily proton-
density-weighted while the rightmost image (TR/TE = 3000/200 ms) is primarily T2-weighted. Note the sharp decline in 
white and gray matter signal intensity as TE becomes longer as predicted by T2 decay curves in Fig. 1-36. CSF signal 
intensity remains strong relative to white and gray matter providing excellent contrast between CSF and brain tissue at 
TE = 100-200ms.  Images here were acquired using a 1.5T clinical scanner and have resolution of approximately 940 
µm.  
 
2.6 Multi-Slice Spin-Echo MRI 
 Consider a spin-echo MRI pulse sequence with TR/TE of 250/11 milliseconds and a desired 
matrix size of 256x256. The time needed to acquire such an image (assuming no averaging of slice 
data) is 250 ms * 256 = 128 seconds (1 minutes and 4 seconds). If it was desired to acquire 8 slices 
at different positions (for example, through the human brain), and each slice was acquired 
sequentially, then the imaging time increases by a factor of 8 to 512 seconds (8  minutes 32 
seconds). As an alternative, the imaging time can be reduced significantly using a multi-slice, spin-
echo MRI pulse sequence, where additional slices are obtain at other positions within the brain 
TR/TE = 3000/50 ms TR/TE = 3000/100 
ms 
TR/TE = 3000/150 
ms 
TR/TE = 3000/200 
ms 
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during the residual portion of the TR interval following the acquisition of the first slice. Consider the 
timing diagram of the spin-echo MRI pulse shown in Figure 1-38.  If the TE value and the data 
acquisition period are such that the first slice is acquired in 50 ms, then the residual time left in the 
TR interval is 200 ms before the 90o RF pulse is applied again at the same slice position (for 
example, to acquire the next line of k-space for that slice). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-38: Timing diagram for a spin-echo MRI pulse sequence showing the time needed to acquire a single slice and 
the residual time in the TR interval before the 90o RF pulse is applied again at the same slice position (for example, to 
acquire the next line of k-space for that slice). 
 
During the residual 200 ms in the TR interval shown in Figure 1-38, several other slices (up to four) 
at different slice positions could be excited. Usually, all slices in a multi-slice scan have the same 
thickness requiring the same RF excitation bandwidth and the same slice-select gradient. Therefore, 
for a multi-slice spin-echo imaging pulse sequence, the RF excitation pulses that select the other 
slices must have a different center frequency with respect to each other. Figure 1-38 can now be 
redrawn (Figure 1-39) to include four additional 90° RF excitation pulses during the residual TR 
period. The center frequency of each 90° RF excitation pulse is usually chosen to provide an 
interleaved acquisition of the slices (e.g., a slice order of 1, 3, 5, 2, and 4 in this case). This 
interleaved scheme reduces “cross-talk” between adjacent slices. 
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Figure 1-39: One repetition time (TR) interval of a multi-slice spin-echo MRI pulse sequence (the time to acquire a 
single slice is 50 ms and TR – 250 ms). By acquiring five slices within one TR period, the total imaging time is reduced 
by a factor of five.  The slice positions are determined by the respective center frequencies, ‘CF’, of the corresponding 
RF excitation pulses. 
 
2.7 Echo-Planar Imaging 
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In 1977, Sir Peter Mansfield recognized that k-space could be filled completely following a single 
RF excitation (13), eliminating the need to fill k-space one line at a time (or one line per TR period). 
Using the echo-planar imaging (EPI) technique, images could potentially be acquired in 30 to 100 
ms (14). Unfortunately, however, the MRI hardware required to implement the pulse sequence was 
not available at the time and it took a number of years before EPI became a practical reality.  By 
1991, Stehling et al. (14) reported various uses for EPI such as flow imaging, water diffusion 
imaging, brain imaging, and functional brain imaging.   
 
2.7.1 Echo-Planar Imaging Methods for Traversing k-space 
To traverse k-space in a “single shot,” EPI employs a number of data acquisition strategies 
that differ from the trajectory path employed by more conventional MRI methods (e.g., spin-echo or 
GRE MRI).  
 
Gradient-echo EPI (GRE EPI) 
Figure 1-40 compares the conventional k-space trajectory with that of the GRE EPI 
implementation.  The k-space trajectory for a conventional MRI pulse sequence is shown in Figure 
1-40a. For each line of k-space, following the RF excitation pulse, a single echo is acquired at a 
particular value of the phase-encoding-gradient amplitude.  During the intervening TR interval, the 
phase-encoding-gradient amplitude is incremented, and then the next line of k-space is acquired.  In 
the case of GRE EPI, however, following the acquisition of the first echo, the phase-encoding-
gradient amplitude is incremented and then a second echo (i.e., line of k-space) is acquired in the 
same “TR” interval.  This process is then repeated until all of the lines of k-space are acquired 
during a single data acquisition interval. After the initial RF excitation pulse, the GRE EPI pulse 
sequence forms a “train” of gradient echoes by rapidly switching the polarity of the readout gradient 
and digitizing the signal at the same time. During the switching time between each echo acquisition, 
a “blipped” phase-encoding gradient is applied to advance to the next line of k-space (Figure 1-40b).  
The entire k-space dataset can typically be acquired in 30-100ms (15). The GRE EPI pulse sequence 
used to traverse k-space as shown in Figure 1-40b is shown in Figure 1-41. 
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Figure 1-40: A) Conventional 2D-FT MRI k-space trajectory; acquisition of each line of k-space requires a separate RF 
excitation and TR period. B) GRE EPI k-space trajectory; following a single RF excitation, all lines of k-space are 
acquired in a “single shot.” 
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Figure 1-41: GRE EPI MRI pulse sequence. The echo time (TE) for the sequence occurs at a time when the duration-
time product of the positive-going “blipped” phase-encoding–gradient pulses (GY) is equal to the duration-time product 
of the initial GY de-phasing gradient pulse. The successive accumulation of gradient duration-time product by positive-
going GY pulses is represented by the first four positive-going GY pulses. All of k-space is filled before complete signal 
dephasing due to T2
* effects (~30-100ms).  
 
Spin-echo EPI (SE EPI) 
The spin-echo EPI MRI pulse sequence is essentially the same as the GRE EPI method except that a 
180° RF refocusing pulse applied at a time TE/2 after the initial 90° RF excitation pulse. Phase and 
frequency-encoding is SE EPI, as shown in Figure 1-42, is the same as for GRE EPI.  
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Figure 1-42: SE EPI MRI pulse sequence. As is the case for GRE EPI, the echo time (TE) for the gradient echoes formed 
in the sequence occurs at a time when the duration-time product of the positive-going “blipped” phase-encoding-gradient 
pulses (GY) is equal to the duration-time product of the initial GY de-phasing gradient pulse. For SE EPI, the RF spin-
echo produced by refocused magnetization (at time TE/2 after the 180° refocusing pulse) occurs at the same TE time as 
for the gradient echos. The successive accumulation of gradient duration-time product by positive-going GY pulses is 
represented by the first four positive-going GY pulses. All of k-space is filled before complete signal dephasing due to 
T2/T2
* effects (~30-100ms). The blipped phase-encoding scheme results in the k-space trajectory shown in Figure 1-40b. 
 
 
 
2.8 Diffusion-Weighted Imaging 
Diffusion-weighted imaging (DWI) is used extensively in clinical and animal studies. For brain 
imaging, DWI is sensitive to changes in brain water content and mobility. DWI finds clinical 
application in imaging tissue pathologies such as inflammation, edema, cell swelling, cell necrosis, 
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membrane damage, demyelination, axonal loss, and gliosis (16). A brief explanation of water 
diffusion theory is provided before discussing DWI in detail. 
2.8.1 Diffusion of Water 
All fluids have an associated diffusion constant D which provides a quantitative description of how 
the molecules within the fluid move among themselves. The movement of molecules within a fluid 
is governed by random thermal agitation and is generally referred to as Brownian motion (after 
Robert Brown of Scotland, 1827). The movement of fluid molecules within heterogeneous media, 
such as cells with the brain is less random due to the presence of physical boundaries that interfere 
with the translation of the molecules. For molecules in the bulk phase, the average displacement of 
the molecules as a function of time can be represented by a Gaussian probability distribution: 
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For the case of diffusion with no preferential direction, diffusion is said to be isotropic. For 
molecular diffusion in media with restricting boundaries, diffusion can be anisotropic. In anisotropic 
diffusion, a diffusion tensor is used to represent the degree of diffusion of molecules in nine different 
directions as follows:  
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where Dxx, Dyy, and Dzz represent the diffusion constants along the reference frame axes. The 
diffusion tensor is symmetric since Dij = Dji and, therefore, the tensor can be accurately represented 
by the six elements: Dxx, Dyy, Dzz, Dxy, Dxz, Dyz. In MR the net displacement of diffusing 
molecules is a variable of interest. Equation 1.34 only tells us the probability of finding a molecule 
at position X after a time t. Another means to characterize the net displacement of diffusing 
molecules is via the Einstein equation:  
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where n = # dimensions, t = time allowed for diffusion to occur and <(r-r’)2> is defined as the square 
of the net distance traveled by a molecule undergoing random diffusion as shown in Figure 1-43: 
(1.34) 
(1.35) 
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Figure 1-43: Random walk of a molecule undergoing random diffusion. The molecule accumulates a net displacement, r-
r’, over time. 
 
 
2.8.2 Stejskal-Tanner Diffusion-Weighted Pulse Sequence 
MR can be used to measure the displacement of diffusing water molecules by application of 
a pair of magnetic field gradients surrounding the 180° RF refocusing pulse of a spin-echo imaging 
pulse sequence. This technique developed by Stejskal and Tanner in 1965 (17) is referred to as the 
‘pulsed magnetic field gradient’ (PFG) technique. A typical Stejskal-Tanner PFG diffusion-weighted 
spin-echo MRI pulse sequence is shown in Figure 1-44. 
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Figure 1-44: Stejskal-Tanner PFG diffusion-weighted spin-echo MRI pulse sequence. The amplitude of the spin-echo is 
determined by the separation (∆), duration (δ), and amplitude (g) of the diffusion-sensitive gradient pulses (GD). The 
diffusion time tD is determined by ∆ and δ as tD = ∆ - δ/3 (16). 
 
The first of the diffusion-sensitive-gradient pulses (GD) in the Stejskal-Tanner pulse sequence 
is designed to de-phase nuclear magnetization prior to the 180o refocusing pulse (which in turn 
inverts the phase of the nuclei). For molecules that are not moving (i.e., not diffusing), the second 
diffusion-sensitive-gradient pulse (which has an area identical to the first) completely removes the 
phase shifts imparted by the first diffusion-sensitive gradient pulses. Consequently, there is no loss 
of phase coherence for static molecules and the associated MR signal intensity is unaffected.  For 
moving (i.e., diffusing) molecules, however, the second diffusion-sensitive-gradient pulse does not 
completely remove the phase shifts encoded by the first diffusion-sensitive-gradient pulse.  This is 
because of the spatial displacement of the diffusing molecules to a different location along the 
direction of the applied magnetic field gradient. Consequently, the transverse magnetization from the 
nuclei in diffusing molecules will experience a loss of phase coherence and a concomitant reduction 
in the MR signal intensity. The magnitude of the MR signal reduction will be directly proportional to 
the area of the diffusion-sensitive-gradient pulses, the diffusion time, and the magnitude of the 
diffusion coefficient.  For molecules in regions of restricted diffusion (e.g., brain white and gray 
matter), the signal intensity in a diffusion-weighted MRI (DWI) will be higher than for molecules in 
regions with relatively free diffusion (e.g., CSF). Using the Stejskal-Tanner pulse sequence, the 
degree to which the DWI signal intensity is attenuated (i.e., the degree of diffusion-weighting) 
depends on the factors ∆, δ, g, and D as follows: 
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The ‘b-value’ shown in Eq. 1.36 is the parameter that determines the amount of diffusion weighting 
applied to a DWI. The b value has units of seconds/mm2 and typically range from 20 s/mm2 (low 
diffusion weighting) to 1500 s/mm2 (high diffusion weighting).   
 
2.8.3 Quantification of Diffusion-Weighted Images: The ADC Map 
(1.36) 
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To quantify diffusion in vivo using DWI requires the acquisition of at least two images; one with 
little or no diffusion-weighting (i.e., b = 0 or close to 0) and one with relatively high diffusion-
weighting (e.g., b on order of 1400 s/mm2). The Stejskal-Tanner formula can then be used to solve 
for the diffusion coefficient based on the two images as follows (16): 
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For molecular diffusion in biological systems that contain restricting barriers (e.g., cell membranes), 
the value for D, as shown in Eq. 1.37, is often referred to as the apparent diffusion coefficient 
(ADC).  In this case, the ADC value is reduced compared to that of molecular diffusion in the bulk 
phase and its value often depends on the amount of time that the molecules are allowed to diffuse 
(i.e., the diffusion time). The ADC can be calculated using Eq. 1.37 by plotting the left hand of the 
equation as a function of b-value (as shown in Figure 1-45).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1-45: Calculation of the ADC by linear fitting of the natural log of the signal intensities from two (or more) DWIs 
(asterisks) as a function of b value.  The ADC value is calculated from the slope of the line. 
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2.1 Blood-Brain Barrier (BBB) Background 
 
The concept of a blood-brain barrier (BBB) was conceived in the early 1900s with 
experiments performed by Lewandowsky, Ehrlich, and Goldmann. Lewandowsky noticed during his 
experiments that the stain Prussian blue did not pass from the brain blood vessels into the brain (1). 
Ehrlich performed similar experiments using the stain Trypan Blue and found that while the whole 
body became stained with the dye, the brain was always an exception. Goldmann’s experiments with 
Trypan Blue infusion into the cerebral spinal fluid allowed him to conclude that there was some 
form of barrier separating nervous tissue from brain tissue  (1). Early investigators were therefore 
focused on determining the structure and function of the barriers separating blood, brain tissue and 
cerebrospinal fluid (CSF). 
The modern concept of the BBB was not conceived until 1965 by Crone et al. (2). The BBB 
was found to be capable of regulating the active transport of substances into the brain at a time when 
it was generally accepted that substances crossed the BBB only by passive diffusion. Then, in 1967, 
in an attempt to better understand the anatomy of the BBB, Reese and Karnovsky  (3) determined 
that the BBB consisted of endothelial cells that lined the cerebral vasculature. By 1976, it was 
apparent that the function of the BBB was to regulate the interfaces between blood and the nervous 
system (4). Methods to quantify the permeability of the BBB were established in 1963 by Crone (5) 
and in 1978 by Ohno et al.(6). 
Experimental osmotic disruption of the BBB was first performed in the 1940s (7) and was 
quantified using Evans Blue dye by Rapoport in 1972 (8). Damage to the BBB can result from 
various insults such as trauma, oxygen deprivation, autoimmune disorders, brain tumor, 
hypertension, and excessive osmotic infusions (meant to transiently open the BBB). Osmotic BBB 
disruption in particular has also been shown to result in significant brain edema and long-term brain 
damage in animals. Magnetic resonance imaging (MRI) technology, aided by advances in MR 
contrast-agent design, has advanced our understanding of the function of the BBB and the effects of 
pathologies on the BBB. 
 
2.2 Anatomy of the BBB 
 
The role of the BBB is to separate the brain from the systemic blood circulation. The BBB 
selectively excludes certain blood constituents from being transported into the brain and maintains 
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the homeostasis of the central nervous system. Brain capillaries, therefore, must have the means to 
allow certain substances into the brain while excluding others. In the early days of BBB research, the 
capillaries of the brain were not thought to be different in structure to the capillaries of the 
musculoskeletal system. Scientists, therefore, were curious as to why Trypan Blue dye failed to stain 
the animal brain once injected intra-arterial. Arguments were made leading to a hypothesis that the 
Trypan Blue dye simply had nowhere to go into the brain due to an extremely small extracellular 
brain space (9). Ironically, this idea had already been disproved by Goldmann (10). Goldmann’s 
second experiment included an injection of Trypan Blue into the CSF – which resulted in complete 
staining of the brain – suggesting that there was indeed sufficient extracellular volume to 
accommodate the diffusing Trypan Blue dye stain to diffuse into. Unfortunately, it was not until 
1967 that researchers identified the true anatomical basis of the BBB as being the ultrastructure of 
the brain-capillary endothelium (3). In addition to brain-capillary endothelial cells, the BBB is 
comprised of astroglia, perivascular macrophages, pericytes, and a basal lamina (11). An artist’s 
view of the capillary is provided in Figure 2-1.  
 
Figure 2-1: Artist’s representation of a brain blood vessel and the surrounding endothelium, astrocyte, pericyte and 
neuron. A tight junction is also shown (black bar). From http://bloodbrainbarrier.med.ucla.edu. 
 
2.2.1 Brain Capillary Epithelium 
Tight Junctions  
Capillaries of the brain vasculature are lined with endothelial cells that are closely packed 
together and are apparently linked by ‘tight junctions.’ With the use of electron microscopy, the tight 
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junctions of endothelial cells came to be classified as zonula occludens  (1). Other types of contact or 
junctions between cells exist such as macula adherens, and zonula adherens. In the adherens-type 
junction, cells remain separated by approximately 200 Å and are held together by electron-dense 
material (1). From Figure 2-2, the function of the tight junctions becomes clear; prevention of certain 
solutes from entry into the brain. A close-up view of a tight junction is provided in Figure 2-3. The 
permeability or ‘leakiness’ of the BBB to ions is believed to be a function of the number of ‘tight-
junction elements’ that exist within an endothelial-cell tight junction (1). The electrical resistance 
across a tight junction (in Ohm/cm2) is a function of the number of tight-junction elements (12) and 
reflects the strength of the barrier to passage of ions from blood to brain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2: Tight junction (arrows) between two endothelial cells (E) prevent electron-dense lanthanum (dark areas in 
vessel lumen) from penetrating into brain (http://www.ohsu.edu/bbb/forprof_program.html). 
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Figure 2-3: Close-up view of the tight junction between two endothelial cells. The number of tight-junction elements 
within the tight junction determines the electrical resistance of the tight junction to ions. 
 
Pits and Vesicles 
Small semi-circular-shaped invaginations (vesicles), with a diameter of approximately 50-
100 nm, line the inner (or luminal) membrane (opposite to the basement membrane); with muscle-
capillary-endothelial cells containing fewer vesicles than cerebral-capillary-endothelial cells. The 
vesicles can move further into the endothelial membrane to become pits (9) and a chain of pits can 
form a tubule. It is believed that within tubules, solutes can be transferred from vesicle to vesicle, 
thus allowing certain solutes from the blood to be ‘carried through’ the endothelial cell membrane as 
summarized in Figure 2-4. 
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Figure 2-4: Solute transport across the BBB.  Vesicles move from the lumen membrane into the endothelial cell to form 
pits; which combine with existing pits to form a chain or tubule.  Part or all of the vesicle contents are shared (or 
transferred) between pits in the tubule until the solute reaches the brain  (13). 
 
2.3 Techniques to Determine BBB Permeability 
 
By its nature, the BBB has limited permeability to substances in the blood. As previously 
discussed, the endothelial cells that line the cerebral capillaries are responsible for BBB function and 
integrity. Since the discovery of the anatomical nature of the BBB, researchers have been improving 
upon methods for quantifying the permeability of the BBB. The commonly available techniques for 
measuring the permeability of the brain include (but are not limited to) the IV administration 
technique, the brain-perfusion technique, the indicator-diffusion technique, the brain-uptake-index 
(BUI) technique, or the single-injection external-registration technique (9). For purposes of this 
dissertation, discussion will be limited to the brain-perfusion technique.     
 
2.3.1 Quantification of BBB Permeability Using the Brain-Perfusion Technique 
With the brain-perfusion technique of Takasato et al. (14), one brain hemisphere of an 
anesthetized animal is perfused by retrograde infusion of a particular fluid into the common (or 
external) carotid artery. The uptake into the brain of the perfusate can then be observed after 
sacrificing the animal and removing the brain. A diagram for the brain-perfusion technique is shown 
in Figure 2-5. The perfusion rate is such that blood flow to the right hemisphere is minimized and 
perfusion pressure does not rise significantly above normal blood pressure of the animal. The brain-
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perfusion technique allows close scrutiny of the composition of fluid entering the brain. Osmolality, 
pH, protein concentrations and ionic content of the perfusate can be varied over a wider range versus 
perfusate administered systemically. Disadvantages of the brain-perfusion technique include 
perfusion of one hemisphere only and possible brain hypoxia due to low blood flow to the perfused 
hemisphere for the typical 30-120 second infusion. 
 
Figure 2-5: Brain-Perfusion Technique of Takasato et al. (14). For this technique, the external carotid artery is typically 
severed leaving a small ‘stump’ for insertion of tubing that will deliver fluid to the brain. The stump of the external 
carotid artery is then permanently ligated. The tubing is inserted into the internal carotid artery to ensure flow of fluid 
directly to the brain. The pterygopalatine artery is permanently ligated to prevent leakage of fluid through this route. The 
common carotid artery is left open until immediately before the infusion. A temporary clamp can be placed appropriately 
on the carotid artery to ensure delivery of perfusion fluid to the brain and not towards the heart. Also, temporary 
clamping of the carotid – instead of permanent ligation – helps to maintain the physiological state of the animal. ACA, 
anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery. Reproduced from Ref. (14). 
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2.3.2 A Semi-Quantitative Measure of BBB Permeability Using Evans Blue (EB) Dye 
 
Evans Blue (EB) dye has been used extensively in animals as a marker for BBB integrity 
(15-21). The dye in pure form [MW = 960.82 Daltons (Da)] is known to remain within the cerebral 
vasculature; unable to penetrate the healthy BBB. Evans Blue dye binds to serum albumin in blood 
after approximately five minutes. Wolman et al. (22) used electrophoretic-pattern analysis of free 
EB, cat plasma, and EB in a sample of cat plasma to determine the temporal dynamics of EB binding 
to serum albumin. After binding to serum albumin, the EB-albumin complex has a molecular weight 
of ~68 KDa. The chemical formula, name, and structure for EB dye are provided in Figure 2-6.  
 
 
   
 
 
 
  
 
 
 
 
 
Figure 2-6: A) The empirical chemical formula and name for Evans Blue dye. B) Chemical Structure for Evans Blue 
dye. 
 
Quantifying the permeability of the BBB using EB staining can be complicated by the fact 
that EB binds to serum albumin after five minutes within blood. If EB is infused into an animal with 
an experimentally or pathologically disrupted BBB, the degree of BBB disruption depends on when 
the animal was sacrificed relative to the time of EB infusion. For example, an animal that is 
sacrificed less than five minutes after i.v. infusion of EB will show EB staining in the brain that is 
indicative of BBB permeability to molecules of size 970 Da or less. Consequently, experimental use 
of EB as a marker for BBB permeability requires careful timing of EB infusion relative to animal 
sacrifice.  
 
 
A) C34H24N6O14S4Na4 
tetrasodium 6,6'-((3,3'-dimethyl-(1,1'-biphenyl-
4,4'diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-
naphthalenedisulphonate) 
 
B)  
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Evans Blue Solution Preparation 
 
Evans Blue typically comes in powdered form (and is a known carcinogen). Most animal 
studies using EB as a marker for BBB integrity use a dose of 2ml/kg of 2% (2 g EB in 100 ml saline) 
EB. The powder dissolves readily in saline and the solution is tolerated well by the animal.  
 
EB Staining Histology 
Prior to removing the brain for histological examination, many studies suggest perfusing the 
animal by removing the blood via a controlled infusion of physiologically buffered saline into the 
heart until a colorless liquid prevails.  This procedure prevents the vascular EB from staining the 
brain during the removal process. If perfusion of the animal is not possible, an infusion of EB into 
one hemisphere (using other hemisphere as control) may suffice to control for EB staining in brain 
by vascularized EB at time of sacrifice. Evans Blue staining of the brain is typically graded on a 
scale of 0-3 or 4 where 0 is no staining visible to the naked eye, and 3 or 4 is a deep blue staining.  
 
2.4 Hyperosmotic Disruption of the BBB 
Transport of certain molecules across the BBB is accomplished by transcellular diffusion (of 
lipophilic substances) and several transport mechanisms are shown in Figure 2-7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-7: Various transport routes across the BBB. Taken from Ref.  (23). 
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The most important factors that determine delivery of a substance from the blood into the brain are 
lipid solubility (expressed as the octanol/water partition coefficient), molecular mass, and charge 
(23). Certain substances – such as chemotherapeutic drugs – do not have the necessary 
characteristics for transport across the BBB. Therefore, another means of transport across the BBB is 
needed for efficacious delivery of drugs from the blood into the brain (and into brain tumors). As 
early as 1945, it was recognized that high osmolar solutions destroyed the cerebrovascular 
membranes (7). In 1961, Dodge et al. (24) reported an increase in staining of the brain by Trypan 
Blue after hyperosmotic infusions of NaCl, sucrose and urea into rat brain. In the early 1970s, 
Thompson and Rapoport suggested that the infusion of hyperosmotic solutions into brain resulted in 
dehydration of cerebral endothelial cells with resultant widening of tight junctions. Solutes not 
normally able to cross an intact BBB, such as the Evans Blue-albumin complex, were shown to 
penetrate the BBB for a limited time after hyperosmotic infusions into cerebral vasculature (8,25). 
For delivery of clinically useful drugs across the BBB, the disruption of the BBB by osmotic means 
must be a controlled transient event. Infusion of hyperosmolar solutions into the intracarotid artery is 
the most studied and proven method for a transient (or reversible) opening of the BBB (23). 
Hyperosmolar solutions available for use as a BBB disruption agent are mannitol, arabinose, urea, 
sucrose, and lactamide to name a few. For purposes of this dissertation, only the sugars mannitol and 
arabinose will be discussed further.  
 
2.4.1 Characteristics of Reversible Osmotic BBB Disruption 
The action of shrinking endothelial cells using hyperosmotic solutions is consistent with what 
is known about osmotic shrinkage in cells in general. Consider first the definition of osmolality and 
solution osmotic pressure. The molality (m) of a solution is moles of solute per kg of solvent. 
Osmolality is defined by:  
 
  
 
where k corresponds to a solute species (ion or non-electrolyte) and Φk is the molal osmotic 
coefficient of that species (8). If k is an electrolyte, k = 1 to v where v is the number of moles of ions 
formed from 1 mole of an electrolyte. If k is not an electrolyte, then v = 1. Solution osmotic 
pressure, П, is defined as:  
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where R is the gas constant and T is absolute temperature (in Kelvins) (8). Φ can be calculated from 
molal freezing-point depressions using the following equation:  
 
  
 
 
The final volume of a cell after osmotic shrinkage can be quantified as:  
 
   
 
 
where σ is defined as:  
     
 
 
If the BBB is indeed opened by cell shrinkage, then certain conditions are expected to apply:  
1) Opening of the BBB should be a reversible event. Indeed, as shown by Cosolo et al. (20), 
the BBB is permeable to Evans Blue tracer only up to ten minutes after BBB disruption by 
hyperosmolar mannitol. After ten minutes, it is likely that the endothelial cells begin to return to 
their normal size after shrinkage (thus reestablishing the tight junction contacts). This is in 
agreement with Eq. 2.4, which suggests that cell volume should return to normal if the cell 
environment returns to its original tonicity.  
2) The osmotic agent should not act on the endothelial cells as a drug. As Eq. 2.4 indicates, 
osmotic pressure and cell shrinkage depend only on the concentration of solute and not on any drug 
action of the solute.  
3) With increasing molality BBB opening should increase. Experiments by Rapoport et al. 
(16) (see also Table 2-1) showed that BBB opening occurred only when the sugar infusate 
(arabinose or mannitol) was made at a specific concentration (threshold concentrations for BBB 
opening used in Rapoport’s experiments were reported in terms of molarity (M)).  
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4) The osmotic threshold for BBB opening should be inversely related to endothelial cell 
membrane permeability. The endothelial-cell membrane permeability increases with increasing lipid 
solubility of the solute. Therefore, for highly lipid-soluble solutes, the osmotic threshold for BBB 
disruption is low. Figure 2-8 shows the correlation between lipid solubility (expressed as the 
octanol/water partition coefficient) and BBB permeability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-8: Correlation between lipid solubility and BBB permeability. From Ref. (23). 
 
2.4.2 Mannitol and Arabinose as Hyperosmolar Infusates for BBB Disruption 
Mannitol 
Mannitol is a sugar whose chemical name and empirical chemical formula are hexan-
1,2,3,4,5,6-hexol and C6H8(OH)6, respectively. The chemical structure of mannitol is shown in 
Figure 2-9. The solubility of mannitol in water is 1g mannitol to 5.5 ml water (1g/5.5ml). 
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Figure 2-9: Chemical structure of the sugar mannitol. 
 
 
Arabinose 
Arabinose is a monosaccharide. In nature, L-arabinose is found more commonly than D-
arabinose. The empirical chemical formula for L-arabinose is C5H10O5. The chemical structure of 
arabinose is shown in Figure 2-10. The solubility of arabinose in water is 1g arabinose to 1ml water 
(1g/1ml) and is 5.5 times more soluble than mannitol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-10: Chemical structure of L-arabinose.  
 
Arabinose vs. Mannitol for Successful BBB Disruption 
 
Arabinose and mannitol have a rich history in experimental disruption of the BBB. Arabinose 
is not approved for clinical use, therefore, only mannitol is used in clinical BBB disruption 
protocols. In 1980, Rapoport et al. performed experiments to quantify the reversible opening of the 
BBB by infusing concentrated solutions of arabinose and mannitol into the carotid artery of rats (16). 
The dose and rate of infusion for each sugar was held constant at 0.12 ml/second while the 
concentration for each sugar was varied from 1.0 to 1.8 molal. No difference in BBB disruption (as 
verified by the Evans Blue staining technique) grade was noted between the two sugars. 
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Results from Rapoport’s experiments have been reproduced and shown in Figure 2-11. For 
additional experiments to determine optimal concentration and infusion duration for the 
hyperosmotic solution, arabinose was used due to its lower solubility. Rapoport et al. reported that a 
concentration of 1.6 molal arabinose results in significant BBB disruption as compared to control 
(saline infusion) when infused at 0.12ml/sec for at least 30 seconds. A 20-second infusion resulted in 
less distinct BBB disruption and a 10-second infusion resulted in little or no BBB disruption as 
compared to control. Based on studies of Rapoport et al. in animal models, there is clearly an 
optimal concentration and infusion time required for effective BBB disruption.  
 
Figure 2-11: Results from BBB disruption experiments by Rapoport et al. (16) Solutions of saline, arabinose, or 
mannitol were infused for 30 seconds into the right external carotid artery. Staining of the brain was determined 15 min 
to 2 h after infusion. Grade of staining is as follows: 0 = no staining, 3+ = deep blue stain. For the experimental protocol 
of Rapoport et al., a 1.6 molal solution of either arabinose or mannitol was needed for reliable disruption of the BBB. 
Numbers in parentheses indicate the number of animals in which the infusate was not seen to pass into the internal 
carotid artery (i.e., infusate was likely infused towards the heart). NOTE: At 1.8 molal, mannitol is supersaturated and 
precipitates out at 37° C, possibly resulting in microinfarcts in brain after infusion.   
 
In a separate study using only mannitol as the hyperosmolar solute, Cosolo et al. (20) 
determined the best dose and rate of infusion of 1.4 molar (mol/liter) mannitol to be 0.25 ml s-1 kg-1. 
Furthermore, in the study of Cosolo et al., EB did not stain the brain when infused 10 minutes after 
mannitol infusion. The degree of Evans Blue staining in the brain was maximal only when EB was 
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infused up to five minutes after mannitol infusion. Figure 2-12 represents data of Cosolo et al. which 
clearly suggests a transient opening of the BBB after mannitol infusion. 
Taken together, the results of Rapoport et al. and Cosolo et al. suggest that optimal 
disruption of the BBB requires careful control over the concentrations, dose, and rate of infusion of 
the osmotic solutions. Furthermore, cerebral infusion of hyperosmotic solutions requires that the 
infusate is filtered with high-quality syringe filters in order to avoid the injection of microemboli. 
Additionally, if 1.4 M (25%) mannitol is used, the solution must be warmed to 37° C before infusion 
to prevent precipitation of infusate within the tubing prior to entry into the animal’s blood stream. 
 
Figure 2-12: Results from BBB disruption experiments by Cosolo et al. (20). Mannitol was infused at 0.25 ml s-1 kg-1 for 
30s. Evans Blue staining (measured on scale 0-4) of ipsilateral hemisphere occurred only when the dye was injected 
before mannitol or < 10min after mannitol administration.   
 
Other Factors Influencing Osmotic BBB Disruption 
In addition to the above requirements for the osmotic agents, the anesthetic type partial 
pressure of carbon dioxide (PaCO2) during animal experiments have been shown to be factors in the 
degree of BBB disruption achieved using hyperosmolar infusions (26). Figure 2-13 shows results 
from Remsen et al. indicating a clear dependence of anesthesia and PaCO2 on the degree of BBB 
disruption. These studies noted a significant difference in blood pressure between animal groups 
anesthetized with propofol and those anesthetized with isoflurane. These results were consistent with 
those of Gumerlock et al. (21); who, in earlier studies, had linked cardiovascular parameters to the 
degree of BBB disruption. Gumerlock et al. showed that the use of a volatile anesthetic 
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(methoxyflurane) resulted in poor BBB disruption using 1.4 M mannitol administered at 0.12 ml/s 
for 35 seconds. However, after the blood pressure was normalized (to levels achieved using 
pentobarbitol) by pharmacological manipulation, good BBB opening was achieved with the 
methoxyflurane anesthetic. The investigators concluded that “Osmotic BBB [disruption] is 
maximized within specific cardiovascular parameters and probably correlates best with a normal 
cardiac output/index” (21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-13: From Remsen et al. (26). (A) Percent good BBB disruptions by Evans Blue staining (2-3+) after infusion of 
arabinose, mannitol or saline at 0.12 ml/s for 30 seconds in low (25-30 mm Hg) and high (45-50 mm Hg) PaCO2 
animals. (B) Percent good BBB disruptions by Evans Blue staining in animals infused with arabinose or mannitol at 0.09 
ml/s under propofol and 0.12 ml/s under isoflurane anesthesia.    
 
While these findings may be true, there was no examination of the possible effects on the 
endothelial membrane by the anesthetics. For example, isoflurane (a volatile anesthetic similar to 
methoxyflurane) is a lipophilic agent and decreases cerebral metabolism.  Therefore, the lipophilicity 
of the anesthetic may change the characteristics of endothelial cells in the cerebral vessel; the surface 
area of perfused capillaries in the brain, or both. Chi et al. (27) investigated these claims and found a 
decrease in the transport of small hydrophilic molecules across the BBB during isoflurane 
anesthesia. Chi et al. suggested that the apparently limited BBB permeability due to the presence of 
B 
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hydrophilic molecules was related to the effect of isoflurane on the perfused-capillary-surface-area 
product; but, may also be due to the effect of isoflurane on the lipid bilayers of endothelial cells. In 
any case, the literature suggests that isoflurane protects the BBB from disruption to some degree.  
 
Brain Changes Associated with Osmotic BBB Disruption 
 
Osmotic disruption of the BBB is not without consequence. Several groups have investigated 
the aftermath of osmotic BBB disruption in animals and have found changes in the brain.  These 
include ischemic neuronal death (28), collapsed, acidophilic neurons with macrophage response 
(29), and pronounced watery swelling of astrocytic processes and expansion of dendrites and axons 
(30). Additionally, several labs have show changes in brain structure after osmotic disruption, 
including results from the WPI NMR laboratory (to be presented later). Therefore, for experiments 
relying on delivery of substances across the BBB for later use by brain cells, osmotic BBB 
disruption, if used, must be accompanied by evidence of the brain-cell health/status at some 
appropriate time point following infusion of hyperosmotic perfusate.  
 
2.5 The BBB and Cerebral Edema 
 
Edema in the brain is defined formally as abnormal accumulation of fluid within the brain 
parenchyma, producing a volumetric enlargement of tissue (31). This is not to be confused with 
brain swelling which can occur as a result of increased cerebral blood volume (CBV), cerebral spinal 
fluid (CSF) volume, or a combination of increased water content, CBV and CSF volume (32). 
Several different types of cerebral edema are known to exist: vasogenic, ischemic, osmotic, 
interstitial, and cytotoxic. Cerebral edema and the BBB are linked because in some cases; the former 
causing the latter and vice versa. Figure 2-14 shows characteristics of various brain edema types 
(from (33)). Of particular interest for the current dissertation is vasogenic edema.  
 
Vasogenic Edema 
Vasogenic edema is swelling that results from damage to cerebral vessels, regardless of the 
origin of insult. Trauma, cerebrovascular insults, and brain disorders which result in increased BBB 
permeability, and associated entry of serum proteins into brain parenchyma, are essential elements of 
vasogenic brain edema (31). Therefore, damaged endothelial-cell membranes of the BBB are one 
obvious mechanism for extravasation of extraneous fluid from blood into brain, but may be only part 
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of a larger process. Permeability of the BBB can be affected by several other mechanisms, such as 
enhanced vesicular transport, creation of transcellular channels, opening of the tight junctions, and 
hypertension; each of which can lead to vasogenic edema. In addition, certain chemicals such as 
bradykinin, serotonin, histamine, arachnidonic acid, leukotrienes, and free radicals can affect BBB 
permeability, resulting in vasogenic edema formation (34). The clinical implications of vasogenic 
brain edema are coma, cerebral herniation, and death. 
 
 
 
 
 
 
 
Figure 2-14: Characteristics of different traumatic brain edema types. From Ref. (33) 
 
Retention of Brain Water Essential for Vasogenic Edema 
 Damage to cerebral endothelial cells may allow for the entry of proteins and water into brain, 
but this is not the primary cause of edema because water is known to move in and out of brain fairly 
easily. A study by Vorbrodt et al. (35) showed that proteins that have traversed the BBB can be 
taken up in pinocytotic vesicles of endothelial cell membranes and digested or transported back into 
the blood vessel lumen. However, excess volumes of water left behind are retained, resulting in the 
formation and persistence of vasogenic brain edema (31).  
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Brain Defense Against Vasogenic Edema 
The brain has mechanisms which can protect against excessive edema; first and foremost is 
the BBB, which serves to maintain brain homeostasis. The inter-endothelial tight junctions of 
cerebral capillaries have a high resistance to fluid flow (hydraulic conductivity) (36), as compared to 
peripheral capillaries, and thus do not support vesicular transport of proteins or fluid. Since the brain 
does not have a lymphatic system, the continuous capillary endothelium is essential in preventing 
fluid entry into brain. Any plasma protein that does enter brain, and is not metabolized by astrocytes, 
must make its way through brain parenchyma slowly until it reaches the CSF, which is recycled 
every 8 hours (36). The structure of the brain also provides protection from edema. Gray matter is a 
dense tangle of cellular structures and offers significant resistance to edema fluid flow. White matter, 
however, has a more orderly arrangement of cells and therefore is less resistant to the flow of edema 
fluids. In addition, the brain is resistant to distortion by increased hydrostatic pressure and to fluid 
flow under a hydrostatic pressure gradient (36). 
 
Spread of Edema 
 Although the structure of the gray matter (and to a lesser extent white matter) in the brain 
may prevent the flow of edema fluid, the resistance of tissue elements may eventually be overcome. 
The force at which edema spreads is characterized by the Starling equation applied to fluid flow 
from blood into tissue:  
 
 
where Jv is the flow of fluid across the cerebral vessel wall, Lp is the hydraulic conductivity of the 
endothelial membrane, Pplasma is the intravascular hydrostatic pressure influenced by the systemic 
blood pressure, Ptissue is the brain tissue hydrostatic pressure, σ is the osmotic reflection coefficient 
(where a value of 0 indicates high or total permeability of the BBB to the solute, and 1 indicates low 
or no permeability of the BBB to the solute), Пplasma is the osmotic pressure in plasma, and Пtissue is 
the osmotic pressure in the brain tissue. Substances of different molecular weights have been shown 
to flow at the same rate from the site of BBB injury, suggesting a bulk flow of edema fluid (37). The 
speed and extent of distribution of edema fluid throughout brain is determined by the size of the 
BBB injury, arterial blood pressure and pressure gradients between edematous tissue and the CSF  
(31,32). The spread of edema stops when the fluid flow across BBB-injured sites is matched by the 
2.6 
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clearance of edema fluid; which is again dependent on the size of the BBB injury and the arterial 
blood pressure. 
 
Brain Response to Vasogenic Edema After Hyperosmotic BBB Disruption 
Edema formation is not common during the acute stage of hyperosmolar infusion, when brain 
shrinkage is most likely to occur. Studies have shown that during acute hypernatremia 
(hyperosmolarity), the loss of brain water was less than expected because the brain is capable of 
accumulating solute to stabilize its volume (38). However, disruption of the BBB by hyperosmotic 
means is always associated with some degree of brain edema (23). Therefore, it should be expected 
that some cellular response to acute decreases in brain water volume is present within endothelial 
cells, astrocytes, glia, microglia, neurons or all brain cells during and after hyperosmotic insults to 
cerebrovasculature. It is well known that cells exposed to hypertonic extracellular fluid shrink, 
reflecting the osmometer characteristics of the cell, but the cell tends to return to its original volume 
by so-called regulatory cell-volume increase (RVI) (39).  Due to volume-regulatory ion transport, 
RVI is accomplished within minutes of a cells exposure to hypertonic solute (39). During vasogenic 
edema, glia are known to influence extracellular K and Cl composition as well as metabolize serum 
albumin that may have crossed an injured BBB (36). In addition, astrocytes (macroglia) initiate 
calcium (Ca2+) signaling in response to many stimuli, including extracellular hypoosmolarity. 
Therefore, if the BBB is to be disrupted using hyperosmolar infusions, careful attention to the type 
and dynamics of the brain response is required.   
 
2.6 MRI Detection of BBB Disruption 
 
With the use of an extracellular MR contrast agent, such as gadopentate dimeglumine 
(gadolinium diethylenetriaminepentaacetic acid or Gd-DTPA), that does not cross a normally intact 
BBB, pathologies of the BBB are more easily detectable in human or animal subjects. After i.v. 
infusion, pathological alteration of the BBB allows passage of Gd-DTPA into the brain extravascular 
extracellular space (EES (40)), where it collects and results in positive localized enhancement in a 
MR image. Gd-DTPA remains in the extracellular space for many minutes or hours; after which it 
diffuses back into the vasculature and is excreted by the kidneys (40). Use of i.v.-administered Gd-
DTPA to enhance the contrast of MR images is sometimes referred to as dynamic contrast-enhanced 
magnetic resonance imaging or DCE-MRI. Gd-DTPA can also be used to detect areas of BBB 
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detection as a binary event, i.e., to detect if enhancement is seen or not. When the degree of BBB 
disruption is of interest, methods such as DCE-MRI can be used to provide additional information 
regarding the response of tissue pathologies (as they relate to BBB disruption) to therapy (41).  
 
 
2.6.1 Gd-DTPA Used to Detect Regions of Pathological BBB Disruption 
Gd-DTPA-enhanced MRI allows detection of BBB disrupted regions in the brain. Therefore, 
MRI can detect BBB disruption resulting for a number of different pathologies such as multiple 
sclerosis (MS), brain tumor, and stroke.  
 
Multiple Sclerosis 
MS is recognized by inflammatory demylenated lesions in brain white matter. Demyelinated, 
but less inflammatory lesions, are also observed in the cortex and normal appearing white matter 
(NAWM) of the brain (40). Figure 2-15 shows a MS lesion in the brain using two different MR 
techniques; Gd-DTPA enhancement and T2-weighting. Note the difference in the shape of the lesion 
between the two images. The Gd-DTPA image indicates BBB damage in the area shown. Gd-DTPA-
enhancing MS lesions microscopically show perivascular inflammation with demyelination and 
some myelin breakdown, while non-enhancing MS lesions show little inflammation and near 
complete loss of myelin (42).  
 
Figure 2-15: A) Example of a ring-enhancing lesion on a contrast-enhanced T1-weighted MR image. B) The same lesion 
as seen on a T2-weighted image. From Ref. (43).  
Characteristics and Manipulation of the BBB   81 
    
 
 
 
Figure 2-16: Magnetic resonance images exhibiting evidence of early BBB disruption. Hyperintense signal in the 
patient’s left central and precentral sulci is caused by extravasation of Gd-DTPA contrast agent into the cerebral spinal 
fluid. Note that enhancement resides primarily in the sulci; the adjacent parenchyma is unexceptional. From Ref. (44). 
 
 
Stroke 
The integrity of the BBB is compromised as a result of a reduction or loss of blood flow to 
brain.  In clinical situations, reperfusing occluded arteries is the most effective treatment for acute 
stroke (44,45). Reperfusion injury is possible, however, and may lead to exacerbated BBB and 
neuronal damage. Latour et al. showed that early detection of BBB damage by Gd-DTPA-enhanced 
MRI may be a useful target for adjunctive therapy to reduce the negative side-effects of occluded 
artery reperfusion, thus improving the clinical outcome of stroke. Results from Latour et al. are 
shown in Figure 2-16.  
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Introduction 
 
Manganese-enhanced magnetic resonance imaging (MEMRI) is a relatively new MR 
technique for functional and anatomical MR imaging based on unique physiological response 
mechanisms to divalent manganese (Mn2+). Lin and Koretsky first used MEMRI for functional brain 
imaging.  Following infusion of MnCl2 into the brain extracellular space, regions of the rat brain that 
responded to electrical forepaw stimulation could be visualized using MEMRI (1). Following Lin 
and Koretsky’s work, a number of MEMRI studies of functional brain imaging were published. For 
example, MEMRI was used to trace odor-induced activation in the olfactory bulb of mice (2); for in 
vivo trans-synaptic tract tracing in murine striatum (3); for in vivo characterization of 
neuroarchitecture in rat brain (4); and for visualization of cortical spreading depression (CSD) in rat 
brain (5).  
One of the characteristics that makes Mn2+ a unique MR contrast agent for visualizing brain 
function is its ability to enter cells through voltage-gated calcium channels (6). Manganese competes 
with calcium for cellular entry, is retained in cells for substantially longer time periods than calcium, 
and supports exocytosis (6,7). Once inside the cell, the paramagnetic properties of Mn2+ change the 
MR relaxation times of water protons in the cell; resulting in localized signal increases in T1-
weighted MR images in regions of Mn2+ uptake (1). The ability of MEMRI to image brain function 
is limited by MnCl2 toxicity in vivo, heterogeneous distribution of Mn
2+ in the brain extracellular 
space, and non-specific brain activation by environmental stimuli. This chapter reviews some of the 
concepts needed to understand the use of MEMRI for the applications presented in this dissertation. 
These include MR-contrast-agent physics, Mn2+ in biological systems, and Mn2+ as a MR contrast 
agent. 
 
3.1 Magnetic Resonance Contrast Agent Physics 
 
The selection of an appropriate MR contrast agent depends on several important factors such 
as the tissue of interest, the type of contrast desired (i.e., positive or negative enhancement), and the 
experimental setting (i.e., clinical or animal research). In the design of MR contrast agents, several 
characteristics must be considered to effectively enhance the MR signal in vivo and to prevent 
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adverse side effects to the animal or patient receiving the MR contrast-agent injection. An extensive 
list (although not exhaustive) is provided here (8): 
 1) Effects of the contrast agent on the MR signal should depend on the concentration of the 
agent and should be reproducible from experiment to experiment. 
 2) The contrast agent should be a strong MR relaxation agent so low doses can be 
administered with efficacy.  
 3) In vivo reactivity of the contrast agent is low or non-existent and the contrast agent is 
non-toxic. 
 4) The contrast agent should have a reasonably long shelf-life.  
 5) The contrast agent is quickly (i.e., within hours) excreted and/or deactivated. In the case 
of animal studies, such as those performed in this dissertation, a number of non-clinical MR contrast 
agents (e.g., manganese chloride or MnCl2) are also available.  Although the toxicity of MnCl2 
precludes its use in humans, the compound has been used extensively at sub-lethal doses in animal 
models. This review will focus on Mn2+ (usually administered as MnCl2) as an MR contrast agent 
but will also discuss the use of gadolinium-based MR contrast agents in both experimental and 
clinical practice. Differences in contrast mechanisms between the two MR contrast agents will be 
noted where appropriate throughout the text.  
 
3.1.1 Effect of Contrast Agents on MR Parameters 
 
As discussed in Chapter 1, the T1 and T2 relaxation times are main MR parameters used to 
control MR image contrast (although proton density is also important, it is unaffected by MR 
contrast agents). For positive enhancement in an MR image (i.e., high signal-intensity regions in an 
image as compared to background tissue), the T1 relaxation time of a particular tissue must be 
shortened (while leaving T2 relatively unaffected). Negative contrast enhancement in an MR image 
(i.e., dark regions as compared to the surrounding tissue) is generally accomplished by shortening 
the T2 or T2
* relaxation times of the tissue of interest (while leaving T1 unaltered). The T2
*, or 
magnetic susceptibility agents, are also sensitive to molecular translation and can result in significant 
MR signal loss (again negative contrast) for molecules diffusing in the vicinity of the agents. The 
discussion in this chapter will focus on manganese (Mn2+) as a paramagnetic MR contrast agent that 
primarily affects T1-weighted MRI contrast.  
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3.1.2 Relaxation Effects of Paramagnetic Ion Metal Complexes 
 
Divalent manganese (Mn2+) ions possess five unpaired electrons and are therefore 
paramagnetic by nature.  Each unpaired electron in the Mn2+ ion possesses an electron MDM (just as 
in the case of nuclei, electron spin pairing results in a net cancellation of the respective electron 
MDMs).  The five unpaired electron MDMs then sum to form a net electron MDM for Mn2+, which 
in turn co-adds with any external magnetic field that may be present (9). The presence of unpaired 
electrons in a paramagnetic ion is mandatory for the ability of the ion to affect the T1 and T2 
relaxation times of nearby water protons (10). The relaxation rate of the paramagnetic ion is 
proportional to the spin quantum number S by S*(S+1) (10). Consequently, ions with the largest 
values of S have been exploited most often as MR contrast agents.  For example, S=7/2 for Gd3+ and 
S=5/2 for Fe3+, Dy3+, and Mn2+. When a paramagnetic ion is introduced into a solvent (such as 
water), the longitudinal and transverse relaxation rates of the solvent nuclei, R1 (1/T1) and R2 (1/T2), 
respectively, increase. The magnetic fields associated with the paramagnetic center of the MR 
contrast agent then add to the observed relaxation rate of the solvent. This relationship is represented 
in Eq. 3.1:  
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where the diamagnetic component of relaxation is that of the solvent in the absence of the 
paramagnetic metal ion. The paramagnetic component of (1/T1,2)observed is dependent upon the 
random diffusional translation of the solvent and the paramagnetic complex as well as the chemical 
interactions that occur between the solvent and the metal ion. Since the strength of the local 
magnetic field associated with the paramagnetic center diminishes rapidly as a function of distance, 
the paramagnetic contribution to the solvent T1 relaxation time is not significant unless the solvent is 
in close proximity to the paramagnetic center.  This generally requires a direct chemical interaction 
between the solvent and the paramagnetic complex.  If this is not the case, then the paramagnetic 
effect will only be transmitted by diffusional interactions between the solvent and metal-ion 
complex; resulting in a much weaker effect. The chemical interactions that occur between solvent 
nuclei and the paramagnetic complex can be summarized by three distinct types: primary 
3.1 
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coordination sphere interaction, second coordination sphere interaction, and outer sphere relaxation 
(9). These chemical interactions can be represented schematically as shown in Figure 3-1.  
 
 
Figure 3-1: Chemical and non-chemical interactions between solvent molecules (in this case water) and a paramagnetic 
metal complex (M) that enhance the relaxation time of the solvent molecules.  A) Solvent molecule primary coordination 
sphere; B) Solvent molecules binding indirectly (e.g., by hydrogen bonding) to the paramagnetic complex in its second 
coordination sphere; and C) translational diffusion of the solvent molecule in the outer sphere of the paramagnetic metal 
(or metal complex) with no direct or indirect chemical binding interaction between the two species. Reconstructed from 
Ref. (9).  
 
Relaxation mechanisms by water-molecule binding to the primary and second coordination sphere of 
the metal ion are typically lumped into one relaxation effect referred to as “inner-sphere relaxation” 
(A and B of Figure 3-1). Relaxation mechanisms by translational diffusion of the water molecule 
past the metal ion is commonly referred to as “outer sphere relaxation” (10).  
 
Inner-Sphere Relaxation 
In contrast agent design, it is important to consider the formation of a ‘coordinate covalent’ 
molecular bond between a water molecule and the primary coordination sphere of the paramagnetic 
ion. As the number of water molecules that are able to bind or interact with the paramagnetic ion 
increase, the relaxation effect also increases. Since water molecules are in rapid chemical exchange 
between the outer and inner spheres of the paramagnetic complex, the residence time – or the time 
each water molecule spends bound to the metal complex – is important.  If the residence time is 
short, many water molecules in the vicinity of the paramagnetic complex have an opportunity to bind 
on the time scale of the MR experiment. A rapid exchange rate – on the order of one microsecond or 
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less – is desirable for a significant relaxation effect (10). The effect of inner-sphere relaxation on the 
longitudinal relaxation rate, R1 (1/T1) is given by Eq. 3.2 (9).  
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where PM is the mole fraction of metal ion, q is the number of water molecules bound per metal ion, 
T1M is the T1 relaxation time of the water protons bound to the metal, and τM is the residence time of 
the bound water. Clearly, as the residence time of the bound water decreases, the relaxation rate 
(1/T1) increases.  As the number of bound water molecules (q) increases, the relaxation rate 
increases. Finally, as might be expected in the design of an MR contrast agent, an increase in the 
concentration of the MR contrast agent (PM) also increases the relaxation rate. 
 
Outer-Sphere Relaxation 
No direct bonding of chemical exchange is involved with outer-sphere relaxation effects of 
paramagnetic ions. The primary determinant of the outer-sphere relaxation properties of the 
paramagnetic ion is the rotational and translational diffusion properties of the ion. The faster a 
contrast agent can diffuse throughout solvent the greater the relaxation effect of the contrast agent 
because more water molecules are encountered and affected along its diffusional path. This is an 
important aspect of MR contrast-agent design because paramagnetic ions are typically chelated with 
a ligand, such as diethylenetriamenepentaaceticacid (DTPA), to minimize toxicity. In so doing, the 
rotational and translational diffusion rate of the chelated paramagnetic complex is reduced, resulting 
in a less efficient relaxation effect. 
The outer-sphere relaxation effect is also dependent on how close water molecules can get to 
the magnetic dipole field at the center of the paramagnetic complex. If the attached chelates are too 
large, water molecules may only experience little or no effect from the paramagnetic ion dipole, 
resulting in low relaxation efficiency of the contrast agent (10). Indeed, the paramagnetic effect 
depends strongly on the distance between the metal ion and water proton, as shown in Eq. 3.3, 
6
1
r
effecticparamagnet ∝ , 
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where r is the mean distance between the paramagnetic center and the resonating water protons (11). 
The effect of outer-sphere relaxation on longitudinal relaxation is represented in general form by Eq. 
3.4 and incorporates the effects of translational diffusion and electronic relaxation (9). 
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In Eq. 3.4, C is a numerical constant, NS is the number of metal ions per cubic centimeter, d is the 
closest distance achieved between the metal complex and solvent molecule, and τD is the 
translational diffusion time. τD depends on the diffusion coefficients of the metal complex and water, 
DS and DI, respectively, as given by Eq. 3.5  
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During the process of designing MR contrast agents, organic ligands are chemically bonded 
to the metal ion to form a metal chelate.  Complexation ensures in vivo stability (minimizing the 
toxicity of the free metal) but also reduces the chemical exchange capability (and the inner-sphere 
relaxation effect) of the MR contrast agent. Therefore, enhancing the effects of outer-sphere 
relaxation is also an important consideration in the design of MR contrast agents.  
 
3.2 Manganese as a Calcium (Ca) Analog 
 
Divalent manganese (Mn2+) has an ionic radius similar to calcium (Ca2+) (.92Å for Mn2+ vs. 
1.14Å for Ca2+) and is handled similarly to Ca by biological systems (6). The uptake of Mn2+ by 
active brain cells results in localized contrast enhancement in T1-weigthed MR images. This makes 
Mn2+ a useful brain anatomical and functional contrast agent. The mechanism of Mn2+ uptake by 
brain cells and the consequence regarding MR imaging and in vivo toxicity are discussed here.  
 
 
 
3.4 
3.5 
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3.2.1 Neurotransmission in Brain: The Role of Calcium Channels 
The topic of neurotransmission in brain is vast and is not covered in detail in this section. 
However, a review of neuronal structure and function will serve as an appropriate foundation upon 
which the role of calcium channels in neurotransmission can be based.  
 
Brain Neuron Structure and Neurotransmission 
The neuron is unique in structure among mammalian cells. Three unique elements make up 
the neuron:  the axon, specialized for intracellular information transfer; the dendrite, very often the 
site at which information is received from other neurons; and the synapse, which is the point of 
information transfer between neurons (12). Figure 3-5 is an artist’s depiction of two adjacent 
neurons and one synapse between them. Communication between neurons is made possible by 
electrical impulses or action potentials along the axon and by chemical transmission of information – 
via neurotransmitters – across the synapse. Arrival of an action potential at the presynaptic terminal 
(signal-emitting neuron in Figure 3-2) initiates a sequence of events that leads to the release of 
neurotransmitters to the postsynaptic neuron (signal-receiving neuron in Figure 3-2). As part of this 
sequence, the opening of Ca channels causes a rapid influx of Ca into the presynaptic cleft, due to 
the steep concentration gradient of Ca across the cell membrane (external [Ca] ~ 1mM, internal [Ca]  
~ 0.1µM) (13). In response to a transient rise in cytoplasmic calcium concentration, 
neurotransmitters are released from the presynaptic terminal to the postsynaptic terminal.  
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Figure 3-2: Two neurons separated by a synapse. From 
www.niaaa.nih.gov/Resources/GraphicsGallery/Neuroscience/synapse.htm 
 
3.2.2 Mn2+ Passage into Cells via Voltage-Gated Calcium Channels 
Due to its similar ionic radius and charge, Mn2+ enters cells via voltage-gated calcium 
channels (VGCCs). Methods to show Mn2+ accumulation in cells through VGCCs have been 
performed by several groups using in vitro techniques. Drapeau et al. (6) used pinched-off 
presynaptic nerve endings (synaptosomes) isolated from rat brain to compare uptake of Ca2+ and 
Mn2+ after nerve stimulation. The time course of Mn2+ uptake was similar to that of Ca2+, suggesting 
one mechanism for mediating cellular uptake of Ca2+ and Mn2+. Figure 3-3 shows the Ca2+ and Mn2+ 
uptake time course from Drapeau et al. (6). To further support the hypothesis that Mn2+ enters cells 
through VGCCs, Drapeau et al. tested an organic calcium-channel antagonist (blocker), verapamil, 
for its effectiveness in preventing cellular uptake of Mn2+. Results from these experiments are shown 
in Figure 3-4. Verapamil has also been used to inhibit uptake of Ca2+ and Mn2+ in frog motor nerve 
terminals. Narita et al. (14) showed a decline in the frequency of miniature end-plate  
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Figure 3-3: The time course of K-stimulated Ca2+ or Mn2+ uptake in striatal synaptosomes. The solutions with radiotracer 
Ca2+ (filled circles) or Mn2+ (open circles) contained 0.02mM of both these divalent cations. Reproduced from Ref. (6).  
 
Figure 3-4: The effect of verapamil (80µM) on the K-stimulated uptake of Ca2+ and Mn2+. The first bar of each pair 
shows the uptake in the absence of verapamil. The second bar shows the uptake in the presence of verapamil (V). 
Reproduced from Ref. (6) 
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potentials (MEPPs; generated by tetanic stimulation of the motor nerve) when verapamil was added 
to the Mn2+-containing solution in which the nerve was bathed.  Figure 3-5 shows the effect of 
verapamil on the frequency of MEPPs generated while in Mn2+ solution. The results of Narita et al. 
suggest that Mn2+ does indeed enter active nerve cells via VGCCs.  
 
Figure 3-5: Effect of verapamil on the increase of MEPP frequency during tetanic stimulation of the [frog] motor nerve 
in Mn2+ solution. The preparation had been soaked for 4h in a low Ca2+ solution at 5 °C before the measurements were 
begun. The MEPP frequencies shown at 0 min are the average frequency during 10 min just before the tetanus in the 
respective solutions. The nerve was stimulated tetanically for 2 min. MEPPs before, during, and after tetanus were first 
recorded in the low Ca2+ solution (∆), then in the Mn2+ solution (O), and finally in the same solution with 40 µM 
verapamil (●). Reproduced from Ref. (14).  
 
In addition to in vitro preparations of nerve cells used in experiments to monitor Mn2+ uptake 
by cells, whole rat hearts have been used to test whether Mn2+ could be used as a probe for the slow 
inward Ca2+ channel of the myocardial cell. Hunter et al. excised hearts from Sprague-Dawley rats 
and perfused them to maintain a semblance of in vivo conditions (see Circ Res. 47:721-727 (1980) 
for a description of this perfusion technique). To the working heart (~220 beats/min) was added 
radiolabeled Ca2+ and Mn2+ (45Ca and 54Mn, respectively). The washout dynamics of 45Ca and 54Mn 
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were monitored and showed that the cellular retention of Mn2+ was longer than that of Ca2+, as 
shown in Figure 3-6 (15).  
 
 
Figure 3-6: Comparison of 45Ca and 54Mn washout from rat heart. Hearts were perfused in the working mode for 10 min 
with the basal perfusate containing either 45Ca (●) or 54Mn (o). Reproduced from Ref. (15).  
 
Data from Figure 3-6 were used to determine that the selective accumulation of Mn2+ by the 
heart ‘compartment’ is 8 times greater than that for Ca2+. This compartment was suggested to be the 
heart cell and the method of entry was tested by using the Ca2+ channel blocking agent verapamil. 
Table 3-1 shows data from the Hunter et al. study, indicating that an inhibition of cellular Mn2+ 
accumulation was observed for hearts that were perfused with verapamil following perfusion with 
Mn2+.  
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Table 3-1: Hearts were perfused with basal perfusate for 5-min in the working mode before turning on the perfusion 
pump which added verapamil, oligomycin or ethanol (control) to the perfusate. Reproduced from Ref. (15).  
 
In addition to evidence showing the accumulation of Mn2+ within the cell via passage 
through VGCCs, Hunter et al. show that of the Mn2+ that enters cells, 30% is taken up by 
mitochondria. The accumulation of Mn2+ in mitochondria is suggested to occur via a mechanism of 
Ca2+-Mn2+ co-transport (15,16). The very slow rate of Mn2+ efflux from brain mitochondria is 
believed to contribute to brain mitochondria accumulation and uptake of Mn2+ in brain tissue in 
general. Apparently, brain mitochondria possess a mechanism for Mn2+ influx – but no method for 
Mn2+ clearance – other than by the slow Na+-dependent mechanism (17). Ample evidence suggests 
that Mn2+ can enter cells through VGCCs.  
 
Additional experiments show that Ca2+ and Mn2+ compete for the same entry routes into the 
cell. This suggests that Mn2+ could affect the function of the cell with possible adverse physiological 
effects to the cell in vitro or in vivo. Indeed, Mn2+ is known to be toxic in humans and animals at 
certain doses and MEMRI studies must confront this matter, especially for experiments in vivo. For 
infusions of low doses of Mn2+ that are not toxic, it is still important to consider the effects that Mn2+ 
may have on the cell after transport via VGCC’s. These effects may alter the outcome of MEMRI 
experiments in brain; for example, those that rely on normal brain response to external stimuli, or the 
outcome of MEMRI experiments in other organs, such as the liver.  
 
3.3 Manganese Toxicity and Cellular Effects of Manganese 
 
Manganese Toxicity 
Several heavy metals, such as lead (Pb), mercury (Hg), nickel (Ni), zinc (Zn), barium (Ba), 
and manganese (Mn2+), are known to be toxic in animals and humans. Most heavy metals interfere 
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with the voltage-gated entry of Ca2+ into the nerve terminal and interfere with normal rapidly-acting 
Ca-buffering processes and ATP-dependent processes for maintenance of internal Ca2+ balance (18). 
Figure 3-7 shows the sites of action in the neuromuscular junction which may be affected by heavy 
metals.  
 
Figure 3-7: Simplified representation of the neuromuscular junction showing sites of action and processes which may be 
affected by heavy metals: (1) action potential propagation; (2) voltage-gated entry of Ca2+ into the nerve terminal; (3) 
interaction of Ca2+ with vesicles and plasmalemma at “active zones” to affect exocytosis; (4) buffering of Ca2+ by Na+-
Ca2+ exchange and ATP-driven Ca2+ pumps; (5) maintenance of membrane potential by ATP-dependent Na+-K+ pumps; 
(6) diffusion of acetylcholine (ACh) (neurotransmitter) within the synaptic cleft and hydrolysis of ACh by 
acetylcholinesterase; (7,8) interaction of ACh with endplate receptors; and (9) maintenance of endplate potential and 
other membrane properties. Reproduced from Ref. (18).  
 
Some heavy metals are clearly more toxic than others. Our main concern is the toxicity of 
Mn2+. First, however, it is important to consider that Mn2+ is an essential trace element and is present 
within all mammalian cells. In humans, the normal body content of Mn2+ is 12 to 20 mg (218 to 364 
µmol) (19). Normal dietary levels of Mn2+ are not likely toxic due to the regulation of 
gastrointestinal absorption. Mn2+ has important metabolic functions for the cell as a coenzyme in 
protein synthesis (19) and appears to be important for the proper function of the pancreas according 
to experimental evidence which showed that Mn2+ stimulates enzyme secretion from the rat pancreas 
(20).  The toxicity of Mn2+ in man is typically a result of exposure to high levels of Mn2+ in dust 
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form (most notably in mine workers and employees of Mn2+-processing industries). Mn2+ is known 
to be focused in three organs; the brain, lung and liver (7,19), but its specific mechanism of action is 
not known. Chronic Mn2+ toxicity manifests itself in humans by symptoms similar to those 
associated with Parkinson’s disease and dystonia (bradykinesia, cephalalgia, hypersomnia, gait 
disturbances, speech disturbances, tremors, mask-like face, irregular handwriting, fatigability, 
anorexia, asthenia, apathy, and inability to concentrate) (19,21). Several theories to explain the 
neurotoxicity of Mn2+ have been proposed and are summarized in Table 3-2.  
 
Direct toxicity of high-valence species of Mn2+ (such as the trivalent cation (Mn3+) for the 
dopaminergic cells) 
Ability of Mn2+ to enhance the formation of reactive species (e.g., spheroid, hydroxyl radical, H2O2) 
Toxicity resulting from diminution of catalase and GSH peroxidase levels of the substantia nigra 
Mn2+-induced production of 6-hydroxydopamine or other toxic catecholamines and quinines 
Reduces glutathione (GSH) levels 
Auto-oxidation of dopamine (eliminate dopamine and produce cytotoxic quinines) 
 
Table 3-2: Hypotheses to explain Mn2+ neurotoxicity. Reproduced from Ref. (19) 
 
In one case report of Mn2+ poisoning in man, Nelson et al. (1993) describe the effects of 15 
years of Mn2+ dust inhalation in a 44-year old man who had been an arc-welder for 25 years. Eight 
months after leaving his job, the arc-welder “showed decreased hand grips, impaired vigilance, 
recall, rate of learning, amnestic processing, dysarthric speech, dyscalculia, and graphic construction 
dysfunction” (22). As part of the arc-welder’s diagnosis, MRI showed hyperintensities in the basal 
ganglia and midbrain as shown in Figure 3-8. Experimental studies also have shown accumulation of 
Mn2+ in the brain after inhalation or intravenous MnCl2 injection. Regions of brain affected were 
detected by a shortening of the spin-lattice relaxation time (T1) in the caudate and lenticular nuclei, 
substantia nigra, subthalamic area, ventromedial hypothalamus, and the pituitary (23). 
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Figure 3-8: Left: Axial T1-weighted image (TR/TE, 500/15ms) at the level of the basal ganglia. Increased signal intensity 
in the globus pallidus (arrows) that is bilateral and symmetrical reflects shortened T1 relaxation due to the paramagnetic 
effect of Mn2+. Right: T2-weighted image (TR/TE, 2500/70ms) is unremarkable. Some decreased signal intensity in the 
basal ganglia is normally expected for this age of patient. Reproduced from Ref. (22). Note: Although the author 
suggests here that the T2 image is ‘unremarkable’, this is not clear since the regional T2 hypointensities correspond very 
closely to the regions of T1 hyperintensity shown in the T1 image. Therefore, the T2 hypointensities may also be due to 
high local concentrations of paramagnetic Mn2+. Discoloration in left side of image is due to artifacts from scanning 
images from reference material.  
 
Adverse Effects of Intracellular Mn
2+
 
Mn2+ is required for the basic metabolic regulation of the cell. For example, Mn2+ is 
complexed to the astrocytic enzyme, glutamine synthetase, involved in the synthesis of the 
excitatory and neurotoxic amino acid glutamate. Also, Mn2+ is an important cofactor for the outer-
mitochondrial form of superoxide dismutase which is a major enzyme protecting cells from 
oxidative stress (24,25). Mn2+ homeostasis necessary to maintain normal cell function can be 
disrupted by overexposure of Mn2+. In cases of Mn2+ overexposure, cell death can be provoked by 
apoptosis and necrosis. Apoptosis, however, is not the only means of cytotoxic actions of Mn2+. 
Roth and colleagues showed that inhibitors of apoptotic markers, including the caspase family of 
proteases and p38 kinase, failed to prevent Mn2+-induced cytotoxicity (26). Therefore, Mn2+ must 
provoke other methods of cytotoxic events in the cell. Indeed, it has been shown that Mn2+ disrupts 
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mitochondrial function by inhibiting the sodium-dependent and sodium-independent exporter of 
mitochondrial calcium (17,27). Mn2+ also interferes with oxidative phosphorylation resulting in 
depletion of ATP (28). Taken together, inhibition of mitochondria function and depletion of ATP 
may be the prevalent mechanism behind Mn2+-induced cell death, even in the presence of apoptotic 
signaling (25). Figure 3-9 shows the mechanisms that are known to regulate cellular transport and 
toxicity of Mn2+.  
 
3.3.1 Mn2+ In Vivo After Intravenous (I.V.) Infusion 
 
Regions of Mn
2+
 Accumulation After I.V. Infusion 
In the arc-welder case study, the primary route of entry of Mn2+ was through inhalation with 
clear neurotoxic effects. After oral administration or ingestion, the gastrointestinal tract metabolizes 
Mn2+.  Manganese is then transported to the central nervous system (in Mn3+ form) by a path which 
includes the portal venous circulation, binding to transferrin in blood and then transported across the 
blood-brain barrier (BBB) via transferrin receptors (7). The rate at which Mn2+ is absorbed by the 
gastrointestinal tract depends on the amount ingested or administered and the plasma levels of Mn2+. 
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Figure 3-9: Mechanisms regulating Mn2+ cellular transport and toxicity. Mn2+ and iron are taken up into cells via 
transferrin-dependent and independent pathways requiring the divalent metal transporter 1 (DMT 1). Mn2+ is also 
transported into cells via the voltage-regulated Ca2+ channel (VR-Ca2+) and glutamate receptor Ca2+ channel (Glu Rec). 
Once inside the cell, Mn2+ is transported into the mitochondria via the Ca2+ uniporter. Mn2+ interferes with mitochondrial 
F1-ATPase and complex I (CI) causing a decrease in ATP production. Mn2+ inhibits Na+-dependent and –independent 
export of Ca2+ out of the mitochondria causing activation of the permeability transition pore (PTP), which eventually 
leads to disruption of mitochondrial function. Disruption of mitochondria leads to stress and possible reactive oxygen 
species (ROS) promoting both apoptotic and necrotic cell death. Reproduced from Ref. (25). 
 
The amount of Mn2+ absorbed in rats is anywhere between 1% and 4% (7,29). Intravenous 
(i.v.) administration of Mn2+ is common and usually includes an infusion of solutions of MnCl2 
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experimentally or Mn-DPDP clinically. Intravenous infusion bypasses some of the body’s 
safeguards or ‘Mn2+ filters’, an idea supported by the fact that the median lethal dose of orally 
administered MnCl2 in rats (7.5 mmol/kg) is 25 times higher than that after intravenous infusion (0.3 
mmol/kg) in mice (30). After i.v. infusion, Mn2+ accumulates in liver, kidney, pancreas, heart and 
brain. Of particular interest here is the accumulation of Mn2+ in brain after an i.v. infusion (and 
without experimental blood-brain barrier disruption). Uptake of Mn2+ into brain after i.v. infusion is 
a time-dependent phenomenon. Takeda et al. showed that 1h after i.v. infusion of 54MnCl2, 
54Mn was 
largely concentrated in the lateral and third ventricles including the choroid plexus. At 6 days after 
injection, high levels of 54Mn were found in the thalamus, hypothalamus, hippocampus and other 
subcortical brain regions (31). One day after i.v. infusion, Aoki et al. showed brain accumulation of 
Mn2+ in ventricles, circumventricular organs without a blood-brain barrier such as Pit and 
subfornical organ (32-34), olfactory bulb, hippocampus, basal ganglia, ventral striatum, brain stem 
and spinal cord (4).  
 
Mn
2+
 in Blood 
After a bolus i.v. infusion of Mn2+ in rats, Mn2+ concentration in plasma decays according to 
a bi-exponential equation. As indicated by the results of a study performed by Zheng et al., a bolus 
i.v. injection of MnCl2 into male Sprague-Dawley rats results in the blood plasma concentration-time 
profile shown in Figure 3-11. Concentration of Mn2+ in blood as a function of time was also given 
as: 
 
tt eetC 44.024.4 08.294.41)( −− +=  
After i.v. bolus injection, therefore, Mn2+ appears to undergo two phases of elimination from the 
body; an initial fast phase and a slower terminal phase. Zheng et al. found the initial fast clearance 
phase to last for 1.8 hours while the slower terminal phase of Mn2+ clearance lasted 12 hours; at 
which time the concentration of Mn2+ in plasma returned to normal values in all animals (35). 
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Figure 3-10: Plasma concentration-time profiles of Mn2+ in male Sprague-Dawley rats following an i.v. administration of 
MnCl2 (6.0 mg Mn
2+/kg). Plasma concentration of Mn2+ was determined by atomic absorption spectrophotometry 
analysis. The line indicates the best fit of a two-compartment model with first-order elimination from the central 
compartment to the observed data. Reproduced from Ref. (35). 
 
The reason for the bi-exponential nature of Mn2+ clearance from blood is likely due to the 
different rates of clearance of Mn2+ from liver and from brain. Mn2+ levels in liver after i.v. injection 
are quick to decrease (90% decrease in 5 days) as compared to clearance in brain (which showed an 
increase in Mn2+ concentration in same 5-day period) (36). When in blood, Mn2+ binds weakly to 
serum albumin, and strongly to transferrin (7,37,38). As a result of binding to transferrin, Mn2+ may 
be transported across the BBB where it accumulates in areas of brain that are efferent to areas of 
high transferrin receptor density, such as ventral-pallidum and globus pallidus, which receive input 
from caudate-putamen and substantia-nigra (two regions rich in transferrin receptors (39)).  
 
Elimination of Mn
2+
 
Excretion of free and protein-bound Mn2+ from the body occurs predominantly through the 
bile across a concentration gradient suggesting an active transport mechanism (7). Mn2+ is also 
excreted by gastrointestinal mucosa and pancreatic secretions with practically no secretion via the 
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kidneys (19). In situations of chronic liver disease, elimination of Mn2+ is incomplete, resulting in 
long-term storage of Mn2+ in the basal ganglia region of the brain (40). 
 
 
 
3.4 Mn2+ Transport Across the Blood-Brain Barrier (BBB) 
Mechanisms exist for the transport of Mn2+ across the BBB as evidenced by the fact that 
proper brain cell function is dependent upon Mn2+ and that Mn2+ must be introduced into blood 
through dietary ingestion. Mn2+ transport across the BBB, therefore, must be mediated by transport 
and/or diffusion mechanisms to limit amounts of Mn2+ in blood that may prove cytotoxic. 
Understanding the mechanisms of Mn2+ transport across the BBB can help to elucidate the 
cytotoxicity of Mn2+. In addition, as will be described later, certain experiments using Mn2+ as a MR 
contrast agent rely on the transport of blood Mn2+ across the BBB for brain anatomical and 
functional imaging.  
 
Mn
2+
 Transport Across the BBB 
In most experimental studies, Mn2+ is infused in vivo as a solution of MnCl2. In this form, 
Mn2+ is in the 2+ oxidation state (divalent Mn2+). In blood, Mn2+ can be oxidized to the 3+ oxidation 
state (trivalent Mn2+) by ceruloplasm. Trivalent manganese has been shown to access the brain via a 
transferrin receptor-mediated mechanism at the BBB (41); but, as suggested later by experiments in 
hypotransferrinemic mice, tissue distribution of divalent Mn2+ did not depend on transferrin in blood 
(42,43). Additional experiments have argued for and against a divalent metal transporter (DMT-1) at 
the BBB. Gunshin et al. argue that Mn2+ ion influx into brain is mediated by DMT-1 (44) while a 
study by Crossgrove et al. suggests the lack of DMT-1 in rats does not affect the transport of Mn2+ 
into brain (45). An additional study by Crossgrove and Yokel provide further evidence against 
DMT-1 as a transporter of Mn2+ into brain. According to their results, Mn2+ entry into brain depends 
on at least two pathways; one that does not have a high affinity for calcium and one that is a nickel-
blocked, cyclopiazonic acid-induced calcium pathway consistent with store-operated calcium 
channels (45). A study of Mn2+ transport using an in vitro model of the BBB tested the role that 
temperature, energy, pH, iron (Fe) and sodium (Na) may play in the transport of Mn2+ across the 
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BBB. In their model, Fitsanakis et al. confirmed that Mn2+ transport is temperature dependent 
suggesting that the transport of Mn2+ across the BBB is not due to simple diffusion (46). Also, their 
data suggest that a proton gradient is related to Mn2+ transport across the in vitro BBB and that Mn2+ 
transport is Na+-dependent – but may not be Fe-dependent – due to discrepancies with in vivo Fe 
data (47). As Fitsanakis et al. suggest, Mn2+ and Fe2+ either share a common BBB-transport 
mechanism or regulation of brain Fe2+ and Mn2+ concentrations is tightly linked. According to the 
literature reviewed here (and others not cited), no single transporter is responsible for Mn2+ influx 
into brain. Experiments in vitro and in vivo clearly show passage of Mn2+ across the BBB and brain 
neurotoxicity due to Mn2+ exposure is well known. New methods are gaining acceptance as non-
invasive means of detecting Mn2+ in brain. MRI is one method that can be used to detect significant 
quantities of Mn2+ in brain after experimental i.v. infusion of Mn2+ solutions.  
 
3.5 Mn2+ as MR Contrast Agent – Mn2+-Enhanced Magnetic Resonance Imaging 
(MEMRI)  
 
Early uses of Mn2+ as a MR contrast agent were primarily focused on liver imaging, owing to 
the ability of Mn2+ to selectively accumulate in hepatocytes. A chelated form of Mn2+, FDA-
approved Mn-DPDP, was used to reduce the toxic side effects of the free manganese ion, Mn2+. In 
this section, a brief review of imaging with Mn-DPDP is given followed by a review of MR imaging 
of brain anatomy and function using Mn2+ administered as MnCl2. MR imaging after injections of 
either Mn-DPDP or MnCl2 constitute Mn
2+-enhanced magnetic resonance imaging or MEMRI. 
  
3.5.1 MEMRI with Mn-DPDP  
Use of Mn2+ as a clinical organ-specific contrast agent requires the metal complex to be 
designed such that it continues to affect MR relaxation rates in vivo but does not adversely affect the 
health of the patient (thus becoming a ‘chelated’ contrast agent). Complexation of divalent 
manganese (Mn2+) with an organic ligand fodipir (DPDP) results in a paramagnetic chelate useful as 
a clinical contrast agent. This type of clinical Mn2+ contrast agent is referred to as Mangafodipir (Mn 
dipyridoxyl diphospate) trisodium or Mn-DPDP (48). The molecular structure of Mn-DPDP is 
shown in Figure 3-12.   
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Figure 3-11: Molecular structure of Mn-DPDP trisodium. Reproduced from Ref. (48). 
 
Mn-DPDP is metabolized by dephosphorylation to Mn dipyridoxyl monophosphate (Mn-
DPMP) and Mn2+ dipyridoxyl ethylenediamene diacetate (Mn-PLED) and is simultaneously 
transmetallated with zinc to the corresponding zinc compounds (49). Transmetallation releases the 
Mn2+ from the ligand which is likely bound and transported to the liver by α2-macroglobulin and 
albumin (49). In normally functioning liver, hepatocytes take up the majority of Mn2+ (50), which is 
excreted in the feces via the bile (51). Liver metasteses take up little or no Mn2+, leading to a reliable 
method for increasing contrast between normal and diseased liver tissue on MR images. The first 
human liver MR imaging results using Mn-DPDP were reported by Lim et al. (52) in 1991. Images 
(acquired using a 1.5T clinical MR scanner) from their experiments are shown in Figure 3-12.  
 
 
Figure 3-12: MR images of the liver obtained a) before and b) 10 minutes after injection of Mn-DPDP (10µmol/kg, 
0.016ml/sec). Reproduced from Ref. (52).  
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Mn-DPDP continues to be used as a liver MR contrast agent and is helpful in preparing for liver 
surgery. Joarder et al. used Mn-DPDP in preparation for MR-guided thermal ablation of liver tumor 
(53). Clinical images (using a 0.5T open MR scanner) from their work are shown in Figure 3-13.  
 
 
 
Figure 3-13: Axial FMSPGR images showing two colorectal metastases before (a) and after (b) Mn-DPDP.  
Note improved delineation of the metastases adjacent to the IVC and portal and hepatic veins on the post-Mn-DPDP 
scans. Mn2+ not only improves lesion conspicuity but also puncture planning, enabling the avoidance of structures such 
as the IVC and portal vein in this case. Reproduced from Ref. (53) 
 
3.5.2 MEMRI with MnCl2 
Working With Solutions of MnCl2 – Dose, Concentration, pH, and Osmolarity  
Manganese chloride is a salt that is readily available from any major biochemical company 
and, in solution form, is the simplest way to deliver Mn2+ experimentally (i.e., in rats or mice). For 
experiments detailed in this thesis, the hydrated form of Mn2+ chloride, MnCl2·4H2O (molecular 
weight 197.9 g/mol) was used. Solutions of MnCl2 must be compatible with the biological system of 
interest. Therefore, chemical properties of the solution such as osmolarity and pH should be 
considered to reduce potential toxic side effects of Mn2+. Systemic infusions of MnCl2 solution 
should use a [MnCl2] of 100mM to ensure the solution is neither hypertonic nor hypotonic (54). 
Hypertonicity or hypotonicity may be more important for targeted injections such as stereotaxic 
brain infusions. At 100mM, MnCl2 has a pH of 5.5-5.8 (54) significantly below the normal 
physiological level. Bicine dissolved to 100mM in deionized water and pH adjusted to 7.4 with 
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NaOH can be used to keep the pH of MnCl2 solutions to within the physiological range (54). Dosing 
the MnCl2 infusion requires careful attention to the route of administration of Mn
2+ and to the size of 
the animal. Doses used in past MEMRI studies are summarized in Table 3-3. 
 
Species Route Dose Reference 
Rat Intravenous 
Intravenous 
Intra-arterial 
Intravenous 
54 mg/kg 
60 mg/kg 
53 mg/kg 
175 mg/kg 
Lin and Koretsky (1) 
Duong et al (55) 
Aoki et al (56)  
Aoki et al. (57)  
Mouse Nasal 
Intravenous 
Intravenous 
Intraperitoneal 
65 mg/kg 
175 mg/kg 
6.6 mg/kg 
20 mg/kg 
Pautler et al. (58)  
Lee et al. (59)  
Hu et al. (60)  
Watanabe et al. (61) 
  
Table 3-3: Systemic doses of MnCl2 used in current MEMRI experiments. Reproduced from Ref.  (54) 
 
3.5.2.1 – A Review of Experiments in Brain Imaging with MnCl2 
Experiments using MnCl2 for experimental brain anatomical and functional imaging are 
numerous. Therefore, this section is divided into brain imaging using MnCl2 with and without 
disruption of the blood-brain barrier. MEMRI of brain with an intact BBB is useful for brain 
anatomical imaging as well as general functional imaging (i.e., uptake of Mn2+ in neuron-rich areas 
of hippocampus) while MEMRI of brain with a disrupted BBB is more appropriate for imaging of 
specific brain function such as the response to stroke, cortical spreading depression, or forepaw 
stimulation.  
 
MEMRI with MnCl2 – Brain Imaging with Intact Blood-Brain Barrier (BBB) 
Early imaging studies utilizing MnCl2 for Mn
2+-induced contrast enhancement in MR images 
were focused on determining the distribution of Mn2+ in the brain as part of Mn2+ neurotoxicity 
studies. For example, London and colleagues (62) used i.p. injections of MnCl2 in rats to show that 
brain uptake of MnCl2 occurs relatively rapidly in the ventricles and pineal and pituitary glands 
(regions devoid of BBB), supporting further study of the toxicity of Mn2+ after accumulation in these 
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brain regions. More recent MEMRI studies have used:  (1) i.v. infusion (via the tail vein) of MnCl2 
solutions for delineation of neuroarchitecture in rat (57); (2) direct CSF injection of MnCl2 to 
determine distribution of brain Mn2+ uptake via CSF (63); and (3) i.v. infusion of MnCl2 to 
determine the temporal evolution of T1 contrast in brain (59). Due to the fast initial clearance phase 
of Mn2+ in blood (~11 minutes) (35), studies using i.v. infusion of Mn2+ rely on fast uptake of Mn2+ 
by CSF and resulting homogeneous distribution of Mn2+ in brain by cardiac and respiratory 
pulsations that circulate CSF throughout both hemispheres. As shown in these studies, MEMRI is a 
powerful semi-noninvasive tool for imaging the neuroarchitecture of animals. Consider as examples, 
Figures 3-14 and 3-15, which show enhancement of brain neuroarchitecture in rat. MEMRI has the 
potential to become a useful tool to image changes in brain neuroarchitecture in response to 
pathologies.  
 
Figure 3-14: Typical horizontal (left), sagittal (center), and axial (right) cuts from a T1-weighted spin-echo 3D-MEMRI 
of a mouse brain acquired 24 hr after a systemic injection of 88mg/kg of MnCl2. Bright Mn
2+-enhanced structures are 
well visualized in all 3D orientations. CEB: cerebellum; CA1, CA2, CA3: CA formation of hippocampus; DG: dentate 
gyrus; fi: fimbria of hippocampus; IP: interpeduncular nucleus; OB: olfactory bulb; APit, IPit, PPit: anterior, 
intermediate, and posterior lobes of pituitary gland; pv: periventricular tissue zone. The increased contrast allows clear 
visualization of other anatomic details of the complex brain neuroarchitecture. For example, the internal capsule (ic) and 
the gigantocellular reticular nucleus (Gi, below ‘CEB’ in center view, black arrow), appear darker than surrounding 
tissue in the T1-weighted MEMRI. Reproduced from Ref. (59). 
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Figure 3-15: T1-weighted MRI of the hippocampal formation in the rat after systemic MnCl2 infusion. Horizontal slices 
(Bregma: -6mm) of T1-weighted MRI from the hippocampus of a rat after MnCl2 administration: (C) 2 h, and (D) 24 h 
after MnCl2 administration in the same rat. The characteristic arrowhead-shaped DG and hippocampal formation are 
readily detected. fi = fimbria of hippocampus. Reproduced from Ref. (4). 
 
MEMRI with MnCl2 – Brain Imaging after Blood-Brain Barrier (BBB) Disruption 
MnCl2 has recently been shown to be a MR contrast agent that is directly sensitive to brain 
activation (1). The implications of this approach is increased specificity over currently available 
functional brain MRI techniques such as blood oxygenation level dependent (BOLD) imaging (64). 
BOLD imaging tracks brain function by changes in hemoglobin oxygenation status and is, therefore, 
not able to detect brain function directly. Since Mn2+ has been shown to enter active cells through 
Ca2+ channels and Mn2+ is paramagnetic, active regions of brain can be imaged by MEMRI 
providing an approach for direct imaging of brain function. 
 
An experimental limitation to using Mn2+ as a brain-activation-specific MR contrast agent is 
that the BBB must be disrupted to allow passage of Mn2+ into the brain interstitial space in a time-
efficient manner. Historically, for MEMRI experiments, osmotic disruption of the BBB has been the 
method of choice for gaining Mn2+ access to the brain parenchyma. A summary of sugar solution 
concentration, dose, route and rate of infusion, as well as anesthetics used during experiments is 
given in Table 3-4. As is apparent in Table 3-4, a solution of concentrated mannitol is the substance 
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of choice for osmotic BBB disruption in most MEMRI experiments. The common usage of mannitol 
may be a historical trend based on the first MEMRI study used for brain activation. Also, mannitol is 
approved for clinical use, which may explain the typical use of this compound for MEMRI studies. 
  
The use of mannitol as a BBB-opening agent has some disadvantages. Because of the limited 
solubility of 1.37 M (25%) mannitol at room temperature, the solution must be maintained at body 
temperature (37 °C) or warmer to prevent precipitation of the solute prior to in vivo administration. 
If 25% mannitol recrystallizes due to exposure to room temperature for an extended period of time, 
infusion of the solute may result in microinfarcts in the brain (65). For the studies described in this 
dissertation, solutions of arabinose were deemed to be a better choice for osmotic BBB disruption. 
At 1.4 M arabinose will not precipitate out at room temperature because arabinose is 5.5 times more 
soluble than mannitol (see Chapter 2 for more details on arabinose and mannitol). It is noteworthy 
that of the studies listed in Table 3-4 no evidence of BBB disruption is provided. Some experiments 
also fail to list the rate of mannitol infusions. It is well known that the rate of infusion of mannitol is 
an important factor that determines the success of BBB disruption (66). 
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Male Rat 
Species 
Osmotic 
Agent  
(OA) 
OA Dose 
(ml/kg) / 
[OA] 
(Molar) 
OA Route of 
Infusion / Rate 
of Infusion 
(ml/min) 
Anesthetic Reference 
Sprague-
Dawley 
Mannitol 5 / 1.37 Right ECA / 
??? 
1.8-2.5% halothane, 
pancuronium bromide 
Lin et al. (1)  
Sprague-
Dawley 
Mannitol 5 / 1.37 Right ECA /  
2.3 – 2.7 
1-2% halothane, 
continuous 
α-chloralose 
Duong et al.  
(55) 
Wistar-
Hamamatsu 
Mannitol 5 / 1.37 Right ECA / 
??? 
enflurane, 
urethane/  
α-chloralose mixture 
Morita et al. 
(67) 
Wistar Mannitol 5 / 1.37 Right ECA /  
??? (“Bolus”) 
diethyl ether, 
2.0-2.3% halothane, 
urethane/  
α-chloralose mixture, 
Pancuronium  bromide 
Aoki et al.  
(56) 
 Wistar Mannitol 5 / 1.37 Right ECA /  
0.83 
diethyl ether, 1.2-1.5% 
halothane, pentobarbital 
Aoki et al. 
(68)  
Sprague-
Dawley 
Mannitol 5 / 1.37 Right ECA /  
??? (“Bolus”) 
chloral hydrate, 1.2% 
isoflurane 
Henning et 
al. (5)  
 
Table 3-4: Summary of osmotic agent, dose, concentration, route and rate of infusion, and anesthetics used during 
MEMRI experiments that employ osmotic disruption of the BBB for passage of Mn2+ into brain parenchyma.  
 
Future MEMRI studies that depend on homogeneous delivery of Mn2+ to one hemisphere of 
brain should incorporate evidence of BBB disruption to circumvent this discrepancy. A diagram 
showing the arteries that need to be ligated to ensure flow of osmotic solution to one hemisphere of 
brain (with the other hemisphere acting as control) is shown in Figure 3-16.  
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Figure 3-16: Arteries in the rat brain that must be ligated to ensure flow of mannitol or arabinose to one hemisphere of 
the brain for successful osmotic BBB disruption. The common carotid artery (CCA) can be permanently ligated without 
ischemic damage to the brain. However, clamping the CCA temporarily (only during the osmotic infusion) is 
recommended to ensure flow towards the brain during infusion while maintaining normal physiological state of the 
animal for as long as possible. ACA; anterior cerebral artery, MCA: middle cerebral artery, PCA: posterior cerebral 
artery. Recreated based on Ref. (31) 
 
 
Although similar concentration, dose and route of infusion are used to deliver mannitol in the 
studies of Table 3-4, there were some differences in concentration and route of delivery of MnCl2. 
This information is summarized in Table 3-5. Infusion of MnCl2 via the femoral vein has the 
advantage of fairly simple surgical preparation for catheter placement. However, MnCl2 infused into 
the femoral vein is directed towards the heart and can result in cardiac arrest at high concentrations 
of MnCl2 or at rapid infusion rates (unpublished results). Additionally, if MnCl2 infusion via the 
femoral vein is initiated prior to osmotic disruption of the BBB, further stress on the heart by the 
subsequent mannitol infusion (66) can lead to death. A safer route of MnCl2 infusion is via the 
external carotid artery. The same catheter employed for BBB disruption can also be used for delivery 
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of MnCl2, as long as the catheter is warmed (to 37 °C if mannitol is used and remains within tubing) 
between infusions.  An alternative is to flush the catheter with saline between infusions.  
 
Male Rat Species Dose of MnCl2   
[MnCl2] 
MnCl2: Route of 
infusion / Rate of 
infusion 
Reference 
Sprague-Dawley 3.6 µmol/min  
120 mM 
Femoral vein /  
1.8 ml/h 
Lin et al. (1) 
Sprague-Dawley 4.0 µmol/min  
(0.7 - 1.0 ml) 
120 mM 
Femoral vein /  
2.0 ml/h 
Duong et al. (55)  
Wistar-Hamamatsu 2.1 – 3.0 µmol/min 
(1.1 – 1.6 ml)  
100 mM 
Femoral vein /  
1.25 – 1.8 ml/h 
Morita et al. (67)  
Wistar 3.97 µmol/min  
(1.7 ml) 
74.5 mM 
Right Carotid 
Artery / 3.2 ml/h 
Aoki et al. (56) 
Wistar 1.0 µmol/min 
(0.3ml) 
10 mM  
 
Right External 
Carotid Artery / 
4.5 ml/h 
Aoki et al. (68) 
Sprague-Dawley 3.97 µmol/min 
(1.7 ml) 
74.5 mM 
Femoral vein / 
3.2 ml/h 
 
Henning et al. (5) 
 
Table 3-5: MnCl2 dose, concentration, route and rate of infusion in previous MEMRI experiments. 
 
MEMRI with MnCl2 – T1-Enhancement Due to the BBB-Disruption Process 
Ideally, in MEMRI experiments that utilize osmotic BBB disruption, the BBB-opening 
process itself should not result in Mn2+-induced T1-enhancement. Such enhancement may obscure or 
confound any subsequent changes in T1 contrast that might arise from a specific neuronal stimulus. 
Based on the six references in Table 3-4 and 3-5, two show dynamic data that includes MR signal 
intensity before, during, and after mannitol infusion. This data is reproduced here as Figure 3-16 and 
3-17. 
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Figure 3-16: Time course of T1-weighted MRI signal intensity changes in the cortex (■), paraventricular hypothalamic 
nucleus (●), lateral habenular nucleus (▲), lateral ventricle (○), and superior sagittal sinus (∆) in rat brain. Time 0 is the 
start of MR imaging. The period of MnCl2 infusion is shown by the horizontal bar and the points at which the mannitol 
and NaCl injections were given are shown by the arrows. Reproduced from Ref. (67). 
 
Data points shown in Figures 3-16 and 3-17 are MR signal intensity values in various regions 
of the brain as a function of time relative to the initiation of MnCl2, mannitol, glutamate, and NaCl 
infusion. As shown in Figure 3-16, brain MR signal intensity changes due to MnCl2 infusion alone 
do not vary as a function of time except in the lateral ventricle and the superior sagittal sinus. 
Following mannitol infusion, however, significant signal changes are detected in the ventricle and 
the cortex. Following BBB disruption (and with concurrent MnC12 infusion), the injection of 
glutamate – an excitatory neurotransmitter – initiates Mn2+ uptake into excitable cells.  The resulting 
increase in T1-weighted MR signal intensity allows visualization of the excited brain regions.  From 
Figure 3-17, it is apparent that glutamate administration is associated with further MR signal-
intensity increases; however, the relative change is somewhat obscured by the previous signal 
increase observed following BBB disruption by mannitol. Although the specifics of the two 
experiments depicted in Figure 3-16 and 3-17 are different, such as delivery route and concentration 
of MnCl2, there is a clear need to monitor MR signal intensity after disrupting the BBB. Non-
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specific changes in T1-contrast, such as those shown in Figure 3-16 and 3-17, could be 
misinterpreted as brain activity resulting from a specific neuronal stimulus.  
 
Figure 3-17: Typical dynamic activity-induced time-courses of relative signal intensities in the cortex and ventricle 
obtained from the glutamate administration (filled symbols) and control (open squares) groups. The inset indicates 
typical ROIs. The first set of images (#1-16) was obtained before D-mannitol administration, but after start of MnCl2 
infusion. The second set (#17-32) was obtained before injection of glutamate, but after opening the BBB with mannitol. 
The signal increases significantly, in a non-specific manner, following opening of the BBB. The third set (#33-48) was 
obtained after glutamate injection. The signal intensity in the cortex of the glutamate-administration group (filled circles) 
increases substantially after glutamate injection, but not in the control group following saline administration (open 
squares). The fourth set (#49-64) was obtained during rest after cessation of the MnCl2 infusion. Reproduced from Ref. 
(56). 
 
MEMRI with MnCl2 after BBB Disruption  – The Importance of Anesthetic Depth 
In addition to non-specific T1-contrast due to the BBB disruption process, insufficient levels 
of anesthetic have been shown to result in Mn2+-induced T1-contrast in MR images.  Lin and 
Koretsky showed that when halothane anesthetic level was reduced from 1.3% to 0.3%, large non-
specific signal intensity changes were seen in the Mn2+-loaded brain after BBB disruption by 
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mannitol (1). Figure 3-18 is a reproduction of images acquired by this group under these 
circumstances. Clearly, the level of anesthesia is critical for suppression of non-specific T1-
enhancement in MEMRI experiments. Curiously, however, the subject of anesthesia and the 
electrical state of brain during MEMRI experiments has not been discussed in depth in the literature. 
A brief discussion of depth of anesthesia, as it relates to MEMRI, has been reported as a subsection 
in an article by Aoki et al. (57). An important conclusion by these investigators, with regard to 
anesthetics and MEMRI, is that “the optimal anesthetic level is the one that suppresses overall 
baseline activation without inhibiting activation of intentionally stimulated areas.” Much work is 
needed to determine the proper level of anesthesia for suppression of baseline brain activity in 
MEMRI experiments.  Comparisons of different anesthetics and anesthetic mixtures are needed to 
optimize the results from MEMRI experiments that rely on specific neuronal stimuli. 
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Figure 3-18:T1-weighted MRI signal enhancement in the presence of MnCl2 due to light anesthesia (A, B, and C) and 
compared with normal anesthesia (D, E, and F). (A,B) Representative images obtained from a rat anesthetized with 0.3% 
halothane. The steady-state MnCl2 infusion (3.6 µmol/min) was started 25 min after lowering the halothane dose. (A) T1-
weighted image obtained 47 min after initiating MnCl2 infusion with intact BBB. (B) T1-weighted image taken 18 min 
after unilateral BBB opening and 70 min after the onset of MnCl2 infusion. (C) Difference image formed from (B) – (A). 
(D,E) Representative images obtained from a rat anesthetized with 1.3% halothane. (D) T1-weighted image obtained 37 
min after initiating MnCl2 infusion with an intact BBB. (E) T1-weighted image taken 20 min after unilateral BBB 
opening and 60 min after the onset of MnCl2 infusion. (F) Difference image formed from (D) – (E). Reproduced from 
Ref. (1) 
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Abstract 
 
Blood-Brain Barrier (BBB) opening was visualized using manganese-enhanced MRI 
(MEMRI) following hyperosmotic disruption of the endothelial cells in the cerebral vasculature of 
the rat brain. BBB disruption was verified histologically using Evans Blue (EB) staining. Evans Blue 
dye was mixed with MnCl2 to provide a means of tracing the distribution of i.v. administered 
Mn2+ in brain following osmotic BBB disruption. Nonspecific MEMRI signal increase (MEMRI 
signal-enhancement) was observed following infusion of 5ml/kg 1.6M arabinose into the internal 
carotid artery. Relative to the contralateral control region, MEMRI signal-enhancement was: (1) 
81% ± 23% in animals anesthetized with 2% isoflurane (MnCl2+EB infused two minutes after 
osmotic BBB disruption); (2) 77% ± 22% in animals anesthetized with 3% isoflurane (MnCl2+EB 
infused two minutes after osmotic BBB disruption); (3) 76% ± 33% in animals infused with 
MnCl2+EB ten minutes following osmotic BBB disruption (2% isoflurane anesthesia); and (4) 42% 
in one animal infused with MnCl2 only. A significant difference (P < 0.05) in MEMRI signal-
enhancement was found between the animal infused with MnCl2 only (ten minutes after osmotic 
BBB disruption, 2% isoflurane) and animals infused with MnCl2+EB (two minutes after BBB 
disruption, 2% isoflurane). MEMRI signal-enhancement was seen in the hippocampus (CA1-CA3), 
cortex, caudate putamen, hypothalamus and geniculate nucleus. A quantitative comparison of brain 
regions with MEMRI signal-enhancement and those stained on Evans Blue histological sections 
showed good correlation and correspondence between the two methods. It is not likely that MEMRI 
signal-enhancement, as reported here, is due to the uptake of manganese into active brain cells as a 
result of low anesthetic depth. We hypothesize that nonspecific MEMRI signal-enhancement is due 
to diffuse uptake of Mn2+ by brain cells adjacent to endothelial-cell tight junctions undergoing 
osmotic transitions or by irreversibly damaged neurons. The results from this study suggest that the 
osmotic BBB-opening process itself gives rise to non-specific MEMRI signal-enhancement 
following MnCl2 administration.  This source of MEMRI signal-enhancement confounds the 
interpretation of data from experiments that attempt to visualize a specific neuronal stimulus in the 
brain using the same method. Alternatively, MEMRI may prove to be a useful method for imaging 
experimental BBB disruption as a result of disease.   
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4.1 Introduction 
 Manganese has recently been reported as a cell membrane depolarization-dependent 
magnetic resonance (MR) contrast agent useful for functional imaging (1), neuronal fiber tracking 
(2,3), and ischemia detection in the brain (4,5). The manganese ion, Mn2+, has an ionic radius and 
charge similar to calcium and is treated similarly to calcium in biological systems (6). With five 
unpaired electrons, Mn2+ is a strong paramagnetic cation and thus useful as a MR contrast agent. The 
T1 and T2 relaxation times of cellular water can be significantly reduced when Mn
2+ enters glia 
and/or neurons through voltage-gated calcium channels during nerve action potentials (1,6). This 
mode of Mn2+ entry is supported by observations that the calcium-channel blocker verapamil can 
inhibit the influx of Mn2+ into cells (7). The manganese-induced changes in T1 result in localized 
increases in signal intensity on T1-weighted MR images (i.e., MEMRI signal-enhancement). 
Experiments using MEMRI to image brain function rely on delivery of divalent manganese ion 
(Mn2+) to the brain parenchyma via an osmotically-disrupted blood-brain barrier (BBB). Subsequent 
brain activation results in cellular uptake of Mn2+ through voltage-gated calcium channels. Ideally, 
the action of osmotic BBB disruption does not itself induce cellular uptake of Mn2+ that would give 
rise to MEMRI signal-enhancement.  However, if this is not the case, any change in T1 contrast by 
the action of osmotic BBB disruption could potentially obscure subsequent MEMRI signal-
enhancement related to a specific neuronal stimulus. 
 
4.1.1 Challenges in MEMRI 
  
Non-Specific MEMRI Signal-Enhancement in MEMRI Experiments 
Monitoring specific brain activity using MEMRI requires minimal activity in brain due to 
baseline neuronal activity, environmental stimuli and/or physiological state of the animal. These 
factors can be controlled by deep anesthesia, pain relief, immobilizing drugs, and physiological 
monitoring during the experiment. Lin and Koretsky showed the importance of anesthetic depth in 
preventing unintended (i.e., non-specific) brain activity during an MEMRI experiment (1). During 
their experiment, halothane anesthetic was reduced from 1.3% to 0.3% resulting in non-specific 
MEMRI signal-enhancement. Aoki et al. (4) also detected non-specific brain activity on MEMRI 
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when animals were anesthetized with 2.5% isoflurane; experienced brain swelling (after mannitol 
injection); and responded to MR scanner acoustic noise. A summary of images acquired by Aoki et 
al. is given in Figure 4-1.  
 
 
 
Figure 4-1: Brain swelling after mannitol injection (A), inhomogeneous BBB disruption and MEMRI signal-
enhancement after infusions of glutamate (B), MEMRI signal-enhancement due to acoustic noise from gradient coil (C), 
and MEMRI signal-enhancement in lateral hypothalamus without stimulation 15 min after MnCl2 administration (D). 
(A) Images obtained from a rat on 2.0% halothane without control of intracranial pressure (A1) and with pre-infusion of 
15% mannitol (A2, 0.25 ml/min) before BBB disruption. (B) MEMRI signal-enhancement obtained after 25mM MnCl2 
and glutamate mixture injection with BBB disruption. Inhomogeneous BBB disruption was observed after Anti-EBA 
injection in this case (B1). MEMRI signal-enhancement was homogeneous after MnCl2 and glutamate injection in the 
case (B2). (C) Moderate MEMRI signal-enhancement was observed over the entire cortex and caudate-putamen without 
(C1) and with (C2) earplug for blocking noise from the magnetic-field-gradient coils used for MRI. (D) T1-weighted 
images obtained immediately (D1) and 15 min (D2) after 25 mM MnCl2 injection from carotid artery without any 
stimulation under 2.5% isoflurane. MEMRI signal-enhancement in the lateral hypothalamus was observed on the 
difference image (D3) formed from (D2) – (D1). Reproduced from Ref. (4). 
 
Non-specific MEMRI signal changes following osmotic BBB disruption in presence of 
intravascular Mn2+ were also observed in rats anesthetized with urethane/α-chloralose mixture (8) 
and chloral hydrate (9). Therefore, although low levels of anesthetic are detrimental for certain 
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MEMRI experiments, the timing of osmotic BBB disruption relative to Mn2+ infusion may also 
contribute significantly to unwanted non-specific MEMRI signal-enhancement.  
 
Delivery of Mn into Brain - Challenges at the Blood-Brain Barrier (BBB) 
A technical challenge accompanying certain MEMRI experiments is the introduction of Mn2+ 
into the brain extracellular space prior to a specific neuronal stimulus. Mn2+ in blood plasma crosses 
from blood into brain via carrier-mediated processes at the blood-brain barrier (BBB) but this 
process is relatively slow. For MEMRI experiments investigating brain response to specific neuronal 
stimuli, the Mn2+ must be present in the brain parenchyma at the time of neuronal stimulus to ensure 
that different levels and/or regions of MEMRI signal-enhancement accurately reflect different levels 
and/or regions of brain activity, respectively. The Mn2+ is generally delivered to the interstitial space 
by disrupting the blood-brain barrier (BBB) by infusion of hyperosmolar sugar (mannitol or 
arabinose) solution (osmotic BBB disruption). Recent MEMRI experiments report no MEMRI 
signal-enhancement as a result of osmotic BBB disruption (1,9); however, these and other recent 
MEMRI experiments have not reported evidence of the degree of BBB disruption (1,5,8-11). 
Without evidence of BBB disruption, the distribution of Mn2+ in the brain prior to neuronal stimulus 
is assumed to be spatially homogeneous. This assumption may prove false leading to inaccurate 
interpretation of images during MEMRI experiments. Additionally, BBB disruption may be spatially 
heterogeneous resulting in higher concentrations of Mn2+ being delivered to certain regions. 
Heterogeneous MEMRI signal-enhancement in this situation can be difficult to interpret with respect 
to the regional response to brain activation.  
 
4.1.2 Evans Blue as a Marker for Osmotic BBB Disruption 
 
The BBB – located at the cerebrovascular endothelium – prevents passage of proteins, 
electrolytes, and water-soluble non-electrolytes from blood into the brain. To open the BBB to non-
permeable substances – such as chemotherapeutic drugs – the BBB can be disrupted by infusion of 
hyperosmolar mannitol (12) or arabinose (13) solutions. Evans Blue (EB) dye (a tetrasodium diazo 
organic salt with MW = 960.8 (14)) has been used for several decades as a means to measure the 
integrity of the BBB in animals after hyperosmotic insult (13,15,16). The pure dye, or the dye bound 
to serum albumin, is excluded from the brain by a healthy intact BBB.  
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4.1.3 Co-Infusion of MnCl2 and Evans Blue (EB) Dye as a Qualitative Method for Validating 
MnCl2 Distribution in Brain 
After infusion into the bloodstream, Evans Blue (EB) dye binds quickly (≤ 5 min (17)) and 
strongly (14) to albumin resulting in a molecule with molecular weight of approximately 68,500 Da. 
Manganese can also bind to albumin in the blood plasma; however, depending on the residence time, 
Mn2+ is oxidized to Mn3+ and then binds preferentially to transferrin at iron (Fe) binding sites 
(18,19).  Critchfield et al. (20) showed in vitro that 54Mn binds to several proteins and after 1 minute 
and 1 hour approximately 15% and 40%, respectively, of the 54Mn in blood binds to transferrin. 
During the early stages (< 30 min), most plasma Mn2+ is bound to a very low molecular weight 
(VLMW) ligand (<1 kDa) which may be responsible for regulating the oxidation of Mn2+ to Mn3+ 
(20). The VLMW ligand is not albumin since the protein is known to have a molecular weight of 
66.3 kDa (21). Additionally,  there is almost no tendency for Mn2+ to bind to –SH groups or to 
amines and Mn2+ has very low affinity for endogenous complexing ligands (log10k = 3, 4, 5, and 3, 
for glycine, cysteine, riboflavin, and guanosine, respectively, where k is the affinity constant) 
(22,23). Although Mn and EB bind to different serum proteins in blood – resulting in different size 
molecules – in a solution containing Mn and EB, both protein complexes are expected to have 
similar access to the brain parenchyma following osmotic disruption of the BBB. 
Indeed, Ziylan and coworkers suggest that convective bulk flow contributes to molecular 
size-independent BBB transfer following osmotic BBB disruption (24). The physiological evidence 
to support bulk flow following osmotic BBB disruption is a transient increase of 1-1.5% in brain 
water content 10 minutes after hyperosmolar arabinose infusion into rat brain (13). Consequently, 
for blood infused with a solution of both Mn2+ and EB, the evidence suggests that since the two 
substances will not compete for binding to the same serum protein, the protein complexes of both 
compounds will be transported across the osmotically-disrupted BBB to a similar extent. One aim of 
this study is to use EB dye to provide evidence of BBB opening in MEMRI experiments by co-
infusing EB dye with Mn2+ following disruption with hyperosmotic arabinose.   Since EB dye is a 
known marker for BBB integrity (12), co-infusing EB with Mn2+ should provide a qualitative and 
quantitative marker for the degree of osmotic BBB disruption as well as the distribution of Mn2+ in 
rat brain that could potentially contribute to MEMRI signal-enhancement.  
Although T1 enhancement associated with the Mn
2+ delivery process itself is undesirable, the 
ability to visualize the spatial extent and degree of BBB disruption could be important.  For example, 
the lack of MEMRI signal-enhancement following a stimulus could result from ineffective delivery 
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of Mn2+ to the parenchyma of brain regions that are expected to exhibit a neuronal response; 
potentially confounding the interpretation of the experimental results. Alternatively, MEMRI may be 
useful for visualizing pathology whose etiology involves BBB disruption.   
 
 
 
4.1.4 Experimental Design to Test Mechanisms of Nonspecific MEMRI Signal-Enhancement 
In this paper we evaluate the experimental conditions that may give rise to nonspecific 
MEMRI signal-enhancement following Mn2+ delivery to the brain parenchyma via osmotic BBB 
disruption. Quantitative characterization of the mechanistic and spatio-temporal aspects of these 
changes would be helpful in separating MEMRI signal changes associated with Mn2+ delivery from 
those associated with a particular response to a neuronal stimulus. Specifically, we have designed 
experiments to test the dependency of non-specific MEMRI signal-enhancement on; 1) anesthetic 
(isoflurane) level and 2) the timing of MnCl2+EB infusion relative to osmotic BBB disruption.  
As noted by Aoki et al. (4) and Lin et al. (1) the anesthetic condition of the animal is 
important for prevention of non-specific MEMRI signal change. However, in these past studies, data 
from only one animal is provided.  In the current study, therefore, we propose a controlled study of 
anesthetic level and its effect on non-specific MEMRI signal-enhancement following osmotic BBB 
disruption. In addition, because mannitol causes blood pressure fluctuations in rats that stabilize 
approximately 2 min following bolus injection (25) we propose to test the dependency of non-
specific MEMRI signal- enhancement on the timing of MnCl2 infusion in relation to osmotic 
challenge by infusing MnCl2+EB 2 and 10 minutes after osmotic BBB disruption. We restrict the 
later MnCl2+EB infusion time to 10 minutes in order to correspond to the time window during which 
the BBB is open to molecules of size large enough to allow entry of MnCl2 (MW=198), EB 
(MW=961), and EB bound to serum albumin (MW=68,500) (24). We hypothesize that increasing 
the level of anesthesia from 2% isoflurane to 3% isoflurane and delaying the infusion time of 
MnCl2+EB from 2 to 10 minutes following osmotic BBBD will significantly reduce non-specific 
MEMRI signal-enhancement.  
 
4.1.5 Relevance of Experiments to Future Work   
Ideally, following osmotic BBBD, no MEMRI signal-enhancement will be observed 
allowing for subsequent neuronal stimulus to generate localized T1-weighted signal changes in brain. 
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Specifically, in our pursuit of imaging experimental anoxic depolarization in brain in real-time (in-
bore), experimental methods that decrease or eliminate non-specific MEMRI signal changes would 
be very helpful if not absolutely essential. Therefore, in this chapter we investigate methods to 
reduce or eliminate unwanted MEMRI signal changes in brain. As a continuation of this work in 
Chapter 5, we investigate other unwanted side effects of osmotic BBB disruption that can obscure 
desired MEMRI signal-enhancement and changes in brain that would normally be related 
specifically to anoxic depolarization and/or stroke. Indeed, Aoki et al. have suggested that anoxic 
depolarization is detectable by MEMRI methods (5), but their work does not include histological 
evidence of BBB disruption or of tissue damage by anoxic depolarization making their results 
difficult to interpret. 
 
4.2 Methods 
4.2.1 Animal Preparation 
This study was approved by the Institute Animal Care and Use Committee (IACUC) of the 
University of Massachusetts Medical School (IACUC Protocol A-1756). Male Sprague-Dawley rats 
(250-360g; Charles River Laboratories, Worcester, MA) were divided into five groups: infusion with 
MnCl2+EB 2 minutes following BBB disruption while breathing 2% isoflurane (2% iso/2-min 
group, N=3), infusion with MnCl2+EB 2 minutes following BBB disruption while breathing 3% 
isoflurane (3% iso/2-min group, N=6), infusion with MnCl2+EB 10 minutes following BBB 
disruption while breathing 2% isoflurane (2% iso/10-min group, N=4), infusion with EB only while 
breathing 2% isoflurane (EB control group, N=2), and infusion with MnCl2 only while breathing 2% 
isoflurane (MnCl2-only group, N=1). Data from the 2% iso/2-min group were compared to the 3% 
iso/2-min group and the 2% iso/10-min group to monitor potential changes in MEMRI signal-
enhancement due to; 1) infusion of MnCl2+EB at 2 and 10 minutes following osmotic BBB 
disruption and 2) an increase in anesthetic level. Three rats in the 3% iso/2-min group died due to 
severe cardiac depression and were not used for data analysis. Rats were initially anesthetized with 
5% isoflurane and maintained at 2% isoflurane during surgery. PE-50 and PE-10 polyethylene 
catheters were placed in the left femoral vein (i.v.) for blood pressure and gas monitoring and right 
external carotid artery (ECA) for drug administration, respectively. 
For catheterization of the right ECA, a ventral midline incision was made in the neck. The 
omohyoid muscle was separated longitudinally and retracted laterally to isolate and expose the right 
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common carotid artery (CCA), ECA, internal carotid artery (ICA) and pterygopalatine artery (PPA). 
The PPA was permanently ligated. Following temporary clamping of the CCA, the ECA was ligated 
and a small incision was made into it for placement of the PE-10 catheter. The PE-10 catheter tip 
was inserted such that the tip would not disturb blood flow in the CCA towards the ICA. After 
properly securing the PE-10 catheter, the CCA clamp was removed allowing normal blood flow to 
the right ICA (the CCA was clamped for 10 minutes on average). Cannulation of the right ECA 
limited drug delivery to the right side of the brain allowing the left side to serve as control. During 
the surgical procedures, body temperature was continuously monitored with a rectal probe and 
maintained at 37.0 °C using a thermostatically-controlled heat lamp (Model 73ATD, YSI Inc., 
Yellow Spring, OH).  
 
4.2.2 Osmotic BBB Disruption and MnCl2+Evans Blue Administration 
To disrupt the BBB, 1.6 M L-arabinose or 1.4 M D-mannitol solution (5 ml/kg, Sigma, St. 
Louis) was infused into the right ECA over a period of 55 seconds using an infusion pump (Model 
PHD 2000; Harvard Apparatus, Holliston, MA). Two minutes prior to the 55-second infusion of L-
arabinose, a slow (6 ml/hr) infusion of L-arabinose  – at the same concentration – was initiated and 
continued for 1 minute in an effort to reduce vasogenic edema induced by the osmotic BBB 
disruption (4). Physiologically buffered saline (PBS), containing 10mM manganese chloride 
(MnCl2·H2O; Sigma, St. Louis) and 2% Evans Blue (EB) (Sigma, St. Louis), was infused into the 
right ECA at a rate of 4.5 ml/hr using an infusion pump (Model 11; Harvard Apparatus, Holliston, 
MA) until a volume equivalent to 2 ml/kg was infused. MnCl2+EB mixture solution was infused at 2 
or 10 minutes following osmotic BBB disruption. Infusion of the MnCl2+EB solution in certain 
animals commenced 2 minutes after arabinose injection to coincide with the optimal time window 
during which the BBB is maximally open after osmotic disruption (5-10 minutes (12)). Infusion of 
the MnCl2+EB solution in other animals at 10 minutes after arabinose was scheduled to coincide 
with the optimal time window during which the physiological state of the animal begins to stabilize 
following intraarterial infusion of hyperosmolar agents (25). To minimize the likelihood of 
recrystallization in the catheter tubing during infusion, arabinose was chosen as the osmotic agent 
because of its higher solubility relative to mannitol (a commonly used agent for osmotic BBB 
disruption). To avoid introduction of any micro-emboli, all solutions were filtered with 0.22 µm 
syringe filters (Nygene) prior to administration. 
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4.2.3 Timing of Drug Administration 
In order to evaluate the effects of administration of MnCl2+EB infusion time (relative to 
BBB disruption) on non-specific MEMRI signal-enhancement, a group of animals received 
MnCl2+EB infusion at 10 minutes after BBB disruption (N=4). Timing of infusions are summarized 
in Figure 4-2. 
 
4.2.4 Level of Anesthetic During MnCl2+EB Infusion 
To determine the effect of different levels of anesthesia on non-specific MEMRI signal-
enhancement, animals were subdivided into two groups: infusion of MnCl2+EB with animals 
spontaneously breathing 2% isoflurane in breathing-quality air (N=3) and infusion of MnCl2+EB 
with animals spontaneously breathing 3% isoflurane in breathing-quality air (N=6).  
 
 
Figure 4-2: Timing of MnCl2+EB infusion relative to arabinose infusion.  
 
 
4.2.5 EB Stain Histology 
Immediately following imaging, isoflurane anesthetic was increased to 5% and shortly 
thereafter animals were decapitated. The brain was quickly removed, placed on a section of parafilm 
and subsequently cooled for thirty minutes to facilitate handling. Brains were then dissected into six 
2-mm slices that corresponded spatially to MR slices (first slice at 1mm ventral to the rhinal fissure 
of olfactory bulb). After dissection, brain slices were placed in zinc formalin for fixation overnight. 
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The next day brain slices were scanned using a Hewlett-Packard Scanner (Model #3970) at a 
resolution of 1200 dpi. For the EB control group, animals were perfused with 4% paraformaldehyde 
via the aorta prior to sacrifice to remove EB from the brain capillary system prior to removal of the 
brain. The EB group was used to test whether or not EB staining artifacts were present as a result of 
trapped EB in the brain capillary system.  
 
 
4.2.6 MRI Measurements 
MR experiments were performed using a Bruker Biospin 2.0T/45 cm imaging spectrometer 
equipped with ± 20 G/cm self-shielded gradients. T1-weighted imaging was performed with the 
following acquisition parameters: TR/TE = 500.0/10.8 ms, FOV = 3 cm x 3 cm, matrix size = 
128x128, six slices with 2-mm thickness, NEX = 8. The imaging plane was referenced to the rhinal 
fissure at the boundary of the olfactory bulb. Acquisition time for one set of images was 8.5 minutes. 
Animals were imaged continuously for approximately 2 hours to monitor changes in MEMRI signal-
enhancement. During imaging, animals were placed prone within a home-built animal holder. The 
head of the animal was fixed within an 8-element, 4.3-cm diameter, birdcage 1H volume coil. 
Animals were anesthetized with 2% or 3% isoflurane delivered at 1.5 L/min in breathing-quality air. 
Body temperature was maintained at 37.0 ± 1°C in the magnet by circulated warm air using a T-type 
thermocouple and a double-point feedback control system.   
 
 
4.2.7 Data Analysis 
MEMRI Signal-Enhancement 
MR image reconstruction was performed using Paravision’s Image Processing and Display 
Software (Xtip). Region of interest definitions and calculations were made using ImageJ (NIH) 
software (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/, 1997-2006.). Regions of MEMRI signal-enhancement were determined by 
correlation to a standard rat brain atlas (26), based on the slice location relative to the distance from 
bregma. ROIs were user defined using ImageJ to distinguish between MEMRI signal-enhanced 
regions and normal brain tissue. The percent-signal increase in T1-weighted images was calculated 
by comparing MEMRI signal-enhanced regions in the ipsilateral hemisphere to the homologous 
contralateral control regions on a slice-by-slice basis: 
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where SIIC is the signal intensity for an ROI in the ipsilateral hemisphere and SICC is the signal 
intensity in the homologous contralateral ROI. Ipsilateral ROIs, drawn for percent signal increase 
calculations, and ROIs drawn around the brain were used to determine the spatial extent (area) of 
MEMRI signal-enhancement in mm2 as shown by Eq. 4.2. Data are presented as mean ± standard 
deviation (SD), with a separate term for the inter-slice signal variability (IS-SD).  
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Evans Blue (EB) Histological Image Analysis 
EB stain images (RGB) were transformed into Hue, Saturation, and Intensity using ImageJ 
software. Hue refers to the dominant wavelength in the color image; Saturation represents the degree 
to which white is mixed with the dominant wavelength; and Intensity represents the intrinsic 
reflectivity of the object viewed (27). EB-Saturation images were compared to MR images for 
correlation of EB-stained regions with MEMRI signal-enhanced regions. Percent-saturation increase 
in EB-stained images was calculated by comparing EB-stained regions in the ipsilateral hemisphere 
with the homologous contralateral control regions on a slice-by-slice basis: 
 
100(%) ×
−
=
CC
CCIC
SatInt
SatIntSatInt
IncreaseSaturationEB  
where SatIntIC is the saturation intensity for an ROI in the ipsilateral hemisphere and SatIntCC is the 
saturation intensity in the homologous contralateral ROI. Ipsilateral ROIs, drawn for saturation 
increase calculations, and ROIs drawn around the brain (using RGB EB stain images) were used to 
determine the spatial extent of EB saturation in mm2 as shown by Eq. 4.4. Data are presented as 
mean ± standard deviation (SD), with a separate term for the inter-slice saturation variability (IS-
SD).  
 
4.1 
4.3 
4.2 
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4.2.8 Statistical Analysis 
Comparison between 2% iso/2-min, 3% iso/2-min, 2% iso/10-min, and MnCl2-only groups 
was performed using analysis of variance (ANOVA) with the Tukey multiple comparison method. 
For EB saturation-increase-specific data, Kruskal-Wallis one-way ANOVA was used. Correlation 
between EB-staining data and MEMRI signal- enhancement data was performed using the Pearson 
product moment correlation coefficient. A P value of less than 0.05 was considered significant for 
all statistical tests. All statistical analyses were performed using SigmaStat (v3.5, Dundas Software, 
Ltd. Germany). 
 
4.3 Results 
 
4.3.1 MEMRI Signal-Enhancement 
Regional Coverage and Enhancement Level  
Figure 4-3 shows multi-slice T1-weighted MRI for animals in the EB control group (2% 
isoflurane), MnCl2-only group (2% isoflurane), 2% iso/2-min group, 3% iso/2-min group, and the 
2% iso/10-min group. The MEMRI signal-enhancement is non-specific in each of the groups, since 
no neuronal stimulus was applied to any subjects in the groups. The average percentage increase in 
signal intensity in MEMRI signal-enhanced regions was 42% ± 29% in the MnCl2-only group, 81% 
± 23% in the 2% iso/2-min group, 77% ± 22% in the 3% iso/2-min group, and 76% ± 33% in the 2% 
iso/10-min group. In almost every animal from every group, MEMRI signal-enhancement was 
visible across all six MR slices (exceptions were slice #4 & #5 in 1 animal in the 3% iso/2-min 
group and slice #6 in 1 animal in the 2% iso/10-min group). Brain regions with MEMRI signal-
enhancement included cortex, hippocampus (CA1-CA3), geniculate nucleus, deep mesencenphalic 
nucleus, thalamic nucleus, hippocampal commissure, and caudate putamen. Patterns of MEMRI 
signal-enhancement within or across groups were not observed.  
 
4.4 
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Figure 4-3. T1-weighted MRI (i.e., MEMRI) following Evans Blue administration only (2% isoflurane), MnCl2 only (2% 
isoflurane), and administration of a solution of MnCl2+EB at different anesthetic levels and at a different time relative to 
osmotic BBB disruption. (A) T1-weighted imaging in rat with infusion of EB (2%, 2ml/kg) only 2 minutes following 
osmotic BBB disruption. No contrast enhancement is present. (B) MEMRI signal-enhancement in a rat infused with 
MnCl2 (10 mM, 2 ml/kg, 4.5 ml/hr) 10 minutes after osmotic BBB disruption (MnCl2-only group). (C) MEMRI signal-
enhancement in a rat infused with a solution of MnCl2+EB 2 minutes after BBB disruption while breathing 2% 
isoflurane anesthetic (2% iso/2-min group). (D) MEMRI signal-enhancement in rat infused with a solution of MnCl2+EB 
2 minutes after BBB disruption while breathing 3% isoflurane anesthetic (3% iso/2-min group). In this case, there is 
more contrast enhancement compared to (C). (E) MEMRI signal-enhancement in rat infused with a solution of MnCl-
2+EB 10 minutes following osmotic BBB disruption while breathing 2% isoflurane (2% iso/10-min group). 
 
Quantitative Summary of MEMRI Signal-Enhancement 
Table 4-1 shows the average percentage signal intensity increase and average MEMRI 
signal-enhancement area for different brain regions for the MnCl2-only group, 2% iso/2-min group, 
3% iso/2-min group, and the 2% iso/10-min group. A significant difference in signal intensity was 
detected only between the 2% iso/2-min and MnCl2-only groups (P<0.05, one-way ANOVA, Tukey 
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multiple comparison method). Increasing isoflurane anesthetic level from 2% to 3% did not result in 
a significant reduction of non-specific MEMRI signal-enhancement.  
Table 4-1: Average MEMRI percentage (%) signal intensity increase (relative to the homologous contralateral region), 
and average MEMRI signal-enhancement area [as a percentage (%) of the total slice volume], for the various treatment 
groups.  
 
Treatment 
Group 
Average MEMRI 
Percentage (%) 
Signal Intensity 
Increase  
in All Brain 
Regions   
(using Eq. 4.1) 
Average MEMRI Signal-
Enhancement Area (as a 
percentage (%) of the total 
slice volume) in All Brain 
Regions  
(using Eq. 4.2) 
 
 
 
MnCl2-only 
 
2% iso/2-min  
 
3% iso/2-min 
 
2% iso/10-min 
 
Mean ± 
SD 
 
42 ± 29 
 
81 ± 23 
 
77 ± 22 
 
76 ± 33 
 
ISSDa 
 
 
29 
 
15 
 
11 
 
16 
Mean ± 
SD 
 
15 ± 13 
 
24 ± 12 
 
24 ± 14 
 
32 ± 13 
 
ISSDa 
 
 
13 
 
9 
 
10 
 
13 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average percentage (%) signal intensity increase (relative to the homologous contralateral region) across slices with 
MEMRI signal-enhancement.  
 
Stability of MEMRI Signal-Enhancement 
MEMRI signal-enhancement in all animals was found to change over time. MEMRI signal-
enhancement had a tendency to spread to surrounding pixels over the 90-100 minutes of scanning. In 
an animal from the 2% iso/2-min group, signal intensity in the caudate putamen was found to 
increase 36% over the 100-minute imaging time (the homologous contralateral control region 
showed a decrease in signal intensity of 9% in the same time period). The ROIs used to determine 
the signal intensity increase over time are shown in Figure 4-6. The signal intensity dynamic curve 
for these ROIs is shown in Figure 4-7. 
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Figure 4-6: ROI definitions for determination of MEMRI signal-enhancement over time. Left: first T1-weighted image 
(slice #5). Right: Last T1-weighted image acquired ~100 minutes following the first image. Notice the spread of the 
MEMRI signal-enhancement over time as well as the increase in signal intensity within the ipsilateral ROI.  Note also 
the diffuse MEMRI signal intensity changes over time in some regions (black arrows).  
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Figure 4-7: Dynamic MEMRI signal intensity changes from the respective ROIs shown in Figure 4-6. As the ipsilateral 
ROI is ‘filled in’ with MEMRI signal-enhancement, the mean signal intensity in this region increases. The maximum 
signal intensity value in the ipsilateral ROI increased from 9.1x108 to 10.2x108 (AU); however, the average values 
plotted above are lower due to the inclusion of unenhanced pixels within the ROI.  
 
4.3.2 Evans Blue (EB) Stain 
Regional Coverage and Saturation Enhancement Level  
Figure 4-8 shows multi-slice EB-stained images for animals in the EB control group, 2% 
iso/2-min group, 3% iso/2-min group, and the 2% iso/10-min group. To quantify the degree of EB 
staining, the EB-stained images were transformed into Hue, Saturation, and Intensity images. An 
example of this transformation is provided in Figure 4-9 using one animal from the 2% iso/2-min 
group. The EB-Saturation image provided the best contrast for quantifying the EB-staining level as 
compared to the EB-Hue and EB-Brightness images. The average percentage increase in saturation 
intensity in the EB-stained regions was 273% ± 80% in the 2% iso/2-min group, 332% ± 170% in 
the 3% iso/2-min group, 157% ± 80% in the 2% iso/10-min group, and 28% ± 30% (0% in one out 
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of two animals) in the EB control group. Brain regions with EB staining included cortex, 
hippocampus (CA1-CA3), geniculate nucleus, deep mesencenphalic nucleus, thalamic  
 
 
Figure 4-8: Evans Blue (EB) staining following EB administration only, and administration of a solution of MnCl2+EB 
at different anesthetic levels and at different times relative to osmotic BBB disruption. (A) EB staining in rat with 
infusion of EB (2%, 2ml/kg) following osmotic BBB disruption (EB control group). This rat was perfused with saline 
prior to removal of the brain which may account for the lack of gross EB stain in these slices. (B) EB stain in rat infused 
with a solution of MnCl2+EB 2-min after osmotic BBB disruption while breathing 2% isoflurane (2% iso/2-min group) 
(C) EB staining in rat infused with a solution of MnCl2+EB 2-min after osmotic BBB disruption while breathing 3% 
isoflurane anesthetic (3% iso/2-min group). (D) EB staining in rat infused with a solution of MnCl2+EB 10-min after 
osmotic BBB disruption while breathing 2% isoflurane anesthetic (2% iso/10-min group).   
 
nucleus, and caudate putamen. Patterns of EB staining within or across groups were not observed but 
were always confined to the right hemisphere as expected. 
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Figure 4-9: Evans Blue (EB)-stained image (A, RGB image) transformed into Hue (B), Saturation (C), and Brightness 
(D) images (8-bit grayscale). The EB-Saturation image provides the best contrast for determining the degree of EB 
staining and the spatial extent of EB-stained regions. The EB-Hue images in this case (and all other animals aside from 
the EB control group) show gross saturation in EB-stained regions and thus are not useful for determining the level of 
EB staining; however, the EB-Hue images may be useful for determining the spatial extent of EB staining.  
 
 
 
Quantitative Summary of Evans Blue (EB)-Staining Intensity 
Table 4-2 shows the average percentage increase in EB-Saturation intensity for different 
brain regions for the EB control group, 2% iso/2-min group, 3% iso/2-min group, and the 2% iso/10-
min group. Significant differences in EB-Saturation intensity were detected between the EB control 
group and all other groups (P < 0.05 for all comparisons) and between the 3% iso/2-min group and 
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the 2% iso/10-min group (P < 0.05). For the EB control group, one animal (out of 2) showed no 
increase in EB-Saturation intensity in the ipsilateral hemisphere compared to the homologouos 
contralateral region. However, when the EB-Hue image was considered, a difference in EB-Hue 
intensity was observed between ipsilateral and contralateral hemispheres. The EB-Hue image may 
be a more sensitive way to detect EB staining when staining is not grossly visible to the naked eye. 
EB-Hue intensity data for both animals in the EB control group are provided in Table 4-3.  
 
Table 4-2: Average percentage (%) increase in EB-Saturation signal intensity (relative to the homologous contralateral 
region), and average EB-Saturation signal-enhancement area [as a percentage (%) of the total slice volume], for the 
various treatment groups. The EB control group was perfused with paraformaldehyde, which may account for the 
significant difference in EB staining and EB-Saturation signal intensity shown here.  
Treatment 
Group 
Average Percentage (%) 
Increase in EB-Saturation 
Signal Intensity  
in All Brain Regions   
(using Eq. 4.3) 
Average EB-Saturation Signal-
Enhancement Area [as a 
percentage (%) of the total slice 
volume] in All Brain Slices 
(using Eq. 4.4) 
 
 
 
EB control 
 
2% iso/2-min 
 
3% iso/2-min 
 
2% iso/10-min 
 
 
Mean ± SD 
 
28% ± 30%*** 
 
273% ± 80% 
 
332% ± 170%** 
 
157% ± 80%** 
 
 
ISSDa 
 
6% 
 
38% 
 
71% 
 
77% 
 
Mean ± SD 
 
17 ± 18 
 
24 ± 10 
 
21 ± 12 
 
32 ± 10 
 
ISSDa 
 
4 
 
5 
 
11 
 
10 
 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average EB-Saturation signal-intensity increase across slices with EB staining. ***Significant difference between this 
and all other groups, P < 0.05. **Significant difference between these groups, P < 0.05. 
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Table 4-3: Average percentage (%) increase in EB-Hue signal intensity (relative to the homologous contralateral region), 
and average EB-Hue signal-enhancement area [as a percentage (%) of the total slice volume], for the EB control group 
following Infusion of EB solution. The EB control group was perfused with formaldehyde prior to sacrifice.  
Treatment 
Group 
Average Percentage 
(%) Increase in EB-
Hue Signal Intensity 
in All Brain Regions   
(using Eq. 4.3) 
Average EB-Hue Signal-
Enhancement Area [as a 
percentage (%) of the total 
slice volume] in All Brain 
Slices (using Eq. 4.4) 
 
 
EB 
control 
 
 
Mean ± SD 
 
72 ± 23 
 
 
ISSD 
 
14 
 
Mean ± SD  
 
34 ± 13 
 
ISSD 
 
7 
 
4.3.3 Correlation Between Regions of MEMRI Signal-Enhancement and Evans Blue (EB) 
Staining 
Regional Coverage, Signal and Saturation Enhancement Level  
Figure 4-10 shows multi-slice EB-stained histological sections and corresponding T1-
weighted MRI slices, for animals in the 2% iso/2-min, 3% iso/2-min, and 2% iso/10-min groups. 
Although EB-stained sections and MR images are not exactly co-registered, it is apparent that there 
is good spatial correspondence between regions of EB staining and MEMRI signal-enhancement. 
When EB staining is not grossly visible on the histological section, the MEMRI signal-enhancement 
in the corresponding regions is low or undetectable. 
Figure 4-11 shows multi-slice EB-stained histological sections (RGB format), EB-Saturation 
images, and the corresponding T1-weighted MEMR images for an animal in the 3% iso/2-min group 
(left) and 2% iso/2-min group (right). In this case, EB-Saturation images provide another means to 
quantitatively and/or qualitatively correlate EB-stained regions with those showing MEMRI signal-
enhancement in the brain. Quantitative correlation of MEMRI signal-enhancement level and EB-
saturation signal level – on a slice by slice basis – resulted in a correlation coefficient, r, of 0.57 (P < 
0.05) in the 2% iso/2-min group, 0.58 (P < 0.05) in the 3% iso/2-min group, and 0.41 (P = 0.09) in 
the 2% iso/10-min group. A stronger correlation was shown between the average percentage 
MEMRI signal-enhancement area and the average percentage EB-saturation signal-enhancement 
area – on a slice-by-slice basis – with r = 0.80 (P < 0.0001) in the 2% iso/2-min group, r = 0.80 (P < 
0.0001) in the 3% iso/2-min group, and r = 0.82 (P < 0.0001) in the 2% iso/10-min group.  
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Figure 4-10: MEMRI and corresponding EB-stained histological images (RGB format). MEMRI slices and EB-stained 
sections for one animal each from the 2% iso/2-min group (A), 3% iso/2-min group (B), and 2% iso/10-min group (C). 
Only one side of the EB-stained histological section shown and does not account for variations in EB staining through 
the 2-mm thickness of the slice (in contrast to the MEMR image, which volume averages the MRI signal intensity 
through the 2-mm thickness of the slice). Slight differences in spatial registration between the two methods arise from 
inherent difficulties in reproducing the slice thickness and slice positions of the histological sections relative to those 
acquired using MEMRI.  However, in spite of this issue, the spatial correlation between regions of MEMRI signal-
enhancement and the corresponding EB-stained regions on the histological sections is readily apparent. 
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Figure 4-11: Evans Blue (EB)-stained histological (left), MEMRI (middle), and EB-Hue images (right) in an animal 
from (A) the 3% iso/2-min group and (B) the 2% iso/2-min group. The EB-Hue transformation provides useful contrast 
for quantifying gross (i.e., by eye) correlations of regions of EB-staining and MEMRI signal-enhancement in brain. 
 
Quantitative Summary of Correlation between MEMRI Signal-Enhancement and Evans Blue (EB) 
Staining 
Table 4-4 summarizes the correlation between MEMRI signal-enhancement level and Evans 
Blue (EB)-Saturation signal-enhancement level and the correlation between MEMRI signal-
enhancement area and EB-Saturation signal-enhancement area. A weak trend was detected in the 
average percentage change in MEMRI and EB-Saturation signal-enhancement levels in all of the 
animal groups. A stronger trend was detected in the correlation between the areas of MEMRI and 
EB-Saturation enhancement in the brain.  
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Table 4-4: Summary of the correlation between MEMRI signal-enhancement level and Evans Blue (EB)-Saturation 
signal-enhancement level; and the correlation between MEMRI signal-enhancement area and EB-Saturation signal-
enhancement area for all treatment groups.  
Treatment 
Group 
Average Percentage (%) MEMRI 
and EB-Saturation Signal 
Intensity Increase in All Brain 
Slices  
(using Eqs. 4.1 & 4.3) 
Average MEMRI and EB-
Saturation Signal-Enhancement 
Area [as a percentage (%) of the 
total slice volume) in All Brain 
Regions 
(using Eqs. 4.2 & 4.4) 
 
 
 
 
 
MnCl2-only 
 
 
EB Control 
 
2% iso/2-min 
 
3% iso/2-min 
 
2% iso/10-min 
MEMRI 
Signal- 
Enhancement 
Mean ± SD 
 
42 ± 29 
 
 
NA 
 
81 ± 23 
 
77 ± 22 
 
76 ± 33 
  
EB 
Saturation 
Mean ± SD 
 
 
NA 
 
 
28 ± 30 
 
273 ± 80 
 
332 ± 170 
 
157 ± 80 
Corr. 
Coeff. 
(r)a 
 
 
NA 
 
 
NA 
 
0.57 
(P<0.05) 
.58 
(P<0.05) 
0.41 
(P = .09) 
MEMRI 
Signal- 
Enhancement 
Mean ± SD 
 
15  ± 13 
 
 
NA 
 
24  ± 12 
 
24  ± 14 
 
32  ± 13 
EB 
Saturation 
Mean ± 
SD 
 
NA 
 
 
17  ± 18 
 
24  ± 10 
 
21  ± 12 
 
32  ± 10 
Corr. 
Coeff. 
(r)a 
 
 
NA 
 
 
NA 
 
0.80 
(P<0.0001) 
0.80 
(P<0.0001) 
0.82 
(P<0.0001) 
aPearson product moment correlation coefficient. 
 
4.4 Discussion 
Mn2+ is a paramagnetic ion and has been used as a brain activation-specific contrast agent in 
rats after osmotic disruption of the BBB (1). Mn2+ enters cells via ligand- or voltage-gated calcium 
channels during nerve action potentials (6) and binds to magnesium and iron-binding sites and 
accumulates within the mitochondria (19). Retention of paramagnetic Mn2+ by cells makes Mn2+ an 
attractive means to ‘record’ brain function by MR imaging. Previous experiments have shown that 
unintended (non-specific) brain activation in the presence of extracellular Mn2+ may be due to a low 
anesthetic state in animals (1) or to the process of osmotic BBB disruption (11). Unintended brain 
activation in MEMRI experiments can obscure subsequent changes in MEMRI signal-enhancement 
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due to specific neuronal stimulus. No previous MEMRI study has shown histological evidence of 
osmotic BBB disruption prior to or following brain activation. Knowledge of the extent of BBB 
disruption prior to i.v. administration of Mn2+ can aid in the interpretation of MEMRI signal-
enhancement in the presence of specific or non-specific neuronal stimuli. 
In this study we evaluated several groups of animals in an effort to eliminate nonspecific 
MEMRI signal-enhancement and to test the efficacy of co-infused MnCl2+EB for elucidating the 
extent of BBB disruption and Mn2+ distribution in the brain. Experiments were performed at 
different anesthetic levels and using different MnCl2+EB infusion times relative to BBB disruption. 
The two major findings of this study were: 1) using the infusion protocols described in this study, 
nonspecific MEMRI signal-enhancement is a reproducible occurrence when animals are anesthetized 
using either 2% and 3% isoflurane; and 2) the spatial extent of nonspecific MEMRI signal-
enhancement is strongly correlated with the spatial extent of osmotic BBB disruption as verified by 
histological staining.  
 
4.4.1 Isoflurane and Halothane Level and Nonspecific MEMRI Signal-Enhancement 
 
The anesthetic condition of the animal is important in MEMRI experiments for prevention of 
nonspecific MEMRI signal-enhancement. Lin and Koretsky suggested that nonspecific MEMRI 
signal-enhancement was present when animals were anesthetized with 0.3% halothane and non-
existent when animals were anesthetized with 1.3% halothane (1). Aoki et al. failed to elicit specific 
MEMRI signal-enhancement in animals that were heavily anesthetized (2.5% halothane), suggesting 
an optimal anesthetic condition that suppresses baseline activity but does not inhibit activation of 
intentionally stimulated areas (4). The results of this study are comparable to those of Lin and 
Koretsky since similar levels of volatile anesthetics were used (1.3% halothane versus 2% and 3% 
isoflurane, respectively). At 1.3% concentration, halothane has a similar minimum alveolar 
concentration (MAC – level of anesthesia required to just prevent response to painful stimulus, 
usually a tail clamp) as compared to 2% isoflurane (~1.7 MAC for halothane and isoflurane (28)) so 
at these levels we would expect similar anesthetic conditions. Indeed, Hudetz (28) showed that the 
differences in inter-hemispheric electroencephalogram (EEG) readings in rats anesthetized with 
halothane or isoflurane disappear when both anesthetics reach a concentration of 1.5%.  Below 
1.5%, the potency of isoflurane to depress EEG signals (i.e., brain activity) was greater than that of 
halothane at similar concentrations (29). In a study of electrophysiological recordings from CA1 
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neurons in rat hippocampal brain slices, MacIver and coworkers showed that depression of 
electrophysiological signals (glutamate-mediated excitatory synaptic transmissions) was 
equivalently achieved with 1.0% isoflurane and 1.3% halothane (30). Experimental evidence based 
on general (EEG) and localized (electrophysiological) brain activity using isoflurane and halothane 
anesthetics suggest that isoflurane is at least as potent if not more so than halothane at similar 
concentrations. Therefore, when comparing the results from this study to those of others for which a 
similar concentration of anesthetic was used (and considering that no significant difference in 
MEMRI signal-enhancement between the 2% isoflurane and 3% isoflurane groups was found in this 
study), other aspects of our experimental protocol were considered for their potential contribution to 
the nonspecific MEMRI signal-enhancement. Indeed, Lin and Koretsky used 1.4 molar mannitol to 
disrupt the BBB but did not report the rate of mannitol infusion (1). In their case, the BBB-
disruption process may have been just severe enough to allow MnCl2 to permeate the barrier while 
not damaging cerebral capillary endothelial cells, brain astrocytes, or glia.  
 
4.4.2 Nonspecific T1-Enhancement after Osmotic BBB Disruption  
 
For many MEMRI experiments investigating brain function, it is necessary to disrupt the 
BBB using an i.v. infusion of a hyperosmolar agent prior to or shortly after i.v. infusion of MnCl2. 
However, the osmotic BBB-disruption process itself should ideally not induce cellular influx of 
Mn2+ since this could lead to nonspecific MEMRI signal-enhancement. Data from several studies 
indicates that osmotic BBB disruption does result in varying degrees of nonspecific MEMRI signal-
enhancement. Aoki and colleagues used a dynamic imaging approach to show MEMRI signal-
enhancement during MnCl2 infusion and prior to, during, and after osmotic BBB disruption by 
mannitol injection (11). This imaging approach showed a clear increase in nonspecific MEMRI 
signal-enhancement immediately following mannitol injection. Results from the study of Aoki et al. 
are shown in Figure 4-12. Morita and coworkers (11) also showed a nonspecific increase in MEMRI 
signal-enhancement in a dynamic imaging experiment. Mannitol infusion in the studies of both Aoki 
et al. and Morita et al. result in large increases in nonspecific MEMRI signal-enhancement in the 
BBB-disrupted cortex of rat brain (~50% increase compared to baseline signal). Results from the 
study of Morita et al. are shown in Figure 4-13 (8).  
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Figure 4-12. Typical time-courses of relative signal intensities in the cortex and ventricle obtained from the glutamate 
administration (filled symbols) and control (open squares) groups. The inset indicates typical ROIs. The rise in signal 
intensity (MEMRI signal-enhancement) following mannitol injection (arrow at 10 minutes) is clear. Reproduced from 
Ref. (11).  
 
 
Figure 4-13. Time course of T1-weighted MRI signal intensity (MEMRI signal-enhancement) changes in the cortex 
(filled squares), lateral habenular nucleus (filled triangles), and other brain regions. Notice the abrupt change in MEMRI 
signal-enhancement immediately following mannitol infusion (to break the BBB) in the cortex and lateral habenular 
nucleus.  
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Although Aoki et al. and Morita et al. used different concentrations of MnCl2 (74.5 mM and 
100mM respectively) and different routes of administration of MnCl2 (Aoki et al., right carotid 
artery; Morita et al., left femoral vein), it is possible that the nonspecific MEMRI signal-
enhancement observed in this study is also related to the osmotic disruption of the BBB. When 
MnCl2+EB is co-infused immediately after osmotic BBB disruption (2% iso/2-min and 3% iso/2-
min groups), the results suggest that cellular uptake of Mn2+ may be indicative of parenchymal cells 
undergoing osmotic transitions. Introduction of a waiting period after osmotic BBB disruption, that 
does not exceed the time window that the BBB remains open (~15 minutes after osmotic BBB 
disruption), may circumvent the osmotic transitions of the parenchymal cells and allow passage of 
MnCl2 only into the extracellular space of the brain. To test this hypothesis, an experiment was 
designed to investigate the effect of delaying co-infusion of MnCl2+EB from two to ten minutes 
following osmotic BBB disruption. The results suggest, however, that there is no significant 
difference between infusion of MnCl2+EB at two minutes (2% iso/2-min and 3% iso/2-min groups) 
or ten minutes (2% iso/10-min group) following osmotic BBB disruption with respect to levels of 
nonspecific MEMRI signal-enhancement or the area of MEMRI signal-enhancement. Therefore, 
other effects of osmotic BBB disruption that may contribute to nonspecific MEMRI signal-
enhancement – such as influx of Mn2+ into damaged neurons, influx of Mn2+ into disturbed 
endothelial cells, or a combination of these – should be considered.  
 
4.4.3 Cellular Uptake of MnCl2+Evans Blue (EB) Dye after Osmotic BBB Disruption 
 
Several studies report damage to brain cells and uptake of Evans Blue (EB) dye into cells 
following osmotic BBB disruption. Salahuddin and coworkers (30) used electron microscopy to 
observe brain cells in the brain hemisphere that received an infusion of 1.4 molar mannitol 90 
minutes after an i.v. infusion of EB solution. Their experiments revealed darkly EB-stained, 
shrunken, and irreversibly injured neurons in the ipsilateral hemisphere.  Kozler et al. (31) infused 
EB dye two minutes following osmotic BBB disruption by 1.1 M mannitol and used fluorescence 
microscopy to determine the ratio of intracellular to extracellular EB dye. The results of Kozler et al. 
show that of the EB dye in the brain following osmotic BBB disruption, most is found intracellularly 
(>60% of the dye was found intracellularly in cortex, and CA1, CA3 of hippocampus) (31). 
The notion that EB dye can enter cells via i.v. infusion after osmotic BBB disruption has 
ramifications for the results of the present study. The experimental protocol of Salahuddin et al. (30) 
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(EB dye was injected 90 min before osmotic BBB disruption with 1.4 M mannitol @0.12 ml/sec) 
differs significantly from that in this study (where EB dye was injected 2 min after BBB disruption 
with 1.6 M arabinose @~0.03ml/sec), but the effect on the cells may be similar to those in this study. 
The experimental protocol of Kozler et al. (31) was very similar to that used in this study (same EB 
infusion protocol) with the only difference being the rate of infusion of the hyperosmolar agent (5 
ml/kg @0.12 ml/sec for Kozler et al. vs. 5 ml/kg @55 seconds in this study). Therefore, by analogy, 
the MnCl2+EB and arabinose infusion protocol used in this study may result in diffuse cellular 
uptake of EB and MnCl2 into cells. Indeed, in another study by Salahuddin et al. (32), pinocytotic 
and diffuse uptake of fibronectin and fibrinogen into brain cells was reported following osmotic 
BBB disruption with 1.4 M mannitol (1.5 ml in 30 seconds via carotid artery). If Mn2+ enters 
neurons by a diffuse process following damage by hyperosmolar agents, Mn2+ would be expected to 
reduce the intracellular water proton T1 and T2 relaxation times in a manner similar to the situation 
when Mn2+ enters the cell via voltage-gated Ca2+ channels after membrane depolarization.  
 
4.4.4 Limitations 
 
MR Image and Histological Image Correlation 
 
Correlation of regions of MEMRI signal-enhancement with those observed on EB-stained 
histological sections were performed without careful spatial co-registration of the respective images. 
The signal intensity in MR images are inherently volume averaged (i.e., in these studies, the signal 
intensity at each pixel location represents the integral of the entire signal through the 2-mm thick 
brain slice).  By comparison, the EB-stained region on the histological section only represents the 
stained area on the surface of the slice and does not take into account variations in EB staining 
through the thickness of the slice).  Consequently, these differences can give rise to systematic errors 
when comparing the relative areas determined by the two methods.  Ideally, the histological slice is 
dissected into very thin slices (on order of µm) and several of these thin slices can be used to 
estimate the EB-stained area on the histological section. In a future study, in place of many 
micrometer thick histological slides, 2-mm-thick histological sections could be imaged on both sides 
and then averaged to give a more accurate representation of the EB staining through the slice 
thickness. In addition, dissecting the brain ‘by hand’ produced errors by slightly varying the 
thickness of the histological sections as well as slight misregistration between the histological slice 
positions and those of the MRI slices (which were positioned relative to the rhinal fissure of the 
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olfactory bulb). In light of these potential errors, the already strong correlation between the spatial 
extent of the MEMRI signal-enhancement and the spatial extent of the EB-stained regions may in 
fact be better than that reported in this study. 
 
 
 
 
Evans Blue (EB) Staining After Perfusion 
The data from the EB control group of our study is perplexing and suggests that the source of 
EB staining, and indeed MEMRI signal-enhancement, may not be within brain but within brain 
capillaries. This group showed very little or no EB staining (no MEMRI signal-enhancement 
because no MnCl2 was infused) at the same time point of histological staining of all other animals. 
Future studies should include perfusion of all animals prior to brain removal to eliminate any 
staining artifact that may occur as a result of the decapitation and brain removal process.  
 
4.4.5 Conclusions 
In summary, we have shown that co-infusion of MnCl2+Evan Blue (EB) dye following osmotic BBB 
disruption allows for the quantification of BBB permeability changes and an inference as to the 
extent of Mn2+ distribution in the brain. In addition, we have shown that a particular infusion 
protocol of MnCl2+EB and 1.6 M arabinose consistently results in nonspecific MEMRI signal-
enhancement, the extent of which strongly correlates with the extent of BBB disruption. Although 
our protocol results in nonspecific MEMRI signal-enhancement that may obscure subsequent 
changes in MEMRI signal-enhancement by a specific neuronal stimulus, this method may be a 
useful alternative to imaging BBB disruption in rats.  
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Abstract 
 
The goal of this study was to determine the effects of two osmotic blood-brain barrier (BBB) 
disruption protocols on brain tissue, apparent diffusion coefficient (ADC), manganese-enhanced 
magnetic resonance imaging signal changes (MEMRI signal-enhancement), and differences in area 
of ADC deficit and nonspecific MEMRI signal-enhancement (MEMRI-DWI mismatch) in the rat 
brain following infusion of manganese chloride (MnCl2) and Evans Blue (EB).  Significant brain 
edema, tissue damage, ADC deficit, and nonspecific MEMRI signal-enhancement was detected in 
the rat following osmotic BBB disruption by arabinose (arabinose group) or mannitol (mannitol 
group) and MnCl2+EB infusion in rat. Histology by 2,3,5 triphenyltetrazolium chloride (TTC) and 
EB stain verified brain damage and BBB-permeability changes respectively. The mean value of 
ipsilateral hemisphere brain area, TTC lesion area, ADC deficit and deficit area, and MEMRI signal-
enhancement and enhancement area were all increased (or decreased in the case of ADC deficit) 
compared to homologous regions in the contralateral hemisphere by 12%, 7%, 23%, 28%, and 76% 
in the arabinose group and 15%, 9%, 22%, 21%, and 69% in the mannitol group, respectively. 
Nonspecific MEMRI signal-enhancement was seen in the hippocampus (CA1-CA3), cortex, 
caudate putamen, hypothalamus and geniculate nucleus.  The percentage of the ipsilateral 
hemisphere with a MEMRI-DWI mismatch was 9% and 8% in the arabinose and mannitol groups, 
respectively. The MEMRI-DWI mismatch in these experiments is noteworthy because the ADC 
deficit was not elicited by stroke and MEMRI signal-enhancement was not specific to a predefined 
neuronal stimulus. The results of this study suggest that ADC deficit and nonspecific MEMRI 
signal-enhancement is related to cytotoxic brain edema following osmotic BBB disruption. In 
addition, brain regions with MEMRI-DWI mismatch were found to correlate to regions of brain 
tissue damage as verified by TTC stain in several animals. The results of these experiments stress the 
need for careful assessment of baseline MEMRI-DWI mismatch prior to any subsequent neuronal 
stimulus or ischemic intervention; in order to ensure that the osmotic disruption of the BBB itself 
does not contribute significantly to any non-specific brain T1 or ADC changes.  
Key words: manganese-enhanced MRI, blood-brain barrier, osmotic shock, rat brain 
 
Pitfalls in MEMRI After Osmotic BBB Disruption       156      
 
5.1 Introduction 
5.1.1 MEMRI Background 
 
Manganese-enhanced magnetic resonance imaging (MEMRI) is a useful imaging method for 
functional brain imaging (1,2) and neuronal tract tracing (3). In response to cell membrane 
depolarization, paramagnetic manganese ion (Mn2+) enters voltage-gated calcium (Ca2+) channels. 
Once in the cell, Mn2+ alters cell water-proton relaxation times resulting in a localized increase in T1-
weighted (T1W) signal intensity (MEMRI signal-enhancement) (1). This characteristic of Mn
2+ has 
been used to advantage for imaging experimental neuropathologies such as cortical spreading 
depression (CSD) (4) and stroke (5,6). These experiments rely on the delivery of Mn2+ in a 
homogeneous fashion to the brain extracellular space prior to neuronal stimulus (i.e., experimental 
CSD or anoxic depolarization in stroke) via osmotic disruption of the BBB.  
 
5.1.2 Side Effects of Osmotic BBB Disruption 
Unfortunately, osmotic BBB disruption can have severe side effects such as vasogenic edema 
(7) and tissue damage (8). Therefore, the adverse effects of osmotic BBB disruption may interfere 
with normal brain response to neuronal stimulus in certain MEMRI experiments.  
 
MEMRI Experiments That Rely on Osmotic BBB Disruption 
Henning et al. used osmotic BBB disruption to introduce Mn2+ into brain prior to initiating 
experimental CSD via the cortical application of 4 M KCl (4).  In their report, no evidence of the 
extent of BBB disruption or the possible side effects of osmotic agent infusion is provided. 
Nonspecific MEMRI signal-enhancement in their case, although possibly due to the intrinsic 
neuronal connectivity between specifically-stimulated and non-stimulated brain regions as discussed, 
may also be due to cellular response to osmotic BBB disruption. In addition, 3M KCl has been 
shown to induce areas of tissue necrosis local to the site of application on the exposed cortex (9,10) 
as shown in Figure 5-1. Without evidence of BBB disruption, and considering potential tissue injury 
by high concentrations of KCl applied to exposed cortex, interpretation of MEMRI signal-
enhancement is speculative in MEMRI experiments designed to detect experimental CSD. 
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Figure 5-1. Time-dependent and region-specific pattern of labeling of tissue from KCl-exposed animals following in situ 
hybridization with 35S-laelled cRNA probes complimentary to glial fibrillary acidic protein mRNA. At 24 hours post 
application of 3M KCl (ten minute exposure) to the exposed parietal cortex, a focal area of tissue necrosis is evident 
(arrows). Reproduced from Ref. (10).  
 
Of additional interest is the study by Aoki et al., for which MEMRI was used to detect 
anoxic depolarization following experimental focal ischemia in rats (5).  In their study, Aoki et al. 
used osmotic BBB disruption to introduce Mn2+ into the brain parenchyma prior to initiating 
experimental focal ischemia by permanent occlusion of the middle cerebral artery. In their study, 
Aoki et al. used diffusion-weighted (DW) and T1W MRI to monitor the degree of tissue damage 
after stroke and qualitatively compared the spatial extent of apparent diffusion coefficient (ADC) 
deficit (in calculated ADC maps) to the spatial extent of MEMRI signal-enhancement. In so doing, 
the term ‘MEMRI-DWI mismatch’ was coined and was suggested to represent an area of 
salvageable tissue not readily detectable by DWI alone. Missing from the study of Aoki et al. was 
evidence of BBB disruption, distribution of Mn2+ in brain, and baseline MR images to indicate the 
presence or absence of a MEMRI-DWI mismatch prior to experimental stroke (i.e., by osmotic BBB 
disruption and infusion of MnCl2 into brain parenchyma). Also lacking was histological evidence 
showing the effects, if any, of osmotic BBB disruption on brain tissue. Demonstration of healthy 
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brain tissue following osmotic BBB disruption is important because osmotic disruption of the BBB 
has been shown to result in pronounced neuronal changes and astrocytic swelling (11). Therefore, 
without knowledge of the degree and extent of BBB disruption, and the state of brain tissue 
following osmotic BBB disruption, interpretation of MEMRI signal-enhancement and ADC changes 
detected after stroke intervention is potentially ambiguous.  
 
Osmotic BBB Disruption Leads to Changes in MRI Contrast and to Tissue Damage 
In the present study, the goal was to investigate the effects of an infusion of manganese 
chloride following osmotic BBB disruption on DW images and the corresponding ADC maps, T1W 
images, and brain tissue based on the use of two different BBB disruption protocols; one using 
arabinose and one using mannitol as the hyperosmotic agent. The mannitol protocol in our study is 
based on a protocol reported by Aoki et al. (5). The results of our work show significant changes in 
DW image contrast, nonspecific MEMRI signal-enhancement that correlates with Evans Blue-
stained regions, and brain tissue damage by 2,3,5 triphenyltetrazolium chloride (TTC) staining in 
animals with osmotically-disrupted BBB; but without experimental stroke. These findings are 
important considerations for future MEMRI experiments that may utilize similar experimental 
protocols as described here and that rely on normal tissue response to specific neuronal stimuli 
following osmotic BBB disruption.  
 
5.2 Methods 
5.2.1 Animal Preparation 
This study was approved by the Institute Animal Care and Use Committee (IACUC) of the 
University of Massachusetts Medical School (IACUC Protocol A-1756 and A-875). Male Sprague-
Dawley rats (250-385g; Charles River Laboratories, Worcester, MA) were divided into two groups:  
1) infusion of 5 ml/kg of 1.6M arabinose over 55 seconds and 2 ml/kg of MnCl2+Evans Blue (EB) 
solution while under 2-3% isoflurane anesthesia (arabinose group, N=10); and 2) infusion of 5 ml/kg 
of 1.4M mannitol at 50 ml/hr (5) and 0.3 ml of MnCl2+EB mixture solution while under 0.5% 
isoflurane and chloral hydrate (400 mg/kg i.p.) anesthesia (mannitol group, N=4). Arabinose was 
chosen as an alternate osmotic agent based on the higher solubility of compound as compared to 
mannitol. Rats in the arabinose group were initially anesthetized with 5% isoflurane and maintained 
at 2-3% isoflurane during surgery. Rats in the mannitol group were initially anesthetized with 5% 
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isoflurane followed by an i.p. injection of 400 mg/kg chloral hydrate. Isoflurane was reduced to 
0.5% while the rats were under chloral hydrate anesthesia. PE-50 and PE-10 polyethylene catheters 
were placed in the left femoral vein (i.v.) for blood pressure and gas monitoring and right external 
carotid artery (ECA) for drug administration, respectively. 
For catheterization of the right ECA, a ventral midline incision was made in the neck. The 
omohyoid muscle was separated longitudinally and retracted laterally to isolate and expose the right 
common carotid artery (CCA), ECA, internal carotid artery (ICA) and pterygopalatine artery (PPA). 
The PPA was permanently ligated. Following temporary clamping of the CCA, the ECA was ligated 
and a small incision was made into the vessel for placement of the PE-10 catheter. The PE-10 
catheter tip was inserted such that the tip would not disturb blood flow in the CCA towards the ICA. 
After properly securing the PE-10 catheter, the CCA clamp was removed allowing normal blood 
flow to the right ICA (the right CCA was clamped for approximately 10 minutes in each animal). 
Cannulation of the right ECA limited drug delivery to the right side of the brain allowing the left 
side to serve as control. Rectal temperature was continuously monitored with a rectal probe and 
maintained at 37 °C using a thermostatically-controlled heat lamp (Model 73ATD, YSI Inc., Yellow 
Spring, OH) during preparation. 
Five minutes prior to osmotic BBB disruption, animals were switched from air/isoflurane to 
100% O2/isoflurane in preparation for apnea during arabinose and mannitol infusion. Animals were 
switched back to air/isoflurane thirty seconds following the end of the arabinose or mannitol 
infusion. Arterial blood gases were recorded (i-STAT Portable Clinical Analyzer, Heska Corp. 
Waukesha, WI) while breathing air/2-3% isoflurane (N=4 arabinose and mannitol groups) and while 
breathing 100% O2/0.5% isoflurane (N=4, arabinose group) before osmotic BBB disruption. Blood 
pressure (World Precision Instruments Pressure Monitor, Model BP-1) was sampled twice per 
second using Labview-based data acquisition software (N=3, arabinose and mannitol group).  
 
 
5.2.2 Osmotic BBB Disruption and MnCl2+EB Administration 
To disrupt the BBB, 1.6M L-arabinose or 1.4M D-mannitol solution (5 ml/kg, Sigma, St. 
Louis) was infused into the right ECA over a period of 55 seconds or 50 ml/hr, respectively, using a 
syringe pump (Model PHD 2000; Harvard Apparatus, Holliston, MA). Two minutes prior to the 
infusion of L-arabinose or D-mannitol, a slow (6 ml/hr) infusion of (the same) L-arabinose or D-
mannitol was started and continued for 1 minute in an effort to compensate for vasogenic edema 
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induced by the bolus L-arabinose or D-mannitol infusion (12). Physiologically-buffered saline (PBS) 
containing 10 mM manganese chloride (MnCl2·4H2O; Sigma, St. Louis) and 2% EB (Sigma, St. 
Louis) was infused into the right ECA at a rate of 4.5 ml/hr using a syringe pump (Model 11; 
Harvard Apparatus, Holliston, MA) until a volume of 2 ml/kg or 0.3 ml was infused in the arabinose 
and mannitol groups, respectively. The MnCl2+EB solution was infused 10 minutes following 
osmotic BBB disruption in both groups. Infusion of the MnCl2+EB solution was initiated 10 minutes 
after arabinose injection to approximate the time of MnCl2 infusion relative to osmotic BBB 
disruption used by Aoki et al. (5). All solutions were warmed to 37 °C and filtered with 0.45 µm 
syringe filters (Nalgene). Immediately after concluding the MnCl2+EB infusion, rats in the mannitol 
group were switched from 0.5% isoflurane to 1.5% isoflurane in order to maintain anesthetic depth 
without additional chloral hydrate injections. Timing of infusions is summarized in Figure 5-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-2: Timing of MnCl2+EB infusion relative to arabinose or mannitol infusion.  
 
5.2.3 MRI Measurements 
MR experiments were performed using a Bruker Biospin 2.0T/45 cm imaging spectrometer 
equipped with ± 20G/cm self-shielded gradients. T1W MRI was performed using the following 
acquisition parameters: TR/TE = 500.0/10.8 ms, FOV = 3 cm x 3 cm, matrix size = 128x128, six 
slices with 2-mm thickness, NEX = 8. DWI was performed using a DW spin-echo, echo-planar MRI 
pulse sequence with TR/TE = 2000/51 ms, FOV = 3 cm x 3 cm, matrix size = 64x64 zero-filled to 
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128x128 before Fourier transformation, six slices with 2-mm thickness, NEX = 8, six b-values (23, 
92, 207, 828, 1126, and 1471 s/mm2), ∆ = 6.0 ms, and δ = 24.31 ms. The slice profiles of DW and 
T1W images were matched. The imaging plane was referenced to the rhinal fissure at the boundary 
of the olfactory bulb. Acquisition time for one set of images was 8.5 minutes for T1W and 4.8 
minutes for DW imaging. During imaging, animals were placed prone within a home-built animal 
holder. The head of the animal was fixed within an 8-leg, 4.3 cm diameter 1H volume coil. Animals 
were anesthetized with 2-3% (arabinose group) or 1.5% (mannitol group) isoflurane delivered at 1.5 
L/min in breathing-quality air. Body temperature was maintained at 37.0 ± 1°C by circulated warm 
air using a T-type thermocouple and a double-point feedback control system. T1W and DW MRI 
continued sequentially for 3 hours to check for consistency in MEMRI signal-enhancement and DW 
image contrast over time.   
 
 
5.2.4 EB and 2,3,5 TriphenylTetrazolium Chloride (TTC) Histology 
Immediately following imaging, isoflurane anesthetic was increased to 5% and shortly 
thereafter animals were decapitated. The brain was quickly removed, placed on a section of parafilm 
and subsequently cooled for thirty minutes to facilitate handling. Brains were then dissected into six 
2-mm slices that corresponded spatially to MR slices (first slice at 1mm ventral to the rhinal fissure 
of olfactory bulb). After dissection, brain slices were placed in saline and scanned using a Hewlett-
Packard Scanner (Model #3970) at a resolution of 1200 dpi. After scanning, brain slices were placed 
in a 2% solution of TTC (a water and ethanol soluble tetrazolium salt; C19H15ClN4; FW = 335 (13)) 
and warmed to 37 °C in a lab oven (Fisher Isotemp 500 Series). The time from osmotic BBB 
disruption to brain slice placement in TTC solution was approximately 4 hours in each animal. After 
ten minutes in the lab oven, all slices were placed in zinc formalin for fixation overnight. The next 
day, brain slices were scanned using a Hewlett-Packard Scanner (Model #3970) at a resolution of 
1200 dpi. TTC ‘stains’ the brain tissue differently as compared to Evans Blue dye. TTC is reduced 
by enzymes in normal tissue to a red, fat soluble, light-sensitive compound (formazan) that turns 
normal tissue red thereby delineating normal from damaged tissue (14). Specifically, after 
histological staining of brain by TTC, regions that do not appear red are likely to have irreversible 
mitochondrial damage, such as may be caused by stroke or severe hypoxia. Evans Blue, in contrast, 
is a dye that stains brain tissue (and most other tissues) blue upon contact.     
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5.2.5 Data Analysis 
Region of interest (ROI) definitions and calculations in T1W images and ADC maps were 
made using ImageJ (NIH) software (Rasband, W.S., ImageJ, U. S. National Institutes of Health, 
Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997-2006). ROIs were drawn freehand to 
distinguish between MEMRI signal-enhanced regions, ADC-deficit regions, and normal brain tissue. 
MEMRI signal-enhancement increase, MEMRI signal-enhancement area, ADC deficit, and ADC-
deficit area (DA) were all calculated using ROIs drawn freehand by 1) observer visualization; and 2) 
intensity-thresholding on T1W images and calculated ADC maps, respectively. For intensity-
thresholding on T1W images, MEMRI signal-enhancement in the ipsilateral hemisphere was 
determined by voxels whose signal intensity was 2 standard deviations above the mean of all voxels 
in the contralateral hemisphere. This method of analyzing MEMRI signal-enhancement was chosen 
to match the technique of Aoki et al. (5) thus allowing us to compare our MEMRI signal-
enhancement results to theirs.  
For thresholding ADC maps, ADC deficit in the ipsilateral hemisphere was determined by 
pixels whose values were 2 standard deviations below the mean of all pixels in the contralateral 
hemisphere. Results from the two ROI definition techniques were compared to determine if ROI 
thresholding significantly underestimates the degree and spatial extent of MEMRI signal-
enhancement and ADC deficit. Data are presented as mean ± standard error of the mean (SEM), with 
a separate term for the inter-slice standard deviation (ISSD). Regions of MEMRI signal-
enhancement, ADC deficit, and MEMRI-DWI mismatch were determined by correlation to a 
standard rat brain atlas (15) based on the slice location in terms of distance from bregma. T1W and 
DW image reconstruction was performed using Paravision’s Image Processing and Display Software 
(Xtip). 
 
Percent Edema  
Edema in the ipsilateral hemisphere was calculated by comparing the area of the ipsilateral 
hemisphere to the area of the contralateral hemisphere in both T1W and histological images on a 
slice-by-slice basis. Percent edema was calculated using Eq. 5.1.  
 
100% ×
−
=
AreaHemContra
AreaHemContraAreaHemIpsi
Edema  
 
5.1 
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where ‘Ipsi Hem Area’ is the area of the ipsilateral hemisphere in mm2, and ‘Contra Hem Area’ is 
the area of the contralateral hemisphere in mm2. 
 
 
 
MEMRI Signal-Enhancement 
MEMRI signal-enhancement in T1W images was calculated through comparison of T1W MR 
signal intensity in MEMRI signal-enhanced regions in the ipsilateral hemisphere and T1W MR 
signal intensity in the homologous contralateral control regions on a slice-by-slice basis: 
100(%) ×
−
=−
CH
CHIH
SI
SIS
tEnhancemenSignalMEMRI  
where SIIH is the mean signal intensity for an ROI in the ipsilateral hemisphere and SICH is the mean 
signal intensity for the equivalent ROI in the contralateral control hemisphere. Percent area of 
MEMRI signal-enhancement in T1W images was calculated on a slice-by-slice basis by comparison 
of MEMRI signal-enhancement area to the area of the entire ipsilateral hemisphere. 
 
100(%) ×
−
=−
AreaHemIpsiTotal
AreaEnhancedSignalMEMRI
AreaEnhancedSignalMEMRI  
 
 
 
 
Apparent Diffusion Coefficient (ADC) Parameter Mapping 
ADC mapping was performed on DW images on a pixel-by-pixel basis using in-house 
Interactive Data Language (v5.3 Research Systems, Boulder, CO) software based on the relationship 
between the natural log of the signal intensity in DW images and b-value as shown by Eq. 5.4.  
bDeMtM −= 0)(  
where M(t)/M0 is the signal intensity at a particular b-value and D is the apparent diffusion 
coefficient along a particular gradient direction (e.g., x, y, or z). Maps of the average ADC were 
generated by taking the mean of the ADC values acquired along each of the x, y, and z-gradient 
directions.  
 
5.2 
5.3 
5.4 
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Percent ADC Deficit and Percent-Deficit Area (DA) 
Percent ADC deficit in the average ADC maps was calculated through comparison of the 
mean ADC deficit in the ROI of the ipsilateral hemisphere and the mean ADC in the entire 
contralateral hemisphere on a slice-by-slice basis: 
100
)(
(%) ×
−−
=
CH
CHIH
ADC
ADCADC
DeficitADC  
where ADCIH is the mean ADC in the ADC deficit region in the ipsilateral hemisphere and ADCCH 
is the mean ADC in the entire contralateral hemisphere. Percent-ADC-deficit area in the average 
ADC maps was calculated on a slice-by-slice basis by comparison of ADC-deficit area to the area of 
the entire ipsilateral hemisphere. 
 
100(%) ×=
AreaHemIpsiTotal
AreaDeficitADClIpsilatera
AreaDeficitADC  
 
 
MEMRI-DWI Mismatch 
MEMRI-DWI mismatch area was calculated as the area of ADC deficit in the ipsilateral 
hemisphere that exceeded the boundaries of the MEMRI signal-enhancing regions in the ipsilateral 
hemisphere.  In most instances, MEMRI signal-enhancement was confined to the region with ADC 
deficit. For the few cases where MEMRI signal-enhancement extended beyond the boundaries of the 
ADC deficit region, MEMRI-DWI mismatch remained consistently defined as the region of ADC 
deficit outside the border of MEMRI signal-enhancement. Using ImageJ, ADC-deficit ROIs were 
overlayed on the T1W images with regions of MEMRI signal-enhancement. Regions of ADC deficit 
that exceeded the boundaries of the regions of MEMRI signal-enhancement were outlined and 
defined as MEMRI-DWI mismatch. Regions of MEMRI signal-enhancement that exceeded the 
boundaries of the ADC-deficit region were not considered in any calculation. DW and T1W images 
were registered for each slice in every animal. Percent MEMRI-DWI mismatch in T1W images was 
calculated on a slice-by-slice basis by comparison of MEMRI-DWI mismatch area to the area of the 
entire ipsilateral hemisphere. 
 
100% ×
−
=−
AreaHemIpsiTotal
AreaMismatchDWIMEMRI
AreaMismatchDWIMEMRI  
5.6 
5.5 
5.7 
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TTC Histology 
For technical reasons, TTC staining was performed in 4 of the 10 animals of the arabinose 
group, and 3 of the 4 animals of the mannitol group. TTC staining was performed with Evans Blue 
present in brain. Therefore, in regions with deep Evans Blue stain, it was not clear by visualization if 
the underlying brain was or was not stained by TTC. To address this problem, RGB image 
deconvolution was used to separate the two colors (red by TTC and blue by Evans Blue) in the 
histological images. Deconvolved images were subsequently transformed into Hue, Saturation, and 
Brightness images. Saturation images were used due to the superior contrast between stained and 
unstained tissue.  Based on the work of Ruifrok and Johnston, histological images (in RGB format) 
can be deconvolved into images that represent the independent contributions of red (Fast Red) and 
blue (Alcian Blue) stains (16). This method, based on an orthonormal transformation of the optical 
density values found in RGB images of each stain separately (i.e., a RGB histological image of red 
stain only and a RGB image of blue stain only) is summarized in Figure 5-3. Since we were not able 
to experimentally determine the optical density (OD) values for TTC and Evans Blue, we used 
previously determined OD values for Fast Red and Alcian Blue stain. Fast Red and Alcian Blue 
absorb at wavelengths similar to those of Evans Blue and TTC, respectively. The optical 
deconvolution calculations were performed using ImageJ (based on an algorithm written  by G. 
Landini;   http://www.dentistry.bham.ac.uk/landinig/software/software.html). The TTC-stained 
lesion was defined as that region of the brain that did not stain red after exposure to TTC. Brain 
regions with a TTC lesion were outlined freehand in both anterior-posterior and posterior-anterior 
views of the TTC histological image. The area (in mm2) of TTC lesion in both views was averaged 
and compared to the entire brain area. Percent-TTC-lesion area in the TTC histological images (after 
deconvolution and saturation transformation) was calculated on a slice-by-slice basis by comparison 
of TTC lesion area to the area of the entire ipsilateral hemisphere as shown in Eq. 5.8. 
100% ×=
AreaHemIpsiTotal
AreaLesionTTC
AreaLesionTTC  
 
5.8 
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Figure 5-3: Flow chart for the color deconvolution algorithm from Ref. (16). The optical density (OD) values are 
experimentally determined for each stain alone. Since experimental determination of TTC and Evans Blue OD values 
was not possible in this study, the OD values of Fast Red and Alcian Blue (previously determined by G. Landini and 
provided within the ImageJ software) were used to approximate the OD values for TTC and Evans Blue, respectively. 
The OD values of Fast Red and Alcian Blue are comparable to those of TTC and Evans Blue, respectively ((e.g., Fast 
Red: 266 nm, TTC: 247 nm, Alcian Blue: 615 nm, Evans Blue: 611 nm; from Ref (13)). The orthonormal transformation 
of the OD matrix (normalized OD matrix) results in a matrix that describes the independent contribution of each stain 
color to the overall Red, Green, and Blue (RGB) values in a RGB image. If C is defined as a 3x1 vector of the stain 
intensity at a particular pixel N, the OD level at pixel N is defined by y = CM, where M is the normalized OD matrix 
and C is the orthogonal (independent) representation of the stains forming the RGB image. Finally, solving for C is done 
by C = M-1y.   
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Edema Correction 
All MEMRI signal-enhancement area, ADC-deficit area, and TTC-lesion area data were 
corrected for edema. T1W images and calculated average ADC maps were edema-corrected based on 
percent edema calculated from T1W images. TTC-lesion area was edema-corrected based on percent 
edema calculated from TTC-stain images. Percent MEMRI signal-enhancement, percent ADC 
deficit, and percent TTC-lesion area were all edema corrected according to Eq. 5.9.  





 −
−×=
AreaHemContra
AreaHemContraAreaHemIpsi
OriginalEC
(
1  
 
where ‘EC’ is the edema-corrected version of the original percent MEMRI signal-enhancement, 
percent ADC deficit, or percent TTC-lesion area and ‘Ipsi Hem Area’ and ‘Contra Hem Area’ are 
the areas of the ipsilateral hemisphere and contralateral hemisphere in the T1W or histological (TTC) 
images.  
 
5.2.6 Statistical Analysis 
Data are reported as mean ± s.e.m..  Data from the arabinose and mannitol groups were 
compared by paired and unpaired Student’s t-tests. Statistically significant differences were reported 
when P<0.05.  
 
5.3 Results 
5.3.1 Animal Physiology 
Blood Pressure 
The mean arterial blood pressures before osmotic BBB disruption were 89.8 ± 0.4 mmHg in 
the arabinose group and 72.0 ± 0.4 mmHg in the mannitol group. During infusion of arabinose and 
mannitol, the blood pressure fluctuated by approximately 10 mmHg. As shown in Figure 5-4, blood 
pressure reached a steady-state immediately following the end of arabinose and mannitol infusions, 
but followed a downward trend from 90 mmHg to 80 mmHg two minutes later in the arabinose 
group and an upward trend from 80 mmHg to 98 mmHg two minutes later in the mannitol group. 
Immediately following the start of MnCl2+EB infusion in the arabinose group, blood pressure 
dropped by approximately 5 mmHg and then fluctuated between ±10 mmHg until the end of the 
infusion. Blood pressure in the arabinose group reached a steady state after the end of MnCl2+EB 
infusion. Blood pressure in the mannitol group started to drop before the MnCl2+EB infusion and 
5.9 
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continued to drop until a steady-state was reached. Blood pressure in the mannitol group dropped 
again in response to an increase in isoflurane anesthetic concentration.  
 
 
 
 
Figure 5-4: Blood pressure dynamic before, during, and after osmotic BBB disruption and MnCl2+EB infusions. The 
curves represent a 10-point moving average of blood pressure readings from three animals in the arabinose group (A) 
and two animals in the mannitol group (B) for which blood pressure data was acquired. The difference in infusion times 
of MnCl2+EB in the arabinose group was due to the different weights of the animals (250g, 375g, and 385g). Blood 
pressure decreased immediately after and during MnCl2+EB infusion in the arabinose and mannitol group, respectively. 
A decrease in blood pressure during i.v. MnCl2 infusion is expected because Mn
2+ competes for Ca2+ in the heart.   
 
 
 
A) 
B) Average (N=2) BP in mannitol group 
 
Average (N=3) BP in arabinose group 
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Blood Gases 
Blood gases were recorded in certain animals (N=4 arabinose group, N=3 mannitol group) 
prior to osmotic BBB disruption and prior to switching from air/isoflurane to 100% O2/isoflurane. 
Blood-gas data is summarized in Table 5-1.  
 
 
 
Table 5-1: Blood Gases Measured from Animals in the Arabinose and Mannitol Groups. 
Blood Gas Variable Arabinose Group (N=4) 
Average ± SEM 
Mannitol Group (N=3) 
Average ± SEM 
pH 
PCO2 
PO2 
BEECF (mmol/L) 
HCO3 (mmol/L) 
TCO2 (mmol/L) 
SO2 (%) 
Na (mmol/L) 
K (mmol/L) 
iCa (mmol/L) 
Glu (mg/dL) 
Hct (%PCU) 
Hb (g/dL) 
7.4 ± 0.0 
49.8 ± 2.0 
57.8 ± 2.0 
2.3 ± 0.7 
27.8 ± 0.7 
29.5 ± 0.8 
87.5 ± 1.0 
136.0 ± 0.7 
4.5 ± 0.2 
1.4 ± 0.0 
261.5 ± 17.0 
37.3 ± 0.4 
12.7 ± 0.1 
7.4 ± 0.0 
48.0 ± 1.8 
74.0 ± 0.6 
0.7 ± 0.3 
26.5 ± 0.5 
28.0 ±0.6 
93.7 ± 0.3 
135.3 ± 0.9 
5.5 ± 0.1 
1.2 ± 0.0 
245.7 ± 10.3 
42.3 ± 1.5 
14.4 ± 0.5 
 
5.3.2 Brain Edema 
Percent Edema in T1W and Histological Images 
Figure 5-5 shows histological images from one animal in which edema of the right 
hemisphere is apparent. Percent-edema in both animal groups was calculated separately using T1W 
and histological images. Percent-edema in the arabinose group was 4% ± 1% and 12% ± 2% using 
T1W and histological images for edema calculation, respectively. Percent-edema in the mannitol 
group was 9% ± 1% and 15% ± 2% using T1W and histological images for edema calculation, 
respectively. A significant difference between the use of T1W and histological images to calculate 
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edema was detected in the arabinose group (P < 0.01 paired Student’s t-test). A significant difference 
between percent-edema in the arabinose and mannitol groups was detected when edema was 
calculated using T1W images (P < 0.05, unpaired Student’s t-test).  
 
 
 
 
Figure 5-5. Histological images from one animal in the arabinose group shown with the outline of the contralateral (left) 
hemisphere superimposed on the ipsilateral (right) hemisphere of each image. The images correspond to dissected brain 
slices 6 mm posterior (leftmost image) to 4 mm anterior (rightmost image) of bregma. Starting with the image at 6 mm 
posterior of bregma, edema becomes grossly evident in the image at 0 bregma and becomes more severe as the slices 
progress anterior to bregma.  
 
Quantitative Summary of Edema 
Table 5-2 shows the average percent-edema across all dissected brain regions for the 
arabinose and mannitol groups.  
 
Table 5-2: Average Percent-Edema Area (% ipsilateral hemisphere area increase over contralateral hemisphere area) 
from T1W MR and Histological Images Following Osmotic BBB Disruption and Infusion of MnCl2+EB Solution. 
Average Percent-Edema in Brain   
(using Eq. 5.1) 
Edema Calculated By ROIs In 
Group 
T1W Images Histological Images 
 
 
 
Arabinose 
 
 
Mannitol 
Mean ± SEM 
(%) 
 
4 ± 1 
 
 
9 ± 1* 
ISSDa 
(%) 
 
2 
 
 
1 
Mean ± SEM 
(%) 
 
12 ± 2 ** 
 
 
15 ± 2 
ISSDa 
(%) 
 
4 
 
 
2 
*P < 0.05 between arabinose and mannitol groups by T1W images , 
**P < 0.01 between T1W and histological images 
within arabinose group. 
 
 
 
  -6             -4                  -2                     0                      2                   4 
Position Relative to Bregma (mm) 
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5.3.3 MEMRI Signal-Enhancement 
Enhancement Level, Enhancement Area, and Regional Coverage 
Figure 5-6 shows representative multi-slice T1W MRI for animals in the arabinose and 
mannitol groups. MEMRI signal-enhancement is nonspecific, i.e., no neuronal stimulus was applied 
to any animal in either group. The average percentage increase in signal intensity in MEMRI signal-
enhanced regions was 88% ± 6% and 77% ± 6% in the arabinose group by T1W image visualization 
and intensity-thresholding, respectively.  For the mannitol group, the comparable values were 91% ± 
8% and 69% ± 11% by T1W-image visualization and intensity-thresholding, respectively. 
Calculation of MEMRI signal-enhancement by T1W-image visualization and intensity-thresholding 
methods within the arabinose and mannitol groups did not produce significantly different results. 
There was no significant difference in signal intensity in MEMRI signal-enhanced regions between 
the arabinose and mannitol groups (by either T1W-image visualization or intensity-thresholding 
methods).  
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Figure 5-6: Multi-slice T1W MRI for representative animals in the arabinose (A) and mannitol (B) groups (left side of 
image = right hemisphere). MEMRI signal-enhancement in the right (ipsilateral) hemisphere is apparent in both cases. 
T1W images were acquired approximately 50 minutes after osmotic BBB disruption and 40 minutes after infusion of the 
MnCl2+EB solution.  
 
Percent-area of MEMRI signal-enhancement (before edema correction) in the arabinose 
group was 26% ± 2% and 21% ± 2% by the T1W-image visualization and intensity-thresholding 
methods, respectively.  For the mannitol group, the comparable values were 25% ± 4% and 16% ± 
5%, by the T1W-image visualization and intensity-thresholding methods, respectively. Calculation of 
percent-area of MEMRI signal-enhancement by the T1W-image visualization and intensity-
thresholding methods within the arabinose and mannitol groups did not produce significantly 
different results. There was no significant difference in percent area of MEMRI signal-enhanced 
regions between the arabinose and mannitol groups (by either T1W-image visualization or intensity-
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thresholding methods). Brain regions with MEMRI signal-enhancement included cortex, 
hippocampus (CA1-CA3), geniculate nucleus, deep mesencenphalic nucleus, thalamic nucleus, deep 
mesencenphalic nucleus, and caudate putamen. Patterns of MEMRI signal-enhancement within or 
across groups were not observed. MEMRI signal-enhancement was, however, always confined to the 
right (ipsilateral) hemisphere.  
 
Quantitative Summary of MEMRI Signal-Enhancement 
Tables 5-3 and 5-4 show the average percent MEMRI signal-enhancement and average 
percent area of MEMRI signal-enhancement, respectively, for different brain regions for the 
arabinose and mannitol groups.  
 
Table 5-3: Average Percent MEMRI Signal-Enhancement (%, relative to a homologous region in the contralateral 
hemisphere) from T1W MRI for all MEMRI Signal-Enhanced Brain Regions Following Infusion of the MnCl2+EB 
solution. 
Average Percent MEMRI Signal-Enhancement Across All Brain Slices   
(using Eq. 5.2) 
MEMRI Signal-Enhanced Regions Determined By 
Group 
Visualization Intensity-Thresholding 
 
 
 
Arabinose 
 
 
Mannitol 
Mean ± SEM 
(%) 
 
76 ± 6 
 
 
69 ± 11 
 
ISSDa 
(%) 
 
12 
 
 
19 
Mean ± SEM 
(%) 
 
88 ± 6 
 
 
91 ± 8 
ISSDa 
(%) 
 
16 
 
 
13 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average signal increase (%) across slices with MEMRI signal-enhancement.  
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Table 5-4: Average Percent Area of MEMRI Signal-Enhancement (relative to the total brain area) from T1W MRI for all 
MEMRI Signal-Enhanced Brain Regions Following Infusion of the MnCl2+EB solution. 
 
Average Percent-Area of MEMRI signal-enhancement Across All 
Brain Slices   
(using Eq. 5.6) 
MEMRI Signal-Enhanced Regions Determined By 
Visualization Intensity-Thresholding 
Group 
Before  
Edema 
Correction 
After  
Edema 
Correction 
Before  
Edema 
Correction 
After  
Edema 
Correction 
 
 
 
 
 
 
Arabinose 
 
 
Mannitol 
Mean  
±  
SEM 
(%) 
 
 
26 ± 2 
 
 
25 ± 4 
ISSDa 
(%) 
 
 
 
 
10 
 
 
4 
Mean 
± 
SEM 
(%) 
 
 
24 ± 2 
 
 
22 ± 4 
ISSDa 
(%) 
 
 
 
 
9 
 
 
4 
Mean  
±  
SEM 
(%) 
 
 
21 ± 2 
 
 
16 ± 5 
ISSDa 
(%) 
 
 
 
 
7 
 
 
4 
Mean  
±  
SEM 
(%) 
 
 
20 ± 2 
 
 
15 ± 4 
ISSDa 
(%) 
 
 
 
 
7 
 
 
4 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average signal-intensity increase (%) across slices with MEMRI signal-enhancement.  
 
5.3.4 ADC Deficit 
ADC Deficit Level, ADC Deficit Area, and Regional Coverage 
Figure 5-7 shows representative multi-slice, calculated average ADC maps for representative 
animals in the arabinose and mannitol groups. The average percent decrease in ADC value in regions 
with ADC deficit was 23% ± 1% and 29% ± 1% in the arabinose group by the ADC-map 
visualization and intensity-thresholding methods, respectively.  For the mannitol group, the 
corresponding values were 22% ± 3% and 34% ± 5% by the ADC-map visualization and intensity-
thresholding methods, respectively. Calculation of percent-ADC deficit by ADC-map visualization 
and intensity-thresholding methods within the arabinose and mannitol groups was significantly 
different in both groups (P < 0.001 arabinose group; P < 0.05 mannitol group). There was no 
significant difference in ADC deficit between the arabinose and mannitol groups (by either ADC-
map visualization or intensity-thresholding methods).  
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Figure 5-7: Multi-slice, calculated average ADC maps for animals in the arabinose (A) and mannitol (B) groups (left side 
of image = right hemisphere). ADC deficit in the right (ipsilateral) hemisphere is apparent in most of the slices in both 
cases. The DW images used to generate the ADC maps in (A) and (B) were acquired approximately 60 minutes after 
osmotic BBB disruption.  
 
Percent-area of ADC deficit (before edema correction) was 30% ± 2% and 19% ± 1% in the 
arabinose group by the ADC-map visualization and intensity-thresholding methods, respectively.  
For the mannitol group, the corresponding values were 24% ± 7% and 8% ± 4% by the ADC-map 
visualization and intensity-thresholding methods, respectively. Calculation of percent-area of ADC 
deficit by the ADC-map visualization and intensity-thresholding methods was significantly different 
in the arabinose group only (P < 0.001 arabinose group; P = 0.06 mannitol group). Calculated 
percent-area of ADC deficit was significantly different between the arabinose and mannitol groups 
(by ADC-map intensity-thresholding method only, P < 0.05; by ADC-map visualization, P = 0.45). 
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Brain regions with ADC deficit included cortex, hippocampus (CA1-CA3), geniculate nucleus, deep 
mesencenphalic nucleus, thalamic nucleus, and caudate putamen. ADC deficit was confined to the 
right (ipsilateral) hemisphere and may reflect changes in brain volume due to osmotic BBB 
disruption or moderate hypoxia. Patterns of ADC deficit within or across groups were not observed.  
 
Quantitative Summary of ADC Deficit 
Tables 5-5 and 5-6 show the average percent-ADC deficit and average percent-area of ADC 
deficit, respectively, for different brain regions for the arabinose and mannitol groups.  
 
Table 5-5: Average Percent-ADC Deficit (% relative to a homologous region in the contralateral hemisphere) from ADC 
Maps for all Brain Regions with ADC Deficit Following Osmotic BBB Disruption and Infusion of the MnCl2+EB 
Solution. 
Average Percent-ADC Deficit Across All Brain Slices   
(using Eq. 5.5) 
ADC Deficit Region Determined By 
Group 
Visualization Intensity-Thresholding 
 
 
 
Arabinose 
 
 
Mannitol 
Mean ± SEM 
(%) 
 
23 ± 1 
 
 
22 ± 3 
 
ISSDa 
(%) 
 
4 
 
 
4 
Mean ± SEM 
(%) 
 
29 ± 1*** 
 
 
34 ± 5* 
ISSDa 
(%) 
 
6 
 
 
10 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average ADC deficit (%) across slices with MEMRI signal-enhancement. ***P<0.001 compared to ADC-map 
visualization method, *P<0.05 compared to ADC-map visualization method.  
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Table 5-6: Average Percent-Area of ADC Deficit (% relative to a homologous region in the contralateral hemisphere) 
from ADC Maps for all Brain Regions with ADC Deficit Following Osmotic BBB Disruption and Infusion of the 
MnCl2+ EB Solution. 
Average Percent-Area of ADC Deficit Across All Brain Regions   
(using Eq. 5.3) 
ADC Deficit Region Determined By ADC Map: 
Visualization Intensity-Thresholding Group 
Before  
Edema 
Correction 
After  
Edema 
Correction 
Before  
Edema 
Correction 
After  
Edema 
Correction 
 
 
 
 
 
 
Arabinose 
 
 
Mannitol 
Mean  
±  
SEM 
(%) 
 
 
30 ± 2  
 
 
24 ± 7 
ISSDa 
(%) 
 
 
 
 
9 
 
 
7 
Mean 
± 
SEM 
(%) 
 
 
28 ± 2  
 
 
21 ± 6 
ISSDa 
(%) 
 
 
 
 
8 
 
 
7 
Mean  
±  
SEM 
(%) 
 
 
19 ± 1***  
 
 
8 ± 4* 
ISSDa 
(%) 
 
 
 
 
10 
 
 
6 
Mean  
±  
SEM 
(%) 
 
 
18 ± 1***  
 
 
8 ± 3* 
ISSDa 
(%) 
 
 
 
 
10 
 
 
6 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average area of ADC deficit across slices with ADC deficit. ***P<0.001 compared to the ADC map visualization method. 
*P<0.05 compared to the arabinose group. 
 
5.3.5 TTC Lesion Area 
 
TTC- Stain Deconvolution and Saturation Transform 
 
Figure 5-10 shows representative multi-slice histological images after TTC staining for one 
animal in the arabinose group and one animal in the mannitol group. Figure 5-10 also shows the 
same TTC stain images after deconvolution (using the algorithm summarized in Figure 5-3) into 
independent representative EB and TTC images and after transformation into Saturation images. As 
shown in Figure 5-10, deconvolution is useful for separating multicolor histological images (in RGB 
format) into images that represent the contribution of each stain color to the RGB image. The 
Saturation transform is useful for enhancing the contrast between stained and unstained regions in 
the deconvolved images.  
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Percent-TTC-Lesion Area and Regional Coverage 
Percent-TTC-lesion area was 8% ± 1% and 7% ± 1% in the arabinose group before and after 
edema correction, respectively.  For the mannitol group, the corresponding values were 11% ± 6% 
and 9% ± 5% before and after edema correction, respectively. Percent-TTC-lesion area was not 
significantly different between the arabinose and mannitol groups. Regional coverage of TTC lesion 
included regions in which MEMRI signal-enhancement, EB stain, and ADC deficit were detected 
such as cortex (primary somatosensory cortex, secondary somatosensory cortex, primary motor 
cortex, secondary motor cortex), hippocampus (CA1-CA3), geniculate nucleus, deep 
mesencenphalic nucleus, thalamic nucleus, and caudate putamen.  
 
TTC-Lesion Area and ADC Deficit 
When the TTC-lesion area was analyzed on an animal-by-animal basis, there were instances 
when the TTC lesion was outside of the region of MEMRI signal-enhancement and EB stain, but not 
outside of the region of ADC deficit. An animal (from the arabinose group) with TTC lesion outside 
the region of MEMRI signal-enhancement is shown in Figure 5-11. The spatial extent of the TTC 
lesion in this animal does not correlate with areas of MEMRI signal-enhancement or EB staining, 
but does correlate well with a homologous region of ADC deficit and average DW hyperintensity. 
Another slice from the same animal is shown in Figure 5-12 and shows a distinct TTC lesion in the 
cortex on both sides of the histological slice. Brain regions which suffered injury are shown in 
adjacent rat-atlas images and are summarized in Table 5-9. Without the TTC histological staining, 
the absence of MEMRI signal-enhancement in T1W images and/or EB staining in this region may be 
misinterpreted as a region that did not respond to specific neuronal stimulus and/or a region which 
did not experience BBB disruption. As shown here, ipsilateral regions devoid of MEMRI signal-
enhancement may be, in fact, regions with permanent brain damage not capable of responding to 
specific neuronal stimulus.  TTC staining, in this case, clearly provides helpful additional 
information. No significant difference in TTC lesion area was detected between the arabinose group 
(N=4) and mannitol (N=3) group.  
Pitfalls in MEMRI After Osmotic BBB Disruption       179      
 
 
 
 
Figure 5-10: Multi-slice, histological images after TTC and EB staining in two animals, one each from the arabinose and 
mannitol groups. The TTC/EB-stained images were deconvolved into images representative of the independent 
contributions of EB and TTC staining in the ipsilateral hemisphere. Deconvolved images were then transformed into 
Saturation images to enhance contrast differences between stained and unstained tissue. In TTC Saturation images, 
healthy tissue appears bright (relative to surrounding tissue) and dark regions (outside of white matter) correspond to 
regions with tissue injury. Bright regions in the EB Saturation images correspond to EB-stained regions.  
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Figure 5-11: Averaged signal intensity of DW images acquired separately with diffusion-sensitization in the x, y, and z 
directions (b=1126 s/mm2), average calculated ADC map, T1W, EB, and TTC images from one animal in the arabinose 
group. Red arrows point to a region with TTC lesion in which no MEMRI signal-enhancement or EB staining is present. 
The TTC lesion in this case is suggestive of blood-flow levels below the threshold necessary to support cellular viability. 
Low blood flow in this region may be the result of severe edema following osmotic disruption of the BBB. The ‘black 
hole’ in the middle of the slice in the DWAVG image is due to the large paramagnetic reduction of T2 (relative to TE) at a 
high concentration of Mn2+ as verified by dark EB staining and MEMRI signal-enhancement in the same region.  
 
 
 
Figure 5-12: TTC lesion area from an animal in the arabinose group viewed from both sides of a histological slice. EBDS 
and TTCDS are the deconvolved and saturation-transformed representations of EB and TTC staining in the histological 
image. The purple-outlined region defines the TTC lesion. A) Histological slice at -3 mm from bregma. The TTC lesion 
in this slice is confined to the cortex. B) Opposite side of histological slice in A) at -5 mm from bregma (histological 
slices are 2-mm thick). The TTC lesion in this part of the slice is also confined to the cortex. Specific cortical regions 
within the TTC lesion are shown in the corresponding rat-brain-atlas slices (reproduced from Ref. (15)). White areas in 
the EBDS images correspond to sites of EB staining and dark regions in TTCDS images correspond to sites of no TTC 
staining (tissue injury). The region of brain damage indicated by the TTC lesion was likely due to severe edema and 
subsequent lack of blood flow in this region prior to the administration of the MnCl2+EB solution. The lack of EB 
staining in this region supports this assertion. Table 5-9 provides definitions for the abbreviations of brain-region names 
included within TTC-lesion area. 
 
             DWAVG                    ADCAVG               T1W                      Evans Blue                    TTC 
-3.14 mm Bregma 
-4.80 mm Bregma 
          EB + TTC           EB DS     TTCDS 
A) Histological section at -3 mm from bregma. 
 
          EB + TTC           EBDS     TTCDS 
B) Histological section at -5 mm from bregma. 
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Table 5-9: Brain-Region Abbreviations and Corresponding Names from Rat Brain Atlas in Figure 5-12. 
-3.14 mm Bregma -4.80 mm Bregma 
Abbreviation Name Abbreviation Name 
RSA 
M2 
M1 
S1Tr 
 
S1DZ 
 
S1BF 
Retrosplenial agranular cortex 
Secondary motor cortex 
Primary motor cortex 
Primary somatosensory cortex, 
trunk region 
Primary somatosensory cortex, 
dysgranular region 
Primary somatosensory cortex, 
barrel field 
RSA 
V2MM 
 
V2ML 
 
V2L 
Retrosplenial agranular cortex 
Secondary visual cortex, 
mediomedial area 
Secondary visual cortex, 
mediolateral area 
Secondary visual cortex, lateral area 
 
 
 
Quantitative Summary of TTC-Lesion Area 
Table 5-10 summarizes the average percent-TTC-lesion area for different brain regions 
before and after edema correction in the arabinose and mannitol groups.  
 
Table 5-10: Average Percent Area of TTC Lesion Area (% relative to total brain area) from TTC Histological Images for 
all Brain Regions with TTC Lesion Following Osmotic BBB Disruption and Infusion of the MnCl2+ EB Solution. 
Average Percent-Area of TTC Lesion in All Brain Regions   
(using Eq. 5.3) 
TTC Lesion Region Determined By Visualization Group 
Before  
Edema  
Correction 
After  
Edema 
Correction 
 
 
 
 
Arabinose 
 
 
Mannitol 
Mean ± SEM 
(%) 
 
 
8 ± 1 
 
 
11 ± 6 
ISSDa 
(%) 
 
 
3 
 
 
3 
Mean ± SEM 
(%) 
 
 
7 ± 1 
 
 
9 ± 5 
ISSDa 
(%) 
 
 
3 
 
 
2 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for the 
average lesion area (%) across slices with TTC lesion.  
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5.3.6 MEMRI-DWI Mismatch 
Percent Area of MEMRI-DWI Mismatch and Regional Coverage 
 Figure 5-8 shows representative multi-slice, T1W images and a calculated average ADC map for 
an animal in the arabinose group. Images in Figure 5-8 are spatially co-registered and were 
reconstructed with the same matrix size (128x128) by Bruker Paravision software (Xtip). Percent-
area of MEMRI-DWI mismatch (before edema correction) was 10% ± 3% and 10% ± 2% in the 
arabinose group by the visualization and intensity-thresholding methods (using both T1W images 
and ADC maps), respectively.  For the mannitol group, the corresponding values were 9% ± 4% and 
4% ± 3% by the visualization and intensity-thresholding methods (using both T1W images and ADC 
maps), respectively. Calculation of percent-area of MEMRI-DWI mismatch by visualization and 
intensity-thresholding methods within the arabinose and mannitol groups did not produce 
significantly different results. Calculated percent-area of MEMRI-DWI mismatch was not 
significantly different between the arabinose and mannitol groups (by either visualization or 
intensity-thresholding methods). Brain regions with MEMRI-DWI mismatch included cortex 
(primary somatosensory cortex, secondary somatosensory cortex, primary motor cortex, secondary 
motor cortex), hippocampus (CA1-CA3), geniculate nucleus, deep mesencenphalic nucleus, 
thalamic nucleus, and caudate putamen. Regions of MEMRI-DWI mismatch were determined by 
correlation to a standard rat brain atlas (15) based on the slice location in terms of distance from 
bregma as shown in Figure 5-9 and summarized by Table 5-7. Patterns of MEMRI-DWI mismatch 
within or across groups were not observed. MEMRI-DWI mismatch was always confined to the 
right (ipsilateral) hemisphere.  
 
Figure 5-8: T1W (top row) images and ADC maps (bottom row) from one animal in the arabinose group (left side of 
image = right hemisphere). The images and maps correspond to brain slices 6 mm posterior (leftmost image) to 2 mm 
anterior (rightmost image) of bregma. The white outline in T1W images is the region of MEMRI-DWI mismatch. 
MEMRI-DWI mismatch for all animals is defined as the region of ADC deficit that is outside the region of MEMRI 
signal-enhancement. Area of MEMRI-DWI mismatch was greatest in this particular animal.  
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-5.2 mm Bregma 
-5.8 mm Bregma 
-6.8 mm Bregma 
T1W MRI with MEMRI-
DWI mismatch region 
(white outline). This T1W 
MR slice (2mm thick) 
includes MR signal from 
brain regions located -5 
mm to -7 mm bregma. 
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Figure 5-9. Correlation of MEMRI-DWI mismatch region to a standard rat atlas (15). Abbreviations shown here are 
expanded in Table 5-7.  
 
Table 5-7. Names for Brain-Region Abbreviations in Figure 5-9. From Ref. (15) 
V2ML: Secondary visual cortex, mediolateral area 
V2L: Secondary visual cortex, lateral area 
PtA: Parietal association cortex 
AuD: Secondary auditory cortex, dorsal area 
Au1: Primary auditory cortex 
AuV: Secondary auditory cortex, ventral area 
TeA: Temporal association cortex 
CA1: field CA1 of hippocampus 
CA2: field CA2 of hippocampus 
CA3: field CA3 of hippocampus 
OT: Nucleus of the optic tract 
PPT: Posterior pretectal nucleus 
OPT: Olivary pretectal nucleus 
LPMC: Lateral posterior thalamic nucleus, mediocaudal part 
DLG: Dorsal lateral geniculate nucleus 
MGD: Medial geniculate nucleus, dorsal part  
MGV: Medial geniculate nucleus, ventral part 
APTD: Anterior pretectal nucleus, dorsal part 
APTV: Anterior pretectal nucleus, ventral part 
DpMe: Deep mesencenphalic nucleus 
McPC: Magnocellular nucleus of the posterior commissure 
PCom: Nucleus of the posterior commissure 
RSA: Retrosplenial agranular cortex 
RSGb: Retrosplenial granular b cortex 
RSGa: Retrosplenial granular a cortex 
V2MM: Secondary visual cortex, mediomedial area 
V1M: Primary visual cortex, monocular area 
V1B: Primary visual cortex, binocular area 
S: Subiculum 
PrS: Presubiculum 
PaS: Parasubiculum 
RRF: Retrorubral field 
DpWh: Deep white layer of the superior colliculus  
DpG: Deep gray layer of the superior colliculus  
InWh: Intermediate white layer of the superior colliculus 
InG: Intermediate gray layer of the superior colliculus 
Op: Optic nerve layer of the superior colliculus 
SuG: Superficial gray layer of the superior colliculus 
Post: Postsubiculum 
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Quantitative Summary of MEMRI-DWI Mismatch 
Table 5-8 summarizes the average percent-area of MEMRI-DWI mismatch for different 
brain regions before and after edema correction for the arabinose and mannitol groups.  
Table 5-8: Average Percent-Area of MEMRI-DWI Mismatch (% relative to total brain area) from T1W Images and ADC 
Maps for all Brain Regions with ADC Deficit Regions Outside of MEMRI Signal-Enhanced Regions Following Osmotic 
BBB Disruption and Infusion of the MnCl2+ EB Solution. 
Average Percent-Area of MEMRI-DWI Mismatch in All Brain 
Regions  (using Eq. 5.7) 
MEMRI-DWI Mismatch Regions Determined By 
Visualization Intensity-Thresholding Group 
Before  
Edema 
Correction 
After  
Edema 
Correction 
Before  
Edema 
Correction 
After  
Edema 
Correction 
 
 
 
 
 
 
Arabinose 
 
 
Mannitol 
Mean  
±  
SEM 
(%) 
 
 
10 ± 3  
 
 
9 ± 4 
ISSDa 
(%) 
 
 
 
 
4 
 
 
4 
 
Mean 
± 
SEM 
(%) 
 
 
9 ± 3  
 
 
8 ± 4 
ISSDa 
(%) 
 
 
 
 
4 
 
 
4 
Mean  
±  
SEM 
(%) 
 
 
10 ± 2  
 
 
4 ± 3 
ISSDa 
(%) 
 
 
 
 
4 
 
 
4 
Mean  
±  
SEM 
(%) 
 
 
10 ± 2  
 
 
4 ± 3 
ISSDa 
(%) 
 
 
 
 
4 
 
 
3 
 
 
5.3.7 Correlation of MEMRI-DWI Mismatch to TTC Lesion Area 
For certain animals, the region of MEMRI-DWI mismatch appears to be spatially correlated 
with the corresponding region of infarction; as defined on the TTC histological sections. This 
correlation is intuitive at first because a region with reduced ADC deficit – but lacking MEMRI 
signal-enhancement and EB staining – may indeed be a brain region with severely impaired blood 
flow and tissue damage that occurs prior to the administration of the MnCl2+EB solution (which is 
not expected to reach areas with impaired blood flow). Regions of cellular swelling (cytotoxic 
edema) and reduced blood flow are likely to appear hyperintense on DW images and dark on the 
corresponding calculated ADC maps. 
Most animals for which TTC staining was performed showed an observable spatial 
correlation between MEMRI-DWI mismatch area and TTC lesion area; two such animals are shown 
in Figure 5-13. It is clear, however, that there are slices that do not show a MEMRI-DWI mismatch 
Pitfalls in MEMRI After Osmotic BBB Disruption       186      
 
but do exhibit infarction on the TTC histological sections (e.g., in the arabinose group, the top two 
slices and the bottom slice; in the mannitol group, the two bottom slices). Conversely, there are also 
regions of MEMRI-DWI mismatch which do not exhibit infarction on the TTC histological sections. 
These particular observations should be interpreted carefully due to volume averaging effects in DW 
images. 
 
 
 
 
 
 
 
 
Figure 5-13: EB stain image after Saturation transform (EBSAT), T1W MRI (i.e., MEMRI), average ADC map (ADCAVG), 
and TTC stain image after deconvolution and Saturation transform (TTCDS) in two animals; one from the arabinose 
group (left) and the other from the mannitol group (right). Regions outlined in white on the T1W images indicate regions 
of MEMRI-DWI mismatch. Dark regions in TTCDS images (excluding white matter) correspond to regions of tissue 
injury (infarction).  For both animals, the spatial correlation between regions of MEMRI-DWI mismatch and infarction 
of the TTC histological section is apparent.  However, there are instances where there is no spatial correlation between 
TTC-lesion area and the MEMRI-DWI mismatch (white arrows in top two slices of arabinose group) and when TTC 
lesion area is adjacent to MEMRI-DWI mismatch (red arrows in top four slices in mannitol group).  
 
 
 
 
T1W Image 
w/MEMRI-DWI 
Mismatch ROI 
TTCDS TTCDS T1W Image 
w/MEMRI-DWI 
Mismatch ROI 
Arabinose Mannitol 
EBSAT EBSAT ADCAVG ADCAVG 
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5.4 Discussion 
 
 The results of this study have shown that infusions of hyperosmolar mannitol or arabinose – 
followed by i.v. MnCl2+EB in a spontaneously breathing rat anesthetized with isoflurane – lead to 
brain edema, ADC deficit, nonspecific MEMRI signal-enhancement, and permanent brain damage in 
the ipsilateral hemisphere. Previous MEMRI experiments in rats have indicated little or no MEMRI 
signal-enhancement following osmotic BBB disruption and i.v. MnCl2 infusion (1,4,5). In these 
studies, however, DWI was either not performed (1,4) or DWIs were acquired only after stroke (5). 
In addition, there are no reports in the MEMRI literature that have examined brain-tissue status 
following osmotic BBB disruption using histology. Therefore, although there is experimental 
evidence showing that nonspecific MEMRI signal-enhancement is avoidable; it is not known if these 
methods can prevent brain edema, tissue damage, and/or changes in brain ADC. In an attempt to 
explain the results of this study, brain edema and its relationship to the water ADC, TTC staining, 
and tissue damage is discussed.  Furthermore, the implications of the MEMRI-DWI mismatch, in 
absence of a specific neuronal stimulus or experimental stroke, is considered.   
 
5.4.1 Nonspecific MEMRI Signal-Enhancement: Relation to Anesthesia and Blood Gases 
  One major difference between the experimental protocol used in this study and that of Aoki et al. 
is the anesthetic regimen and the MnCl2+EB infusion protocol. Evans Blue is not biologically inert 
(17) and has been shown to cause electrical and behavioral seizures in rats (18), but is not expected 
to affect MEMRI signal-enhancement levels. In a previous study conducted by the authors (see 
Chapter 4), a MEMRI experimental protocol identical to the protocol used in the present study 
(arabinose group) was used with the exception that no EB was mixed with MnCl2. MEMRI signal-
enhancement was clearly present in the absence of EB, ruling out the dye as the primary factor in 
nonspecific MEMRI signal-enhancement. The study of Aoki et al. used a range of anesthetics that 
included diethyl ether, halothane and a 1:1 oxygen/nitrous oxide gas mixture, and pentobarbital; all 
with the animal under artificial ventilation. The use of artificial ventilation allowed for blood 
pressure, pH, PCO2, and PO2 to be held within the physiological range. By contrast, animals in the 
present study were anesthetized with 2% isoflurane under spontaneously-breathing conditions. Even 
without ventilation, blood pressure, PO2, and PCO2 was maintained within the optimal physiological 
range. Table 5-13 summarizes pH, PO2, and PCO2 in animals from the Aoki et al. sham group and 
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the mannitol and arabinose groups in this study. Blood gases were taken prior to the infusion of 
mannitol or arabinose.  
 
Table 5-13: Blood Pressure Immediately Before Osmotic BBB Disruption and Blood Gases Measured from Animals in 
the Aoki et al. Sham Group and the Arabinose (N=4) and Mannitol (N=3) Groups.  
Blood Gas 
Variable 
Aoki et al.  
Sham Group 
(N=5) 
Average ± SD 
Arabinose Group 
(N=4) 
Average ± SD 
Mannitol Group 
(N=3) 
Average ± SD 
Blood pressure 
 (mm Hg) 
pH 
PCO2 (mm Hg) 
PO2 (mm Hg) 
91.4 ± 9.9  
 
7.5 ± 0.1 
37.2 ± 5.3 
129.6 ± 20.6 
88.0 ± ? 
 
7.4 ± 0.0 
49.8 ± 2.0 
57.8 ± 2.0
*
 
75.0 ± ? 
 
7.4 ± 0.0 
48.0 ± 1.8 
74.0 ± 0.6
* 
*Moderately hypoxic 
 
Although this study did not use a combined non-volatile and volatile anesthetic regimen as 
described by Aoki et al., this approach may be helpful in reducing or eliminating any nonspecific 
MEMRI signal-enhancement under these conditions. Indeed, isoflurane, specifically, has been 
shown to increase blood plasma glutamate levels in humans (19,20)  and exacerbate brain edema in 
brain-injured rats (20). It is possible that increased levels of glutamate in the brain during isoflurane 
anesthesia established a baseline neuronal activity high enough to induce nonspecific MEMRI 
signal-enhancement with the presence of extracellular Mn2+. In addition, moderate hypoxia (21) in 
our animals before mannitol or arabinose infusion, together with possible exacerbation of brain 
edema from isoflurane anesthesia, may have led to the significant reduction in brain ADC detected 
in our experiments.  
 
5.4.2 Brain Edema After Osmotic BBB Disruption 
Vasogenic Edema 
Brain edema has historically been categorized into two types; vasogenic and cytotoxic. 
Cytotoxic edema is cellular swelling that is caused by a loss of ionic pump function and 
osmoregulation due to reduction of oxygen and nutrients to the cell resulting from a blood-flow 
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deficit or cessation. Vasogenic edema is characterized by damage to the BBB resulting in bulk flow 
of water from the vasculature to brain. Endothelial cell shrinkage by hyperosmolar agents – such as 
mannitol and arabinose – increases the permeability of the BBB to molecules with higher molecular 
weights, such as [14C]Sucrose (MW = 340 daltons) and [3H]Inulin (MW = 5500); implying bulk 
flow of these molecules from blood to brain (22). Using an osmotic-BBB-disruption protocol similar 
to that used in this study, Rapoport et al. found the arabinose-infused cerebral hemisphere to be 
edematous within 10-minutes after BBB disruption (7). Other studies report consistent vasogenic 
edema in the side of the brain that received the infusion of hyperosmolar mannitol (23,24). 
Vasogenic edema, however, has been suggested to play only a minor role in brain tissue injury as 
compared to cytotoxic edema (25).  
 
Vasogenic Edema and DW Imaging 
Vasogenic edema has been shown to increase the calculated ADC values on DW images. In a 
study specifically designed to determine the effect of vasogenic edema on ADC values, Ito et al. 
showed that vasogenic edema (by infusion of mock CSF into rat brain) results in an increase in ADC 
value while cytotoxic edema (by middle cerebral artery occlusion in rat) results in a decrease in 
ADC value in the affected regions (25). Although vasogenic edema may have been present within 
animals prior to acquiring the initial DWIs in this study, the observed ADC deficits (up to 34%) and 
the absence of ADC increases in any of the study animals suggests that vasogenic edema does not 
have a significant effect on the acute ADC changes observed in either animal group. However, since 
gross brain edema was clearly present following acute osmotic BBB disruption (Fig. 5-5), the BBB-
disruption process itself appears to initiate vasogenic brain edema similar to that observed following 
the loss of BBB integrity that would result, for example, from ischemic damage to the 
cerebrovascular endothelium (except on a much shorter time scale). 
 
Cytotoxic Edema and Percent ADC Deficit  
Using cortical tissue-impedance measurements, cytotoxic edema has been shown to 
accompany early (one minute after middle cerebral artery occlusion in the brain) ischemia-induced 
changes in the volume of the brain extracellular space (26). The water ADC values in regions with 
cytotoxic edema were previously shown to be reduced by ~37% as compared to contralateral 
hemisphere at 1 hour after the onset of focal cerebral ischemia (27). Interestingly, the percent-
reductions in water ADC values measured in this study (22% to 34%) are similar to those that 
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accompany acute cerebral ischemia; suggesting that a process similar to cytotoxic edema may be 
responsible for the ADC reductions observed following osmotic BBB disruption in the brain.   
 
5.4.3 Is MEMRI Signal-Enhancement Indicative of Tissue Damage? 
Aoki et al. asserted that the irreversibly-damaged stroke core following MCAO could be 
visualized as the region of MEMRI signal-enhancement contained within the region of ADC deficit.  
However, the experimental protocol used in this study also demonstrates similar regions of MEMRI 
signal-enhancement within the region of reduced ADC; even though neither animal group was 
subjected to a cerebral ischemic insult.  The water ADC changes observed in this study identify 
brain regions where cell-volume changes or other injury result in alterations of the 
intracellular/extracellular tissue-water content. Since the mannitol BBB-disruption protocol and 
MnCl2 infusion protocol used in this study were similar to those of the sham group of Aoki et al., the 
results of the two studies might be expected to be similar. Table 5-11 summarizes results of 
comparisons between the mannitol group in this study and the corresponding sham group of Aoki et 
al. As shown in Table 5-11, ADC deficit area in our mannitol group is comparable to that in Aoki’s 
sham group. However, ADC deficit area in our arabinose group shows a large difference (that would 
likely be statistically significant) from the ADC deficit area in the sham group of Aoki et al. These 
differences may be the result of a different anesthetic regimen used in our study. Other conditions 
such as severity of BBB disruption and cytotoxic edema in our experiments may also have been 
responsible for the differences in ADC deficit and MEMRI signal-enhancement between our animal 
groups and Aoki’s sham group. 
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Table 5-11: Comparison of Mannitol and Arabinose Group Data for Percent-Area of ADC Deficit and MEMRI Signal-
Enhancement in Rat Brain After Osmotic BBB Disruption with the Results of Aoki et al. (5). 
Group  
 
 
 
 
Percent-Area 
Measurement 
Aoki et al. 
Sham* 
(N=5) 
Present Study: 
Mannitol* 
(intensity-
thresholding 
before EC, 
N=4) 
 
Present Study: 
Arabinose 
(intensity-
thresholding 
before EC, N=10) 
 
 
ADC Deficit 
 
MEMRI Signal-
Enhancement 
 
TTC Lesion 
Mean ± SD 
(%) 
 
8 ± 4 
 
 
5 ± 3 
 
 
 
? 
Mean ± SD 
(%) 
 
8 ± 7 
 
 
16 ± 9 
 
 
 
11 ± 11 
Mean ± SD 
(%) 
 
19 ± 4 
 
 
21 ± 6 
 
 
 
8 ± 2 
* Aoki et al. (5) sham and mannitol groups listed in the table received the same concentration (1.4M) and dose (5 ml/kg) 
of mannitol administered at the same rate (50 ml/hr) and via the same intravenous route (ICA). The region of ADC 
deficit in the sham group of Aoki et al. was determined by thresholding the ADC map pixels at 5.0 x 10-4 mm2/s (i.e., 
ADC pixel values less than this threshold were included in the calculation of the ischemic lesion area). The region of 
ADC deficit in the mannitol and arabinose groups was determined by thresholding the ADC map pixels at 2 SDs below 
the mean of all ADC pixel-values in the contralateral hemisphere. 
 
5.4.4 Brain Damage Verified by TTC Lesion 
TTC Lesion Indicates Damage to Brain Tissue 
The use of TTC staining for the detection of ischemic brain damage was first reported by 
Bederson et al. in 1986 (14). Bederson et al. compared the use of TTC to that of the conventional 
hematoxylin and eosin (H&E) staining technique for the evaluation of ischemic brain damage after 
24 h in the rat. Although TTC staining clearly demarcates region of brain infarction at 24 h after 
ischemia, Bederson et al. notes difficulty in correlating ischemic regions defined by TTC staining to 
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those delineated by H&E staining at times less than 6 h after the onset of ischemia. However, 
because many animals from both groups displayed an absence of TTC staining that was spatially 
correlated to regions of severe ADC deficit in certain brain regions we believe that our TTC stain 
data (acquired 4 hours after osmotic BBB disruption) provides reliable evidence of brain damage. 
 
5.4.5 MEMRI-DWI Mismatch 
Comparison of ADC Deficit Calculation: Aoki et al. Study vs. Present Study  
In a study to determine the efficacy of MEMRI for the evaluation of experimental stroke in 
rats, Aoki et al. found that MEMRI signal-enhanced regions in the ischemic brain were smaller than 
regions of ADC deficit. As a result of this observation, Aoki et al. coined the term ‘MEMRI-DWI 
mismatch’ (5) and suggested that the region of MEMRI signal-enhancement was restricted to (and 
indicative of) the irreversibly-damaged, ischemic core of the lesion. 
As indicated in Table 5-11, the percent-area of ADC deficit in the sham group of Aoki et al. 
is similar to that of the mannitol group in this study. However, this result must be interpreted with 
some caution since the methods for calculating percent-area of ADC deficit were different in each 
case. For the sham group in the study of Aoki et al., the ADC deficit was determined by using a 
fixed threshold (5.0 x 10-4 mm2/s) to identify pixels in the calculated ADC map that should be 
included as part of the ischemic lesion in the ipsilateral cortex.  For the mannitol group in the present 
study, the region of ADC deficit was determined as those pixels in the ipsilateral hemisphere of the 
calculated ADC map that were 2 SDs below the mean of all ADC pixel-values in the contralateral 
hemisphere.  
 
MEMRI-DWI Mismatch: TTC-Lesion Area, ADC-Deficit Area, and Area of MEMRI Signal-
Enhancement  
In this study, the MEMRI-DWI-mismatch region was defined as the region of ADC deficit 
that resides outside the boundary of the region of MEMRI signal-enhancement. Brain regions with 
reduced ADC, but that do not demonstrate MEMRI signal-enhancement or EB staining, are likely 
regions that experienced cytotoxic edema as a result of a cerebral-blood-flow deficit following 
mannitol (or arabinose) infusion. Regional patterns of EB staining, TTC staining, and MEMRI 
signal-enhancement (Fig. 5-13, arabinose group) indicate that the MnCl2+EB solution did not 
permeate the BBB within regions that progressed to infarction (as defined by TTC staining) in those 
particular cases.  
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In contrast to the example in the previous paragraph, there were many instances in this study 
where the region of MEMRI signal-enhancement and EB staining were contained within the 
infracted region as defined by TTC staining and reduced ADC (e.g., Fig. 5-13, mannitol group).  In 
this case, reduced water ADC within the regions of BBB disruption suggests a condition that mimics 
cytotoxic edema.  For example, osmotic BBB disruption may induce cell-volume changes similar to 
those observed during cytotoxic edema (i.e., cell swelling due to acute membrane depolarization), 
but via a different mechanism. These osmotically-induced cell-volume changes may be related to the 
uptake of Mn2+ into cells; assuming that the extracellular Mn2+ is present during that process. In this 
case, extracellular Mn2+ could be transported into the cell along with water that is moving under the 
influence of an osmotic gradient.  Once inside the cell, Mn2+ would reduce the T1 relaxation time of 
the intracellular water, in the same manner that Mn2+ would do so had it entered the cell via voltage-
gated calcium channels (VGCCs) following a specific neuronal stimulus.  However, in this case, 
Mn2+ enters the cell as a result of osmotic water shifts that accompany BBB disruption, rather than 
via water shifts that accompany cell-membrane depolarization. The idea of Mn2+ entry into cells via 
osmotically-induced cell-volume changes is supported by reports of cellular volume regulation 
during exposure to hypertonic solutions (28,29). In one such report, McManus et al. used laser light 
scattering to monitor Rat C6 glioma cells in culture during exposure to hypertonic mannitol (30). In 
their study, McManus et al. show rapid cell shrinkage upon abrupt exposure to mannitol (+70 mOsm 
and +40 mOsm in separate experiments).  After a brief lag time, cell volume was observed to return 
to baseline and proceeded to increase to a swollen state for the duration of a 30-minute observation 
period. Data from McManus et al. is shown in Figure 5-14. Based on the data in Figure 5-14, cell 
shrinkage and swelling are apparent for at least 5 minutes following exposure to hypertonic 
mannitol. If these in vitro conditions are close indicators of potential in vivo cell response to 
hyperosmolar mannitol (or arabinose) during osmotic BBB disruption, changes in ADC (ADC 
decrease due to cell swelling and loss of extracellular space) and entry of Mn2+ into cells is expected. 
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Figure 5-15: A representative recording of the volume behavior of C6 cells exposed to +40 mOsm hypertonic mannitol. 
Reproduced from Ref. (30) 
 
It is not clear at this point how the BBB-disruption process might contribute to the 
irreversible tissue damage demonstrated on TTC (and indirectly on ADC). In this case, the 
mechanism of cell death may or may not be related to blood-flow deficits in brain. 
 
Mechanisms of MEMRI Signal-Enhancement; Nonspecific or Due to Anoxic Depolarizations?  
In the study of Aoki et al., MEMRI signal-enhancement was suggested to result from anoxic 
depolarization of brain cells following experimental stroke in the presence of extracellular 
manganese. This suggestion was supported by data from sham animals, in which no stroke was 
induced and very little MEMRI signal-enhancement was observed as compared to animals in the 
experimental group. 
The present study revealed significant MEMRI signal-enhancement without experimental 
stroke. As with the ADC deficit, the mannitol group in the present study was expected to exhibit a 
similar level of MEMRI signal-enhancement as compared to the sham group of Aoki et al., due to 
the similarity of the experimental protocols between the two studies. Table 5-12 compares the 
MEMRI signal-enhancement in the sham group of Aoki et al. and the mannitol and arabinose groups 
in this study. Although it is clear the differences in MEMRI signal-enhancement between the two 
studies are statistically significant, the differences in the Bo-field strength (and other experimental 
details) between the two studies make it difficult to interpret the significance of this result.   
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Since experimental stroke was not induced in the present study, questions remain as to the 
underlying mechanism responsible for the MEMRI signal-enhancement observed in the mannitol 
and arabinose groups. It is important to consider that TTC lesion area was not always correlated to 
regions with MEMRI signal-enhancement. Therefore, MEMRI signal-enhancement, even when 
correlated to regions of ADC deficit, may not indicate regions of tissue damage. MEMRI signal-
enhancement may indeed be due to low levels of anesthesia or to an undetermined mechanism 
following osmotic BBB disruption that results in sequestration of Mn2+ by brain cells (glia or 
astrocytes) and endothelial cells of the BBB (e.g., the scenario described in the previous section). 
 
Table 5-12: Comparison of Aoki et al. Sham, and Mannitol and Arabinose Group Data for % MEMRI Signal-
Enhancement in Rat Brain After Osmotic BBB Disruption. 
Group  
Aoki 
Sham* 
(N=5) 
Aoki  
Experimental 
(stroke group) 
(N=5) 
Present Study 
Mannitol* 
(intensity-
thresholding 
before EC, N=4) 
Present Study 
Arabinose 
(intensity-
thresholding 
before EC, N=10) 
Average 
Percent: 
 
MEMRI 
Signal-
Enhancement 
Mean ± SD 
(%) 
 
 
 
8.4 ± 1.32 
 
Mean ± SD 
(%) 
 
 
 
71.0 ± 17.5 
 
Mean ± SD 
(%) 
 
 
 
91 ± 13 
Mean ± SD 
(%) 
 
 
 
88 ± 20 
* Aoki et al. sham and the mannitol group in the present study depicted in the table received the same concentration 
(1.4M) and dose (5 ml/kg) of mannitol at the same rate (50 ml/hr) and by the same intravenous route (ICA). The MEMRI 
signal-enhanced region in the Aoki et al. sham group and the mannitol and arabinose groups was defined as those pixels 
in the T1W images with signal intensities that exceeded the mean +2SDs in the contralateral hemisphere. Clearly, the 
level of MEMRI signal-enhancement in our mannitol (and arabinose) group is significantly different from MEMRI 
signal-enhancement in Aoki’s sham group (but not Aoki’s stroke group).  
 
It has been widely reported that Mn2+ is a calcium analog and acts similarly to Ca2+ in 
biological systems (1,31,32). Anoxic depolarizations open Ca2+ channels and is expected to enhance 
Mn2+ accumulation in cells with the presence of extracellular Mn2+ (5). However, since Aoki et al. 
Pitfalls in MEMRI After Osmotic BBB Disruption       196      
 
did not provide histological confirmation of tissue damage following anoxic depolarizations, or DC 
potential measurements during anoxic depolarizations, the notion that anoxic depolarization 
accounts for all of the observed MEMRI signal-enhancement in their study is somewhat speculative. 
Nonspecific MEMRI signal-enhancement has been reported due to a low level of anesthesia (1,33), 
local to regions with brain edema (33), and following osmotic BBB disruption with the presence of 
extracellular Mn2+ (34). Although the data of Aoki et al. is not supported by histology or DC 
potential measurements, they do report a relatively low level of MEMRI signal-enhancement in their 
sham animals (i.e., nonspecific MEMRI signal-enhancement). In this case, the low levels of 
nonspecific MEMRI signal-enhancement may be a result of the anesthetic regimen used.  
 
Conclusions 
Tissue damage by focal edema (8), microvascular pathology (35), and pyknotic neurons (36) 
is, among others, of major concern when using hyperosmolar agents to disrupt the BBB to allow 
passage of Mn2+ (or other substances) from blood to brain. For MEMRI experiments that rely on 
specific neuronal stimulus to stimulate brain cells and sequester extracellular Mn2+ via voltage-gated 
calcium channels, tissue damage by osmotic BBB disruption must be minimized or prevented 
altogether. An optimal osmotic BBB disruption protocol has yet to be determined for MEMRI 
experiments that rely on a homogeneous distribution of Mn2+ to the brain parenchyma prior to 
specific neuronal stimulus. The results of these studies suggest careful study of brain structure and 
function following infusions of hyperosmolar agents for osmotic BBB disruption and delivery of 
Mn2+ to the brain parenchyma.  
Additionally, in future studies that use a combined MnCl2+EB solution, acquisition of the 
electroencephalogram (EEG) signal would be helpful to determine if EB dye has any potential side 
effects on brain function. Perhaps more importantly, the EEG could also provide a measure of the 
anesthetic state of the animal, which could then be correlated to any existing nonspecific MEMRI 
signal-enhancement, in an attempt to rule out anesthesia as a source of unwanted uptake of Mn2+ into 
active brain cells. 
Based on ADC deficit area calculations, arabinose may inflict a larger region of edema when 
infused at 1.6M for 55 seconds as compared to an infusion of 1.4 M mannitol at 50 ml/hr. This point 
again stresses the need to find an optimal osmotic BBB disruption protocol for MEMRI studies. 
Because MnCl2+EB solution does not always reach regions that have ADC deficit, as indicated by a 
correlation between regions without MEMRI signal-enhancement (or EB staining) and regions with 
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TTC lesion, the lack of MEMRI signal-enhancement in particular regions may be difficult to 
interpret unambiguously when histological confirmation of BBB disruption is not available.  
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Abstract 
Manganese (Mn2+) has proven to be a useful MR contrast agent for functional imaging and 
neuronal tract tracing. The paramagnetic properties of Mn2+ provide local contrast on T1-weighted 
(T1W) MRI after cellular sequestration via voltage-gated calcium channels. Researchers have used 
the MRI contrast agent Gd-DTPA to show T1-contrast in MR images near regions of blood-brain 
barrier (BBB) disruption after stroke. Gd-DTPA is an extracellular MRI contrast agent and, 
therefore, is not expected to provide information regarding the state of cells local to a stroke-related 
BBB injury. The results of this study show BBB injury after ischemic insult allows simultaneous 
passage of Mn2+ and Evans Blue (EB) dye into the brain parenchyma, resulting in localized T1W-
MRI-signal increase (MEMRI signal-enhancement). MEMRI signal-enhancement in these 
experiments corresponds to the degree of BBB disruption and is apparent in areas of tissue damage 
as verified by 2,3,5-triphenyltetrazolium hydrochloride (TTC) staining and diffusion-weighted MRI 
(DWI). These findings suggest that Mn2+, used in conjunction with a rat embolic stroke model, can 
produce MEMRI signal-enhancement in areas peripheral to and/or in the stroke core with a 
compromised BBB. MEMRI signal-enhancement using an embolic stroke model with Mn2+ as the 
MRI contrast agent can show regions of injured BBB and may provide insight into the state of brain 
cells local to BBB injury. This method may prove useful for future studies using MEMRI to monitor 
brain response to ischemia.  
 
Key words: manganese-enhanced MRI, blood-brain barrier, stroke, rat brain 
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6.1 Introduction 
In Chapter 4 it was suggested that neuronal damage in the brain following osmotic blood-
brain barrier (BBB) disruption was primarily responsible for uptake of manganese (Mn2+) in brain 
cells, resulting in so-called nonspecific MEMRI signal- enhancement. In Chapter 5 it was suggested 
that cell-volume regulatory mechanisms following osmotic BBB disruption may also play a role in 
the uptake of Mn2+ into the cell leading to nonspecific MEMRI signal-enhancement.  These ideas are 
in conflict with the generally accepted theory which suggests that MEMRI signal-enhancement in 
the brain is a result of cell-membrane-depolarization-dependent mechanisms only (1-3). This chapter 
builds upon the work presented in the previous two chapters by testing the hypothesis that MEMRI 
can be used to monitor BBB disruption and neuronal injury following embolic stroke. This study is 
designed to determine if Mn2+ can cross a pathologically-injured BBB and subsequently enter 
stroke-injured brain cells; thus generating localized contrast on T1W MRI that is specific to stroke-
related BBB disruption and underlying neuronal injury.  
 
Cell Volume Changes Following Stroke Detected by Diffusion-Weighted (DW) MRI (DWI)  
As described in Chapter 1, DWI is sensitive to changes in the mobility of water protons that 
accompanies cell-volume changes in the brain. Following an ischemic insult to the brain, the 
depletion of cellular energy reserves (e.g., adenosine triphosphate – ATP) results in cell-membrane 
depolarization (i.e., anoxic depolarization) and subsequent cellular swelling (cytotoxic edema).  
These cell-volume changes restrict the translational motion of tissue water molecules relative to that 
of normal tissue.  The water molecules with reduced mobility are detected as a signal-intensity 
increase on DWI; reflecting a decrease of the apparent diffusion coefficient (ADC) of water in that 
region of the brain. The temporal dynamics of cell-volume changes (cytotoxic edema) and water 
ADC reductions following experimental stroke has been well documented.  de Crespigny et al. 
showed that global cerebral ischemia in the rat results in a rapid decline in brain-water ADC during 
the first two hours following stroke onset (4). Using an embolic stroke model in the rat brain, Jiang 
et al. (3) also found that tissue-water ADC decline was most  
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Fig. 6-1: A) Plot of water ADC (and ∆R2* and ∆R2) in the rat brain following cardiac arrest. Reproduced from de 
Crespigny et al. (4). Note how the abrupt ADC decline following cardiac arrest (at time 0) levels off starting at 120 
minutes. B) Plot of water ADC in brain regions with hemorrhagic transformation (“HT”) and ischemic (“Ischemia”) 
injury. Note the slight increase in ADC from 2-3 h and only a modes change in ADC from 3-4 h following infusion of an 
embolus to block blood flow to one brain hemisphere (infusion started at point “C”). Reproduced from Jiang et al. (5) 
 
abrupt in the first two hours and then plateaued after three hours. Data from de Crespigny et al. and 
Jiang et al. are shown in Figures 6-1a and 6-1b, respectively, for reference. The data presented in 
A 
B 
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Figure 6-1 indicate that the ADC changes in the brain related to stroke injury stabilize in the first 2-3 
h after stroke onset. Therefore, if Mn2+ is infused i.v. during the time period that the BBB is 
permeable due to stroke-related damage, and at a time point after which cell-volume changes have 
stabilized (~4 h after stroke), then any ensuing MEMRI signal-enhancement would not likely be due 
to dynamic cell-volume changes but rather increase permeability of the BBB.  
 
6.1.1 Stroke Background 
A stroke occurs when a blood vessel that delivers oxygen and nutrients (e.g., glucose) to the 
brain bursts (1)or is obstructed by a blood clot or other types of emboli. Brain injury can occur 
within minutes if blood flow is not restored to normal. There are two main forms of stroke: ischemic 
and hemorrhagic. An ischemic stroke is caused by occlusion of blood vessels by a blood clot or other 
emboli.  A hemorrhagic stroke is caused by bleeding from a burst blood vessel, which diverts blood 
flow away from the brain tissue that is served by the ruptured vessel. Ischemic stroke occurs more 
often (~80%) than hemorrhagic stroke. With modest reductions in cerebral blood flow (CBF), 
disturbances of brain tissue metabolism and function are mitigated by CBF autoregulation in brain 
(6). As a result, the onset of cerebral ischemia does not occur until the CBF is reduced below a 
certain threshold.  Below that threshold, the CBF range is subdivided into regimes that constitute 
mild, moderate, and severe ischemia as depicted in Figure 6-2.  
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Figure 6-2: Ischemic brain injury can be characterized as a contiguous series of thresholds which define ranges of CBF 
values that are correlated to particular pathological events. CMRO2 = cerebral metabolic rate of oxygen, ECF K
+ = 
extracellular fluid potassium, ECF Ca++ = extracellular fluid calcium. The ischemic ‘penumbra’ is defined as tissue with 
a clinical CBF deficit but that can be responsive to therapeutic intervention. Reproduced from Ref. (6). 
 
 
6.1.2 Stroke and the BBB 
Evaluation of BBB integrity following stroke has been accomplished by detection and 
quantification of extravasated EB dye and protein tracers into the brain parenchyma. Sadoshima and 
coworkers evaluated the permeability of the BBB to 131I-albumin and EB following global cerebral 
ischemia by clamping both common carotid arteries in the rat (7). Sadoshima et al. reported 
exudation of EB dye from blood into brain in 18 of 23 rats following 3 h of ischemia followed by 
reperfusion. Albayrak et al. showed exudation of normally BBB-impermeable albumin into brain 
after 2 h of stroke followed by 6 h of reperfusion. Based on findings of Albayrak et al., longer 
transient ischemic events result in BBB disruption at earlier time points (as compared to shorter-
duration ischemic insults) and neuronal damage precedes BBB disruption under these conditions (8). 
Data from a study by Petito et al. confirmed that neuronal necrosis alone was not sufficient to 
increase BBB permeability (to horseradish peroxidase) (9). Therefore, the effects of stroke on blood 
CBF 
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vessels must be considered to understand the mechanisms that lead to BBB damage following severe 
CBF deficits.  
 
Stroke and Brain Microvessel Damage 
The reduction in CBF and oxygen delivery following stroke has several consequences for the 
BBB that lead to a loss of barrier function and uncontrolled entry of blood (hemorrhagic 
transformation), water, and ions into the brain parenchyma: 1) microvascular permeability barriers 
are lost; 2) the basal lamina and extracellular matrix undergo progressive loss of antigens; and 3) 
cell-matrix adhesion interactions within microvessels are altered (10). These steps are depicted in 
Figure 6-3.  
 
 
Figure 6-3: Schematic diagram of the effect of ischemia on microvascular permeability and integrity. (A) Normal 
cerebral microvessel. Endothelial cells and astrocytes bound to basal lamina by integrin adhesion receptors. The BBB is 
intact. (B) Breakdown of the BBB. (C) Leucocyte adhesion by receptors on endothelium and granulocytes; increased 
permeability caused by granule release. (D) Breakdown of basal lamina with loss of astrocyte and endothelial cell 
contacts. Reproduced from Ref. (10). 
 
In the brain, astrocytic end-feet are adjacent to the extracellular matrix or the basal lamina in 
capillaries and provide a connection between the microvascular endothelium and the neuropil 
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(11,12). During brain development, astrocytes, in conjunction with endothelial cells, contribute 
laminin to the extracellular matrix and stimulate formation of the BBB (13). Integrins (heterodimeric 
adhesion receptors) function as structural connections between endothelial cells and underlying basal 
lamina. Laminins serve as a major component of the basal lamina and extracellular matrix and are 
ligands for the integrin heterodimers α1β1, α2β1, α3β1, α6β1, α7β1 (14), and α6β4 (15). The basal lamina 
is uniquely sensitive to focal cerebral ischemia (16) and it has been shown that the expression of 
integrin β4 and the heterodimer α6β4 are rapidly and significantly reduced following stroke (MCAO 
in nonhuman primate model) (12). Since astrocytes are anchored to the cerebral microvascular wall 
by α6β4, and play a role in structural support of the BBB, the lack of α6β4 expression following 
stroke may contribute to pathological disruption of the BBB. 
 
6.1.3 The Embolic Stroke Model and Associated BBB Injury 
There are several methods available to induce experimental stroke in animals.  These include: 
1) global ischemia by cardiac arrest; 2) permanent (or temporary) occlusion of the middle cerebral 
artery using an intraluminal suture (suture occlusion model); and 3) occlusion of the middle cerebral 
artery by infusion of emboli (embolic stroke model).  Since thrombosis and embolism are 
responsible for 80% of human stroke (17), an experimental model of stroke was designed to mimic 
the large middle cerebral artery thromboembolic stroke in human. The rat model of embolic focal 
cerebral ischemia developed by Zhang et al. results in selective occlusion of the middle cerebral 
artery and a highly reproducible CBF reduction and infarct volume (18). Figure 6-5 shows a 
schematic diagram of the catheter placement for infusion of an embolus in the embolic stroke model. 
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Figure 6-4: Schematic drawing of catheter placement into external carotid artery (ECA) and the internal carotid artery 
(ICA) of the rat, with its tip 2 mm from the origin of the middle cerebral artery (MCA). The catheter contains a clot 
(black), which can be injected to occlude the MCA. Reproduced from Ref. (18) 
 
Time Frame of BBB Injury Following Embolic Stroke 
Following experimental stroke by the intraluminal suture occlusion model, Belayev et al. 
showed injury to the BBB as verified by Evans Blue (EB) staining. According to their data, the BBB 
becomes permeable to molecules similar in size to the EB-albumin complex (MW = 68,500) within 
3-5 hours after stroke (and also at 48-50 h, but not 24 h after stroke). Data from Belayev et al. is 
shown in Figure 6-5: 
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Figure 6-5: Concentration of Evans Blue (EB) dye measured in right cortex (A) and right striatum (B) of an MCA-
occlusion group and sham group at different times after intraluminal-suture occlusion of the MCA. Note the biphasic 
character of BBB opening to EB (3-5 h and 48-50 h groups).  Reproduced from Ref  Belayev et al.  
 
Using the embolic stroke model, Ding et al. show stroke-related BBB opening 3 h following 
infusion of emboli in the rat brain. In their study, passage of a gadolinium-based MRI contrast agent 
from the blood into the brain induced contrast changes in T1W images local to sites of BBB injury at 
3 h after stroke onset.  Data from the study of Ding et al. are shown in Figure 6-6. 
 
   
Figure 6-6: The T1W subtraction image (a1) from pre- (a2) and post-contrast (a3) T1W images of the rat brain following 
embolic stroke; but without embolic-stroke-induced hemorrhage (‘no HT’, as confirmed histologically at 48 h after 
stroke onset).  The animal presented with BBB disruption and evidence of gadolinium-MRI-contrast-agent (Gd-DTPA) 
leakage at 3 h after ischemia. Reproduced from Ref. (19).  
 
6.1.4 Intracellular Calcium Level Increase During Stroke – Implications for MEMRI   
 
Intracellular Accumulation of Ca
2+
 Occurs In Concert with BBB Injury 
Cerebral ischemia initiates many different cellular processes that lead to cell death, including 
generation of reactive oxygen species, intercellular release of glutamate, depressed energy 
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metabolism, translocation of protein kinase C, increased production of polyamine and nitric oxide, 
and increased intracellular calcium (Ca2+) (20).  Ionic activity of extracellular calcium in the 
ischemic brain decreases as verified using ion-selective microelectrodes (21,22). In a study by 
Rappaport et al., a significant accumulation of Ca2+ in the ischemic MCA territory was measured 
(via tissue calcium analysis) within 4 h after MCA occlusion. The time frame of calcium 
accumulation coincided with the development of abnormal BBB permeability. In addition, the data 
of Rappaport et al. showed that the concentration of the accumulated intracellular Ca2+ exceeded all 
of the available extracellular Ca2+ in the adjacent brain tissue. Therefore, Rappaport et al. postulated 
that Ca2+ lost from adjacent brain during ischemia was replenished by external sources such as blood 
or CSF. The intracellular accumulation of Ca2+ has been shown by others to occur at the site of the 
stroke core (20). In summary, stroke-related intracellular Ca2+ accumulation 1) occurs at the site of 
ischemic injury; 2) occurs within the same time frame that the BBB is damaged by stroke (3-4 h 
after stroke onset); and 3) is exacerbated by delivery of Ca2+ to the ischemic region by residual blood 
flow or CSF.  
 
Detection of Stroke Core by MEMRI  
As described previously (Chapter 3), manganese (Mn2+) is handled similarly to calcium by 
biological systems and does not cross a healthy intact BBB. Therefore, because high concentrations 
of intracellular Ca2+ and local BBB injury are associated with the core of the stroke lesion, it is 
hypothesized that Mn2+ delivered i.v. following stroke should result in a large accumulation of Mn2+ 
within damaged cells and localized MEMRI signal-enhancement on T1W MRI; indicative of the 
stroke core.  
 
6.2 Methods 
6.2.1 Animal Preparation 
This study was approved by the Institute Animal Care and Use Committee (IACUC) of the 
University of Massachusetts Medical School (IACUC Protocol A-1756). Five male Sprague-Dawley 
rats, weighing 280-350 g, were initially anesthetized with 5% isoflurane and maintained at 2% 
isoflurane, mixed with breathing-quality air, during surgery. PE-50 polyethylene tubing was inserted 
into the left femoral vein for drug administration and the left femoral artery for blood pressure and 
blood gas monitoring. Rectal temperature was continuously monitored with a rectal probe and 
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maintained at 37.0 ± 0.5 °C using a thermostatically-controlled heat lamp (Model 73ATD, YSI Inc., 
Yellow Spring, OH) during preparation.  
 
6.2.2 Embolic Middle Cerebral Artery Occlusion (eMCAO) 
For eMCAO, a blood clot was infused via an i.v. catheter into the right external carotid artery 
(ECA), allowing the left hemisphere to serve as a control. For catheterization of the right ECA, a 
ventral midline incision was made in the neck. The omohyoid muscle was separated longitudinally 
and retracted laterally to isolate and expose the right common carotid artery (CCA), ECA, internal 
carotid artery (ICA) and pterygopalatine artery (PPA). The PPA was permanently ligated. Following 
temporary clamping of the CCA, the ECA was ligated and a small incision was made in the vessel 
for placement of the catheter (PE-10 tubing). PE-10 tubing was inserted into the ECA proximal to its 
ligation, and one red blood clot was injected – with a volume of ~50 µL of saline – into the ICA over 
approximately one second.  The clot was delivered one millimeter distal from the bifurcation of the 
PPA and ICA. eMCAO was verified by Laser Doppler Flowmetry (Perimed PF 5010 LDPM Unit, 
Sweden) as a reduction of the blood flow signal by 70% (data not shown). Three hours after 
eMCAO, animals were transferred to the MR magnet bore for imaging.  
 
Embolus Preparation 
The embolus-preparation protocol was originally described by Toomey et al. (23) and 
modified based on a protocol originally described by Henninger et al. (24). The modification was 
limited to reducing the size of the embolus from 36 mm to 18 mm. Briefly, whole blood (200 µL) 
was withdrawn from the rat, 24 h before surgery, into an Eppendorf tube. The blood was promptly 
mixed with 1.0 National Institutes of Health (NIH) unit (10 µL) of human thrombin and 4.5 µL of 1 
mol/L (M) CaCl2 for a final concentration of 20 mM. Within 5 s, a small amount of this mixture was 
drawn into a 30-cm-long polyethylene catheter (PE-50) and allowed to clot at 37 °C. After 2 h, the 
clot was extruded from the catheter into a saline-filled Petri dish and stored at 4 °C for 22 h. Before 
infusing the clot into the rat ECA, a 5- to 10-cm section of clot was placed into a separate Petri dish 
containing deionized water, incubated for 5 min at room temperature, transferred into a solution of 
isotonic saline, and then dissected into a single 18-mm section. This clot section was collected into a 
PE-10 catheter in a volume of ~50 µL of saline. The interval between this final step and 
embolization of the rat was less than 5 min.  
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6.2.3 MR Imaging 
All MR images were acquired using a Bruker Biospin 2.0T/45 cm imaging spectrometer 
operating at 85.56 MHz for 1H and equipped with ±20 G/cm self-shielded gradients. Diffusion-
weighted MRIs (DWIs) were acquired with six b-values (23, 92, 207, 828, 1126, and 1471 s/mm2), a 
64 x 64 data matrix zero-filled to 128 x 128 before Fourier transformation, FOV = 3 cm x 3cm, six 
2-mm-thick slices, TR/TE = 2000/51.0 ms, ∆= 6.0 ms, δ = 24.31 ms, and NEX = 8. T1W MRI was 
performed with the following parameters: TR/TE = 500/10.8 ms, FOV = 3 cm x 3 cm, data matrix = 
128 x 128, six 2-mm-thick slices, and NEX = 8. The slice positions of DW images and T1W images 
were co-registered. The imaging plane was referenced to the rhinal fissure at the boundary of the 
olfactory bulb. Acquisition time for one set of images was 8.5 minutes for T1W and 4.8 minutes for 
DW imaging. During imaging, animals were placed prone within a home-built animal holder. The 
head of the animal was fixed within a home-built 8-element, 4.3-cm-diameter 1H birdcage coil. 
Animals were anesthetized with 2% isoflurane delivered at 1.0-1.5 L/min in breathing-quality air. 
Body temperature was maintained at 37.0 ± 1°C by circulated warm air using a T-type thermocouple 
and a double-point feedback control system. T1W and DW imaging continued sequentially for at 
least one full scan after the end of MnCl2+EB infusion.   
 
6.2.4 MnCl2+EB Infusion Protocol 
Manganese chloride (MnCl2 · 4H2O,
 MW = 198; Sigma, St. Louis, MO), dissolved to 74.5 
mM in isotonic saline, and Evans Blue (EB; Sigma, St. Louis, MO), dissolved to 2% in MnCl2 
solution, was infused into the left femoral vein at 3.2 ml/h for 30 min using a syringe pump (Model 
PHD 2000; Harvard Apparatus, Holliston, MA). Figure 6-1 shows the timing of image acquisition 
relative to eMCAO. 
 
 
 
 
Figure 6-7. Timing of MR imaging (DWI = DW MRI and T1 = T1W MRI), EB and TTC staining relative to eMCAO and 
MnCl2+EB solution infusion. MnCl2+EB solution infusion was started 4 h after initiation of eMCAO. T1W MRI 
continued for at least 25 min after cessation of the MnCl2+EB infusion.  
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6.2.5 EB and 2,3,5 TriphenylTetrazolium Chloride (TTC) Histology 
Immediately following imaging, isoflurane anesthetic was increased to 5% and shortly 
thereafter the animals were decapitated. The brain was quickly removed, placed on a square section 
of parafilm and subsequently cooled for 30 min to facilitate handling. Brains were then dissected 
into six 2-mm slices that corresponded spatially to the slice positions of the MRIs (first slice at 1 mm 
ventral to the rhinal fissure of olfactory bulb). After dissection, brain slices were placed in saline and 
scanned using a Hewlett-Packard Scanner (Model #3970) at a resolution of 1200 dpi for indications 
of EB staining. After scanning, brain slices were placed in a 2% solution of TTC and warmed to 37 
°C in a lab oven (Fisher Isotemp 500 Series). The time from eMCAO to TTC staining was 
approximately 6 h in each animal. After 10 min in the lab oven, all slices were placed in zinc 
formalin for fixation overnight. The next day, brain slices were scanned using a Hewlett-Packard 
Scanner (Model #3970) at a resolution of 1200 dpi.  
 
6.2.6 Data Analysis 
Region of interest (ROI) definitions and calculations in T1W images were made using NIH 
ImageJ software (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, 
USA, http://rsb.info.nih.gov/ij/, 1997-2006). ROIs were drawn freehand to distinguish between 
MEMRI signal-enhanced regions, ADC-deficit regions, and normal brain tissue. MEMRI signal-
enhancement increase, MEMRI signal-enhancement area, ADC deficit, and ADC-deficit area (DA) 
were all calculated using ROIs drawn freehand by observer visualization. Data are reported as mean 
± SEM.  
 
MEMRI Enhancement 
MEMRI signal-enhancement on T1W images was calculated by comparing the MR signal 
intensity in visually evident MEMRI signal-enhanced regions of the ipsilateral hemisphere with 
homologous control regions in contralateral hemisphere, on a slice-by-slice basis: 
100(%) ×
−
=−
CH
CHIH
SI
SIS
tEnhancemenSignalMEMRI  
where SIIH is the mean signal intensity for an ROI in the ipsilateral hemisphere and SICH is the mean 
signal intensity for the equivalent ROI in the homologous control region in contralateral hemisphere. 
Percent-area of MEMRI signal-enhancement in the T1W images was calculated on a slice-by-slice 
6.1 
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basis by comparing the area of MEMRI signal-enhancement to that of the entire ipsilateral 
hemisphere, as shown in Eq. 6.2. 
 
100(%) ×
−
=−
AreaHemIpsiTotal
AreaEnhancedSignalMEMRI
AreaEnhancedSignalMEMRI  
 
 
 
Apparent Diffusion Coefficient (ADC) Parameter Mapping 
ADC mapping was performed on DW images on a pixel-by-pixel basis using in-house-
written Interactive Data Language (v5.3 Research Systems, Boulder, CO) software based on the 
relationship between the natural log of the signal intensity in DW images and b-value as shown by 
equation 5.4.  
bDeMtM −= 0)(  
 
where M(t)/M0 is the signal intensity at a particular b-value and D is the water apparent diffusion 
coefficient (ADC) along a single gradient direction (x, y, or z). Maps of the average ADC were 
calculated from separate DWIs acquired along the x-, y-, and z-gradient directions.  
 
Percent ADC Deficit and Percent Deficit Area (DA) 
Percent ADC deficit in ADC maps was calculated through comparison of the ADC mean in 
regions with visually evident ADC deficit in ipsilateral hemisphere and ADC mean in homologous 
control regions in the contralateral hemisphere on a slice-by-slice basis: 
100
)(
(%) ×
−−
=
CH
CHIH
ADC
ADCADC
DeficitADC  
where ADCIH is the mean ADC in the ADC deficit region in ipsilateral hemisphere and ADCCH is 
the mean ADC in the homologous control region in the contralateral hemisphere. Percent ADC 
deficit area in ADC maps was calculated on a slice-by-slice basis by comparison of ADC deficit area 
in ipsilateral hemisphere to the area of the entire ipsilateral hemisphere. 
 
100(%) ×=
AreaHemIpsiTotal
AreaDeficitADClIpsilatera
AreaDeficitADC  
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MEMRI-DWI Mismatch & Match 
MEMRI-DWI mismatch area was calculated as the area of ADC deficit in the ipsilateral 
hemisphere exclusive of MEMRI signal-enhancing regions in the ipsilateral hemisphere. ADC-
deficit ROIs were transferred to T1W images with MEMRI signal-enhancement. Regions of ADC 
deficit that did not contain MEMRI signal-enhancement were outlined and defined as MEMRI-DWI 
mismatch. DW and T1W images were registered in every animal. Percent MEMRI-DWI mismatch in 
T1W images was calculated on a slice-by-slice basis by comparison of MEMRI-DWI mismatch area 
to the area of the entire ipsilateral hemisphere. 
 
100% ×
−
=−
AreaHemIpsiTotal
AreaMismatchDWIMEMRI
AreaMismatchDWIMEMRI  
 
Similarly, MEMRI-DWI match (overlap) area was calculated as the area of ADC deficit in 
the ipsilateral hemisphere inclusive of MEMRI-signal-enhancing regions. ADC deficit ROIs were 
transferred to T1W images with MEMRI signal-enhancement. Regions of ADC deficit that contained 
MEMRI signal-enhancement were outlined and defined as MEMRI-DWI match. MEMRI-DWI 
match area was calculated as a percentage of the ipsilateral hemisphere area.  
 
100% ×
−
=−
AreaHemIpsiTotal
AreaMatchDWIMEMRI
AreaMatchDWIMEMRI   
The calculation of a MEMRI-DWI mismatch and match was considered necessary in order to 
determine if MEMRI-enhanced regions had a significantly different ADC deficit as compared to 
non-MEMRI-enhanced regions. A larger ADC deficit in the MEMRI-enhanced regions was 
expected if these regions are truly indicative of the stroke core.  
 
TTC Stain Deconvolution and Saturation Transform 
For technical reasons, TTC staining was performed with EB dye present in the brain. 
Therefore, in regions with deep EB staining, it was not visually clear if the underlying brain did or 
did not stain by TTC. For best results, therefore, a method was employed to separate the two colors 
(red by TTC and blue by EB) from the histological images, based on image deconvolution and 
Saturation transformation (as previously discussed in Chapter 5). Based on the work of Ruifrok and 
6.6 
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Johnston, histological images (in RGB format) were deconvolved into images that represented the 
independent contributions of the TTC stain (red) and the EB stain (blue) (25). This method is based 
on an orthonormal transformation of the optical density values found in RGB images of each stain 
separately (i.e., a RGB histological image of red stain only and a RGB image of blue stain only). 
Since we were not able to experimentally determine the optical density (OD) values for TTC and 
EB, previously determined OD values for Fast Red and Alcian Blue stains were used instead. Fast 
Red and Alcian Blue absorb light at wavelengths similar to those of EB and TTC, respectively 
(wavelengths of light absorption are: Fast Red: 266 nm; TTC: 247 nm; Alcian Blue: 615 nm; EB: 
611 nm; from Ref (26)). All histological-stain deconvolution calculations were performed by ImageJ 
(algorithm written by G. Landini and downloaded from 
http://www.dentistry.bham.ac.uk/landinig/software/software.html). Deconvolved TTC stain images 
were transformed into Hue, Saturation, and Intensity format using ImageJ software. Hue refers to the 
dominant wavelength in the color image, Saturation represents the degree to which white is mixed 
with the dominant wavelength, and Intensity represents the intrinsic reflectivity of the object viewed 
(27). 
 
6.3 Results 
6.3.1 MEMRI signal-enhancement 
MEMRI signal-enhancement was determined from T1W MRIs acquired 5-10 min following 
cessation of MnCl2+EB infusion. The average percent increase in signal intensity in MEMRI signal-
enhanced regions of the ipsilateral hemisphere was 22% ± 5% and the average percent area of the 
ipsilateral hemisphere with MEMRI signal-enhanced regions was 17% ± 5%. One animal did not 
show MEMRI signal-enhancement in any brain slice. Table 6-1 summarizes MEMRI signal-
enhancement data.  
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Table 6-1: Average Percent MEMRI signal-enhancement and Percent MEMRI Signal-Enhancement Area (as a 
percentage of the ipsilateral-hemisphere area) from T1W MRI Following eMCAO and Infusion of the MnCl2+EB 
solution. 
MEMRI Signal-Enhancement 
(using Eq. 6.1) 
% Area of Ipsilateral Cortex w/ 
MEMRI Signal-Enhancement 
(using Eq. 6.2) 
Mean ± SEM 
(%) 
 
22 ± 5 
ISSDa 
(%) 
 
5 
Mean ± SEM 
(%) 
 
17 ± 5 
ISSDa 
(%) 
 
6 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for average 
MEMRI Signal-Enhancement and average MEMRI Signal-Enhancement area (%) across slices.  
 
6.3.2 ADC Deficit 
Because the majority of stroke-related decrease in ADC occurs within the first 2-3 h 
following stroke (28) and, as shown in Chapter 5, the paramagnetic properties of intracellular Mn2+ 
can lead to large susceptibility artifacts in DW images, ADC deficit in the ipsilateral hemisphere was 
determined from DW images acquired 30 min before MnCl2+EB-solution infusion and 3.5 h after 
embolic-stroke onset (Fig. 6-1). The average percent ADC decrease in the ipsilateral-hemisphere 
regions with ADC deficit was 18% ± 2% and the average percent area of the ipsilateral hemisphere 
with ADC deficit was 48% ± 8%. Table 6-2 summarizes ADC deficit data.  
 
Table 6-2: Average Percent ADC Deficit and Percent Deficit Area (as a percentage of ipsilateral hemisphere area) from 
DW Imaging (and corresponding ADC Maps) 3.5 Hours Following eMCAO and 30 Minutes Before Infusion of 
MnCl2+EB Mixture Solution. 
Average % ADC Deficit 
(using Eq. 6.4) 
% Area of Ipsilateral Hemisphere w/ 
ADC Deficit 
(using Eq. 6.5) 
Mean ± SEM 
(%) 
 
18 ± 2 
ISSDa 
(%) 
 
4 
Mean ± SEM 
(%) 
 
48 ± 8 
ISSDa 
(%) 
 
17 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for average 
ADC Deficit and average ADC Deficit area (%) across slices.  
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6.3.3 MEMRI-DWI Mismatch & Match 
MEMRI-DWI mismatch area was calculated as the area of ADC deficit in the ipsilateral 
hemisphere that exceeded the boundaries of the MEMRI signal-enhancing regions in the ipsilateral 
hemisphere.  In most instances, MEMRI signal-enhancement was confined to the region with ADC 
deficit. For the few cases where MEMRI signal-enhancement extended beyond the boundaries of the 
ADC-deficit region, MEMRI-DWI mismatch remained consistently defined as the region of ADC 
deficit outside the border of MEMRI signal-enhancement. Regions in the ipsilateral hemisphere with 
ADC deficit that were within the boundaries of MEMRI signal-enhancement were defined as regions 
with MEMRI-DWI match (overlap). Percent-area of the ipsilateral hemisphere with a MEMRI-DWI 
mismatch and match was 35% ± 6% and 18% ± 7%, respectively. It is noteworthy that the MEMRI-
DWI match regions always coincided almost exactly with the regions of MEMRI signal-
enhancement (86% ± 12% of the area of MEMRI-DWI match regions was contained within 
MEMRI-enhanced regions in all animals). In other words, regions with MEMRI signal-enhancement 
were almost always within regions with ADC deficit, suggesting accumulation of Mn2+ in brain 
regions with BBB and neuronal injury. Regions of brain MEMRI-DWI mismatch and match were 
not confined to particular brain regions. Table 6-3 summarizes MEMRI-DWI mismatch and match 
percent-area data.  
 
Table 6-3: Average Area of MEMRI-DWI Mismatch and Match As a Percentage of the Ipsilateral Hemisphere Area.  
Average % Area of MEMRI-
DWI Mismatch 
(using Eq. 6.6) 
Average % Area of MEMRI-DWI 
Match 
(using Eq. 6.7) 
Mean ± SEM 
(%) 
 
35 ± 6 
ISSDa 
(%) 
 
8 
Mean ± SEM 
(%) 
 
18 ± 7 
ISSDa 
(%) 
 
6 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for average 
% area of MEMRI-DWI Mismatch and Match  across slices.  
 
Percent ADC Deficit in MEMRI-DWI Mismatch and Match Regions 
To determine if brain injury was more severe in MEMRI-DWI mismatch vs. MEMRI-DWI 
match regions, the ADC deficit was summarized and compared in these regions. ADC deficit in 
MEMRI-DWI mismatch and match regions was 19% ± 2% and 20% ± 2%, respectively. The 
difference in ADC deficit between MEMRI-DWI mismatch and match regions was not significant (P 
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> 0.05, Student’s t-test). Table 6-4 summarizes MEMRI-DWI mismatch and match percent ADC 
deficit data. 
 
Table 6-4: Average Percent ADC Deficit in MEMRI-DWI Mismatch and Match Regions.  
% ADC Deficit in MEMRI-DWI 
Mismatch Regions 
(using Eq. 6.4) 
% ADC Deficit in MEMRI-DWI 
Match Regions 
(using Eq. 6.4) 
Mean ± SEM 
(%) 
 
19 ± 2 
ISSDa 
(%) 
 
2 
Mean ± SEM 
(%) 
 
20 ± 2  
ISSDa 
(%) 
 
3 
aTo account for intra-animal variability, the inter-slice standard deviation (ISSD) was calculated from values for average 
% ADC Deficit in MEMRI-DWI Mismatch and Match regions across slices.  
 
6.3.4 MEMRI Signal-Enhancement and ADC Correlation With Evans Blue and TTC 
Histology 
Figure 6-2 shows images from one animal that includes the average signal intensity of DW 
images acquired prior to MnCl2+EB infusion, the corresponding ADC maps, T1W images, EB-
stained and TTC-stained images. Images were acquired according to the timing protocol shown in 
Figure 6-1. 
 
 
 
 
 
 
 
Figure 6-8: DW, Average ADC, T1W, EB-stained, and TTC-stained images from one animal. DW images were acquired 
prior to starting MnCl2+EB infusion. TTC staining (performed 1 h after T1W image shown here) shows a correlation 
between infracted tissue and areas with T1 enhancement. The images enclosed in white outlined region are shown 
enlarged in Fig. 6-3. 
 
A 
 
B 
 DW ADCAVG T1W Evans Blue TTC 
1 2 3 4 5 
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T1W images in Figure 6-2 (A3 and B3) were the last acquired among all of the T1W scans. 
Figure 6-2 (A3 and B3) shows regions of bright MEMRI signal-enhancement corresponding to 
regions with dark EB staining (small arrows) in the hippocampus (Fig. 6-2-A4) and caudoputamen 
(Fig. 6-2-B4). Regions of relatively weak MEMRI signal-enhancement in cortex (large arrows, Fig. 
6-2-A3) do not show correlated (gross) EB staining (A4) but do correspond to areas of tissue infarct 
as verified by TTC staining (A5). Figure 6-3 shows an enlarged view of images from Figure 6-2 
(outlined images) with regions of interest drawn corresponding to MEMRI signal-enhanced regions. 
The table in Figure 6-3 shows an inverse correlation between percent-increase in signal intensity in 
the T1W image and percent-decrease in ADC values compared to the contralateral hemisphere. The 
heterogeneity of the ADC map in Figure 6-3 clearly shows the correlation between ADC deficit and 
low percent MEMRI signal-enhancement. The correlation between high ADC deficit and low 
percent MEMRI signal-enhancement may be a consequence of severe perfusion deficits in these 
regions.  
 
ROI % ADC Deficit % MEMRI 
Enhancement 
A 19 169 
B 33 89 
C 44 22 
Figure 6-9: Enlarged view of calculated average ADC map and T1W image shown in Fig. 6-2 (boxed region outlined in 
white; ADC map is windowed here to enhance contrast). ROIs are drawn for reference. The adjoining table provides data 
suggesting that the ADC decrease is inversely correlates with percent MEMRI signal-enhancement. Values are mean of 
ROI compared to mean of homologous contralateral control region.   
 
TTC Stain Deconvolution 
For clarity in identifying TTC- and EB-stained regions in an independent fashion, TTC-
stained images were deconvolved and transformed into the Saturation format. The deconvolved and 
A 
 
D 
 
C 
 
B 
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Saturation-transformed TTC-stained image from the animal in Figure 6-2 is shown in Figure 6-4. 
EB- and TTC-stained (healthy) regions appear hyperintense in the deconvolved and Saturation 
transformed images. From the deconvolved and Saturation transformed images it is clear that non-
TTC stained regions correlate with regions of gross EB staining. This confirms that the MnCl2+EB 
solution passes across the stroke-damaged BBB.    
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Figure 6-10: T1W MRI (A), EB+TTC histology (B), deconvolved and Saturation transformed representations (C and D) 
of the EB+TTC histological image shown in (B). (C) Independent representation of “EB-stain-only” image from (B). 
Hyperintense regions in Column (C) correspond to regions with significant EB staining and, in turn, BBB disruption. (D) 
Independent representation of “TTC- stain-only” image from (B). Hyperintense regions correspond to regions with 
positive TTC staining. Therefore, dark regions correspond to regions without stain and are considered regions of 
ischemic brain damage. The grayscale format of images in (C) and (D) is a result of Saturation transformation of the 
deconvolved images from (B). Saturation transform images exhibit better contrast between stained (EB in (C)) and non-
stained (TTC in (D)) brain regions compared to the images generated by deconvolution alone.  
 
MEMRI signal-enhancement During and After MnCl2+EB Infusion 
T1W signal intensity over time relative to MnCl2+EB infusion is shown in Figure 6-5. The 
signal intensity in strongly-enhancing brain regions (Fig. 6-3, ROIs A and B) 
A B C D 
 1  
2 
3 
4 
5 
6 
BBB Disruption in Embolic Stroke Detected by MEMRI   223
      
 
 
 
 
 
 
 
Figure 6-11: Time course of T1W signal intensity relative to the initiation (Time 0) of MnCl2+EB infusion.  The data are 
from ROIs A, B, C, and D as shown in Figure 6-3. ROIs A and B show rapid signal increase compared to ROIs C and D. 
A decline or leveling off in signal intensity was detected in all ROIs following cessation of the MnCl2+EB infusion.  
 
increases more rapidly than the signal intensity in more weakly-enhancing brain regions (Fig. 6-3, 
ROIs C and D) over the time course of the MnCl2+EB infusion. Differences in MEMRI signal-
enhancement kinetics among different brain regions may be due to differences in BBB disruption, 
blood flow, and/or cellular activity local to these regions. MEMRI signal-enhancement in the 
ventricle (Fig. 6-3, ROI D) is detected earlier than MEMRI signal-enhancement in the brain 
parenchyma.  This is likely due to differences in the transport pathways available for Mn2+ to access 
the respective spaces (i.e., via the choroids plexus in the case of CSF as compared to the 
compromised BBB in the case of the brain parenchyma). 
 
6.4 Discussion 
 
6.4.1 MEMRI Signal-Enhancement: Detection of Hemorrhagic Transformation During Acute 
Stages of Embolic Stroke? 
Time: Minutes relative to MnCl2+EB infusion at time 0 
A 
 
D 
 
C 
 
B 
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In this chapter we have shown that MEMRI can be used to detect regions of pathological 
BBB disruption. More importantly, our data show MEMRI signal-enhanced regions local to regions 
with spatially-correlated BBB injury and neuronal damage (Fig. 6-2 and 6-4). MEMRI signal-
enhancement detected in these experiments was similar to that seen in experiments summarized in 
Chapters 4 and 5 in that MEMRI signal-enhancement here was correlated to regions with BBB 
injury as verified by EB staining.  
Brain regions with a MEMRI-DWI mismatch and a MEMRI-DWI match were analyzed to 
determine if a significant difference was present between the ADC deficits in both regions. If the 
ADC deficit was lower in the region with MEMRI-DWI match, then this observation would support 
the concept that MEMRI signal-enhanced brain regions in these experiments are indicative of the 
stroke core. However, the data in this study showed that the ADC deficit in MEMRI-DWI mismatch 
regions was not significantly different from the ADC deficit in regions with MEMRI-DWI match 
(Table 6-4). Therefore, it is difficult to confirm that MEMRI signal-enhanced regions are specific to 
the stroke core. 
On the other hand, images shown in Fig. 6-2 and 6-4 confirm that MEMRI signal-
enhancement is local to regions of stroke-related brain damage, as evidenced by EB staining. In 
addition, our use of image deconvolution to independently separate EB stain color from TTC stain 
color in TTC-stained digital images (Fig. 6-4) indicate that in certain instances tissue stained with 
EB dye was local to regions of tissue injury (tissue not stained by TTC). In these cases, dark EB-
stained regions with underlying tissue damage may represent regions undergoing hemorrhagic 
transformation or regions that are destined for hemorrhagic transformation (HT). 
Indeed, Ding et al. using an embolic stroke model in rat and contrast-enhanced MRI (Gd-
DTPA contrast agent), detected ‘microscopic’ HT 3 hours after stroke (19). In their case, HT was 
confirmed by hematoxylin and eosin (H&E) histology. An important observation by Ding et al. was 
“enhancement in [T1W images], or increase in Ki and Vp maps, may not directly reflect HT because 
the size of the Gd-DTPA molecule is smaller that that of the erythrocyte.” This observation is 
relevant to this study because the MnCl2 molecule (MW=198) is smaller than the Gd-DTPA 
molecule (MW=570, (29)); making MEMRI signal-enhancement in these experiments more 
sensitive to tissue destined for HT, if HT is present. 
It is informative to compare the data from Ding et al. to the MR and histological data from 
the experiments in this study. As shown in Figure 6-6, one animal in our study showed similar 
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contrast (MEMRI signal-) enhancement and regions of tissue damage confirmed histologically as 
compared to the findings of Ding et al.  Ding et al. did not note the location within the brain where 
 
 
 
 
Figure 6-12: Top row: Ki map (a), Vp map (c), subtraction T1W image (e), and histology (g) in a representative case of 
microscopic HT from Ding et al. (18).  Bottom row: ADCAVG map (b), EB-stained histological section (d), T1W image 
(f), TTC-stained histological section (h), and the deconvolved and Saturation-transformed version of the TTC-stained 
image (i), in a representative animal from the present study (same images as presented in bottom row of Fig. 6-2 with the 
exception of the TTCDS image). Images in the bottom row are from the same slice in this animal (ADCAVG and T1W 
images are registered exactly; EB, TTC, and TTCDS images are co-registered exactly; MR and histological images were 
registered to the extent possible). Red arrow in (g) represents region of HT as determined by microscopic examination of 
a histological slide in the study of Ding et al. Yellow arrow in (h) indicates the region of dark EB staining that correlates 
to the region of HT in the case of Ding et al. (g). Yellow arrows in (f) and (i) show MEMRI signal-enhanced and tissue-
damaged regions in the T1W and TTCDS image, respectively, that correspond to the region of dark EB staining in the 
TTC image (h).  
 
the images shown in the top row of Fig. 6-6 were obtained.  However, it appears that the brain region 
shown by Ding et al. is closely co-registered to the brain region shown in this study (i.e., the bottom 
row of Fig. 6-6) based on visual comparison of the histological information. The region of contrast 
enhancement as indicated by Ding et al. (Fig. 6-6e) closely matches the region of MEMRI signal-
enhancement as shown in the T1W image from this study (Fig. 6-6f). Also, the region of HT shown 
in the histological section of Ding et al. (Fig. 6-6g) closely matches the region of dark EB staining 
shown in the TTC-stained image in this study (Fig. 6-6h). These regions, therefore, may represent 
regions of HT detected by MEMRI signal-enhancement 3 hours after embolic stroke.     
 
6.4.2 MEMRI Signal-Enhancement in Stroke: Mechanisms Related to Cell Calcium Uptake 
ADCAVG T1W EB TTC TTCDS 
Ding et al. (19) 
Present 
study 
b 
a c 
d 
e 
f 
g 
h i 
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Although HT may indeed be the primary factor governing the MEMRI signal-enhancement 
observed in this study, it is important to consider the complicated nature of MEMRI signal-
enhancement in brain. Gd-DTPA is an extracellular contrast agent and does not accumulate within 
cells. Mn2+, on the other hand, has been shown to produce contrast in T1W images only after cell-
membrane-depolarization events(1). Aoki et al. have also shown that MEMRI signal-enhancement 
in brain may be sensitive to anoxic depolarization following experimental stroke in the rat brain, but 
not sensitive to disruption of the BBB (30). Other investigators have shown that Mn2+ infused i.v. 
following osmotic disruption of the BBB does not result in MEMRI signal-enhancement (31,32). 
Therefore, in interpreting our findings it is important to discuss other mechanisms related to stroke 
that may be responsible in part or completely for the MEMRI signal-enhancement detected in our 
experiments. 
 
MEMRI Signal-Enhancement After Stroke: Specific to Cell Calcium Uptake or Periinfarct 
Depolarization? 
Data presented here are in agreement with a study showing multifocal BBB leakage (by 
albumin extravasation and EB staining) in the caudoputamen after experimental stroke (33) and 
another study showing T1W image contrast enhancement in the caudoputamen by gadolinium-based 
contrast-enhanced MRI after embolic stroke (19). As intended, the permanent occlusion model of 
stroke results in severe perfusion deficits to certain brain regions (in particular the stroke core) and 
may not allow for a significant dose of contrast agent (gadolinium or manganese) to permeate the 
stroke-injured BBB. Therefore, the ability of contrast-enhanced MRI to detect areas of BBB injury 
local to the stroke core is limited when using the embolic stroke model. 
In fact, the data in this study shows a correlation between areas of dark EB staining and near-
normal ADC as shown in Figure 6-2A (compare images in Fig. 6-2A2, A3, and A4); suggestive of 
higher cerebral blood flow (at the time of DW image acquisition) in these regions compared to 
regions with a low ADC and no grossly-visible EB staining. In addition, 1 of 5 animals did not show 
MEMRI signal-enhancement but did show a correlation between ADC deficit and lack of TTC 
staining; typical of stroke-induced tissue injury (data not shown). However, for animals in which 
MEMRI signal-enhancement was observed, stroke-induced BBB injury was severe enough, and 
blood flow levels were high enough, to allow delivery of MnCl2+EB into the brain extracellular 
space. Ensuing MEMRI signal-enhancement may reflect cellular uptake of Mn2+ via transient 
periinfarct depolarizations and/or cells with permanently damaged calcium channels. This 
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hypothesis is supported by reports that show BBB injury in areas peripheral to and central to the 
stroke core (34), periinfarct depolarizations persisting for 6 h beyond the initial ischemic insult (35), 
and calcium accumulation in the rat hippocampus following cerebral ischemia (36). However, the 
possibility that MEMRI signal-enhancement – in the cases presented here – is the result of Mn2+ 
accumulation within BBB endothelial cells or within swollen or damaged astrocytes cannot be ruled 
out.  
 
MEMRI Signal-Enhancement After Stroke: Specific to Cells with Damaged Membranes?  
As suggested in Chapter 5 of this dissertation, osmotic BBB disruption has been shown to 
result in damaged and/or swollen astrocytes and glia. Therefore, in the case of stroke, if infusions of 
Mn2+ coincide temporally with stroke-related BBB injury and the time point at which astrocytes and 
glia are damaged and swollen, Mn2+ may have unregulated (i.e., not only through voltage-gated 
calcium channels) access to the intracellular space resulting in localized signal increase in T1W brain 
images.  
Using the embolic stroke model in rat, Jiang et al. used fibrinogen leakage into brain 
parenchyma as a marker for BBB disruption. Fibrinogen is a large-molecular-weight molecule 
(MW=300,000) that is known to be impermeable to a healthy intact BBB (37,38). In the study of 
Jiang et al., fibrinogen leakage into the brain parenchyma was apparent at 2 h after stroke and levels 
of fibrinogen in brain were increased at 5 h after stroke as compared to the 2-h time point. Other 
models of stroke show similar results. For example, in a study by Albayrak et al., focal ischemia was 
induced in rats by the intraluminal-suture-occlusion method to investigate the correlation between 
stroke-related BBB-permeability changes and cell injury (39). 
In the study by Albayrak et al., albumin, which does not cross the healthy intact BBB, was 
found within cells local to the ischemic focus. In addition, the data of Albayrak et al. shows that the 
BBB is permeable to molecules with sizes similar to albumin (MW=68,500) at a time when neuronal 
damage is already manifest. The findings in this study show a spatial correlation of MEMRI signal-
enhancement to EB staining in brain (Figs. 6-2 and 6-4), consistent with the data of Albayrak et al. 
Indeed, a correlation of MEMRI signal-enhancement with EB staining at a time point after stroke, 
when the BBB and underlying brain cells are damaged, suggests uncontrolled entry of EB-albumin 
and Mn2+ into the cell. In addition, EB dye has been shown to stain the brain after embolic stroke in 
rat. 
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Belayev et al. used the EB-albumin complex to determine the dynamics of BBB permeability 
changes following transient stroke (2 h of intraluminal-suture occlusion followed by various periods 
of reperfusion) in rats (33). In their work, Belayev et al. infused EB i.v. at 2, 3, 24 or 48 h after 
stroke onset (and, therefore, 0, 1, 22 or 46 hours after removal of the suture to re-establish 
perfusion). Rats infused with EB 3 h after stroke onset showed gross EB staining, predominantly in 
caudoputamen. The caudoputamen is frequently within the region of ischemic core in MCA-
occlusion models of experimental stroke (39). The findings in this study are consistent with those of 
Belayev et al., based on the observed ADC deficit, tissue damage verified by TTC staining, and 
MEMRI signal-enhancement in the caudoputamen-region in certain animals as shown in Figure 6-6 f 
and h (and Fig. 6-4-A3 and -B3).   
In conclusion, the data in this study provide evidence of MEMRI signal-enhancement in 
areas of BBB disruption local to areas of stroke-induced tissue injury as verified by gross 
comparison of T1W images and histology. This method may provide insight into the state of tissue 
local to embolic stroke-induced BBB injury and an opportunity for longer retention of MEMRI 
signal-enhancement in areas of BBB injury as compared to Gd-DTPA contrast-enhanced MRI. In 
addition, the data in this study suggest that detection of MEMRI signal-enhanced regions shortly 
after stroke (4 h) may be a more sensitive indicator of tissue destined for HT as compared to 
traditional contrast-enhanced MRI during the acute stages of embolic stroke.  
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The research presented in this dissertation focused on methods to advance the state of the art 
in a relatively new area of research; manganese-enhanced MRI (MEMRI) in the brain. The divalent 
manganese ion (Mn2+) is handled similarly to calcium (Ca2+) in biological systems. Therefore, Mn2+ 
in brain has been shown to act as a cell-membrane-dependent contrast agent useful for direct 
mapping of brain function. Many MEMRI experiments rely on osmotic BBB disruption for delivery 
of Mn2+ to brain parenchyma prior to a specific neuronal stimulus. To date, the MEMRI literature is 
lacking histological (or other) evidence to show the extent of BBB disruption and/or the distribution 
of Mn2+ in brain prior to specific neuronal activity. Therefore, to remedy this, we developed a simple 
but novel method to histologically monitor the degree of BBB disruption and associated passage of 
Mn2+ into brain parenchyma.  
Because Evans Blue (EB) dye is a well-known marker for monitoring the permeability of the 
BBB, we mixed EB with MnCl2 and infused the resulting solution i.v. following osmotic BBB 
disruption. As Chapter 4 makes clear, a co-infusion of MnCl2 and EB allows for the quantification of 
BBB permeability changes and an inference as to the extent of Mn2+ distribution in the brain. In 
addition, we show that using a particular infusion protocol of MnCl2+EB and 1.6 M arabinose (to 
osmotically disrupt the BBB) consistently results in nonspecific MEMRI signal-enhancement. This 
portion of the dissertation shows that another mechanism of Mn2+ influx into cells (other than by 
voltage-gated calcium channels) may be responsible for unwanted signal changes in MEMR images.  
In Chapter 5, the mechanism responsible for unwanted signal changes in MEMR images and 
the potential associated effects on brain structure and function was investigated further by testing the 
effects of two osmotic BBB disruption protocols on brain tissue, apparent diffusion coefficient 
(ADC), MEMRI signal-enhancement, and differences in area of ADC deficit and nonspecific 
MEMRI signal-enhancement (MEMRI-DWI mismatch) in the rat brain following infusion of 
MnCl2+EB solution. Significant nonspecific MEMRI signal-enhancement and brain damage were 
detected using the experimental protocols described in Chapter 5. These findings are important for 
the MEMRI research field in general because many MEMRI experiments rely on normal brain 
function and structure following osmotic BBB disruption. This research makes clear the need for an 
optimal BBB protocol for MEMRI studies.  
Because brain regions with nonspecific MEMRI signal-enhancement were consistently 
spatially correlated with EB-stained regions (and therefore regions with BBB disruption) an 
experiment was designed to test the efficacy of Mn2+ to detect regions of pathological (vs. 
experimental) BBB disruption. The research in Chapter 6 provides evidence of MEMRI signal-
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enhancement in areas of BBB disruption local to areas of stroke-induced tissue injury as verified by 
gross comparison of T1W images and histology (TTC staining). Results from experiments in Chapter 
6 are useful because it was shown that Mn2+ can be used to track BBB injury following stroke and 
shows strong potential for tracking stroke-related nerve damage in brain. Because Mn2+ acts as an 
intracellular contrast agent, the methods described in Chapter 6 may provide insight into the state of 
tissue local to embolic stroke-induced BBB injury. 
A parallel can be drawn from data summarized in Chapters 4, 5, and 6: nonspecific MEMRI 
signal-enhancement in brain is very likely a result of a mechanism related to BBB disruption and/or 
cell volume regulation in response to osmotic challenge. This idea is important because it obviates 
the need for future work that will determine; 1) the exact mechanism related to osmotic and 
pathological BBB disruption that causes nonspecific MEMRI signal enhancement; 2) the optimal 
experimental protocol (in terms of osmotic BBB disruption and anesthetic regimen) for MEMRI 
experiments that rely on specific neuronal stimulus in a healthy brain; and 3) methods other than 
osmotic BBB disruption that will reliably allow delivery of Mn2+ into brain such that time-efficient 
MEMRI experiments are possible.  
 
Future Considerations 
MEMRI Experiments and Osmotic BBB Disruption  
The use of osmotic agents to disrupt the blood-brain barrier (BBB) has several drawbacks, 
such as brain damage and swelling and barrier opening that is inhomogeneous, as outlined in this 
dissertation. MEMRI experiments that utilize osmotic BBB disruption should, therefore, provide 
evidence of healthy brain tissue and the degree of BBB disruption following osmotic challenge. The 
methods of TTC and Evans Blue staining presented in this dissertation provide qualitative evidence 
of brain tissue health and the homogeneity of BBB disruption following infusions of hyperosmotic 
arabinose or mannitol.   
 
MEMRI Experiments and Baseline MR Imaging 
Results of MEMRI experiments that include osmotic BBB disruption performed on the 
benchtop are susceptible to misinterpretation because MRI scans acquired before neuronal stimulus 
and after osmotic BBB disruption are not possible. To monitor possible changes in T1-weighted 
(T1W) or diffusion-weighted (DW) contrast following osmotic BBB disruption and MnCl2 infusion, 
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a control group of animals can be used in which neuronal stimulus is not performed. Although use of 
a control group may be sufficient to rule out unwanted changes in T1W or DW contrast following a 
specific infusion protocol of arabinose (or mannitol) and MnCl2, this group increases the number of 
animals needed to complete the study. In fact, the control group in many studies uses the same 
number of animals as the treatment group, thus doubling the number of animals in the study if 
treatment animals cannot also be used as controls. When MEMRI experiments are moved from the 
benchtop to the bore of the MR scanner each animal can be scanned prior to neuronal stimulus 
allowing 1) each animal to serve as its own control; and 2) more accurate determination of 
nonspecific changes in T1W and DW contrast in the treatment group.  
 
Future Experiments 
Several MEMRI experiments have been carried out that do not rely on osmotic BBB 
disruption (1-3). These experiments were not, however, designed to detect the presence or absence 
of clinically-relevant disease in brain. The methods described in these works may be useful for 
future experiments that can utilize the unique contrast agent properties of Mn2+ to provide new 
information regarding a particular brain disease.  
 
MEMRI and Multiple Sclerosis 
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system which 
results in demyelination of axons (4). Current MRI techniques to monitor MS include image contrast 
that is dependent upon the proportion of water protons that are bound to macromolecules (i.e., 
magnetization transfer contrast) (5). From magnetization transfer (MT) contrast the degree of tissue 
structure (and, therefore, axonal loss) can be inferred but cannot be measured directly. Other MRI 
techniques to measure the degree of axonal loss include MR spectroscopy and conventional T1W 
imaging (5). MR spectroscopy suffers from low spatial resolution and conventional T1W imaging 
does not provide a direct measure of axon structure or function. MEMRI offers an advantage to MR 
spectroscopy and conventional T1W imaging for detection of axonal loss in experimental models of 
MS. The unique mechanism by which normal cells sequester Mn2+ and generate localized contrast in 
T1W images makes MEMRI an attractive alternative to other MRI techniques of neuronal loss 
detection in experimental MS.     
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MEMRI and Parkinson’s Disease 
Parkinson’s disease is a neurodegenerative disorder with symptoms that include body 
tremors, alterations in personality, impaired color vision discrimination, and decreased autonomic 
function (6). One of the distinct pathological features of Parkinson’s disease is progressive loss of 
dopamine (DA) neurons in the pars compacta of the substantia nigra. Although the causes of DA 
neuron loss are not well known, evidence points to oxidative stress, mitochondria dysfunction, 
protein mishandling, and inflammation as possible pathological contributors (7). In addition, Li et al. 
have offered evidence that calcium  (Ca2+) homeostasis disturbance under conditions of proteasome 
inhibition may be a novel pathological mechanism leading to DA neuronal injury (7). Because Mn2+ 
is treated similarly to Ca2+ in vivo, MEMRI may be a useful tool to follow up on Li’s work in in vivo 
experiments. Current in vivo imaging strategies rely, in part, on correlating single photon emission 
tomography (SPECT) and T2-weighted MR images of Parkinson’s disease patients (8). SPECT 
imaging can be used for the noninvasive determination of dopamine concentration in vivo but cannot 
be used to detect DA neuronal injury directly. MEMRI may therefore be a novel method for 
detection of DA neuron injury in animal models of Parkinson’s disease. Because lower levels of 
intracellular calcium are expected with DA neuronal injury under conditions of proteasome 
inhibition (7), lower levels of intracellular Mn2+ are also expected during proteasome inhibition in 
the presence of consistent extracellular [Mn2+]. Lower levels of intracellular Mn2+ will lead to lower 
MEMRI signal-enhancement on high resolution (78 µm in rat) MR scans providing 1) accurate 
localization of regions of brain with DA neuronal injury and 2) additional evidence that DA neuronal 
injury is associated with disturbed calcium homeostasis.  
 
MEMRI in the Clinic 
As described in Chapter 3 of this dissertation, Mn2+ is toxic and is not currently applicable 
for human brain imaging. In addition, although previous studies have suggested the usefulness of 
osmotic blood-brain barrier (BBB) disruption to allow entry of Mn2+ into brain following 
intravenous infusion, Chapters 4 and 5 of this dissertation outlined the serious side effects of osmotic 
BBB disruption under certain experimental conditions. Therefore, to bring MEMRI to the clinic 
there is a clear need to reduce or eliminate the toxic effects of Mn2+ and to eliminate the need for 
osmotic disruption of the BBB in order to introduce Mn2+ to the extracellular space of the brain 
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without causing brain injury and confounding changes in diffusion-weighted (DW) and T1-weighted 
(T1W) image contrast. 
 
Chelation for Mn
2+
 For Reduced Toxicity and Efficient Transport Across the Intact BBB 
The design of a chelate for the Mn2+ ion that allows for efficient (in time and space) transport 
across the BBB and reduced (or eliminated) toxicity in brain while maintaining the unique Ca2+ 
channel dependent contrast agent characteristics of Mn2+ would be a major research effort. As a first 
step towards this goal, different chelates for Mn2+ could be tested that allow for efficient transport of 
Mn2+ across the BBB in such a way that sufficient quantities of free Mn2+ are available for cellular 
sequestration (via voltage-gated calcium channels) once the chelated molecule has passed from the 
vasculature into the brain parenchyma. As the next and necessary step for getting MEMRI into the 
clinic, a chelate must be found for Mn2+ that reduces or eliminates toxicity in the brain. To reduce 
the toxicity of Mn2+ in brain and to maintain the unique characteristics of MEMRI it would be 
important to find a chelating molecule that would; 1) allow entry of Mn2+ to the intracellular space 
via voltage-gated calcium channels; 2) prevent excessive (i.e., more than 4 hours) long-term 
accumulation in the cell (and mitochondria); and 3) allow efficient excretion of Mn2+ via kidneys or 
bile.  
 A chelate that combines the efficient transport of Mn2+ across the BBB (thus eliminating the need 
for osmotic BBB disruption) and reduces or eliminates toxicity in brain is not likely to be found 
soon. In the meantime, therefore, newer MRI techniques (i.e., pulse sequences) may be developed 
and more research at higher magnetic fields may be undertaken that will make very low doses of 
Mn2+ in brain apparent after systemic administration and entry of Mn2+ into brain via the blood-CSF 
barrier. In addition, future MEMRI experiments of brain pathology (stroke, multiple sclerosis, 
Parkinson’s disease) in animals with brain structure similar to humans should be performed in order 
for better translation of MEMRI results in animals to clinical situations.  
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 Figure 1: T1-weighted MRIs (A) 
and corresponding EB-stained 
histological slices (B). 30 mM 
MnCl2/2% EB was administered 2 
min after osmostically-induced 
BBB opening. Areas of MRI signal 
enhancement correlate well with 
regions of BBB opening on EB-
stained slices. Top MRI slice in (A) 
shows the ROIs used for 
enhancement calculations. 
Detection of Blood-Brain Barrier Disruption in Rat Brain After Osmotic Shock Using Manganese-Enhanced 
Magnetic Resonance Imaging (MEMRI) 
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Synopsis. Infusion of manganese two minutes after osmotic disruption of the blood-brain barrier (BBB) resulted in areas of signal enhancement closely correlated with areas of 
Evans Blue histological staining. For MEMRI experiments using applied neuronal stimulus to generate T1-contrast, this infusion protocol may obscure intended results. This 
infusion protocol may, however, be a useful alternative for imaging experimental BBB disruption.         
 Introduction. MEMRI experiments1-3 employ the intracellular uptake of Mn2+ through voltage-gated calcium channels to shorten the T1 relaxation time of intracellular water 
resulting in localized increases in T1-weighted MRI signal intensity which correspond to regions of neuronal activation.1 These experiments rely on disruption of the blood brain 
barrier (BBB) by osmotic shock to deliver a significant concentration of Mn2+ into the extracellular space prior to the neuronal stimulus. In order to optimize the contrast, the 
distribution of extracellular Mn2+ should be homogeneous across the region of interest with little or no initial MR signal enhancement prior to the neuronal stimulus. Here we show 
that the timing of Mn2+ administration relative to BBB opening, as well as the method of Mn2+ delivery, are important factors in achieving this goal.  Regions of T1-contrast 
enhancement were spatially correlated with areas of Evans Blue (EB) dye uptake after hyperosmotic BBB disruption. A significant increase in T1-weighted signal enhancement 
was observed following internal-carotid-artery infusion of Mn2+ two minutes after hyperosmotic BBB opening; indicating a significant role for MEMRI in visualizing BBB 
disruption under these circumstances.  However, this enhancement would also obscure T1-weighted signal increases arising from subsequent neuronal stimuli; thus mitigating 
against using this particular administration protocol for such studies. 
Methods. Four male Sprague-Dawley rats weighing 280-350 g were anesthetized with 2.0 % isoflurane mixed with breathing-quality air. 25% D-mannitol solution (5 ml/kg; 
Sigma) was injected into the internal carotid artery over 50 seconds. Prior to each injection, the common carotid, external carotid and pterygopalatine artery were ligated. Two 
minutes after the mannitol injection was completed manganese chloride (MnCl2, MW = 198; Sigma), dissolved to 30 mM in isotonic saline, and EB (Sigma), dissolved to 2% in 
manganese chloride solution (2 ml/kg), was infused into the internal carotid artery at 4.5 ml/hr.  MR images were acquired using a Bruker Biospin 2.0T/45 cm imaging 
spectrometer operating at 85.56 MHz for 1H and equipped with ±20G/cm self-shielded gradients. T1-weighted MRI was performed with the following acquisition parameters: 
TR/TE = 300/7 msec, FOV = 3 cm x 3 cm, matrix = 128x128, six 2-mm slices with NEX = 8. 
 Results. Figure 1A shows signal enhancement from T1-weighted MEMRIs following administration of 30 mM MnCl2. Figure 1B shows EB staining in the corresponding 
histological brain slices. The average regional enhancement was ~250% of that in the homologous contralateral region (e.g., see ROIs in the top MRI slice of Fig. 1A). As seen in 
Fig. 1 EB histological staining correlates well with areas of increased T1-contrast in the corresponding MRI slices. For this particular animal, the effect of Mn2+ on T2 relaxation 
shows the importance of T1-weighted imaging with a short TE to minimize signal loss due to T2  and T2* as Figure 2 demonstrates.4 Figure 2 shows images acquired with TE = 7 
ms (Fig. 2A and Fig. 1A top row) and 20 ms (Fig. 2B). The negative contrast shown in Fig. 2B is likely due to higher concentrations of Mn2+ in the respective brain regions. Also, 
as seen in Fig. 1, EB histological staining is darker in the regions corresponding to higher [Mn2+] suggesting more extensive BBB opening. Figure 2C shows the MR signal decline 
as a function of TE in the cortical ROI shown in Fig. 1A. 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion. MEMRI experiments for visualizing the brain response to neuronal stimulation rely on disruption of the blood brain barrier 
(BBB) by osmotic shock to deliver a significant concentration of Mn2+ into the extracellular space prior to the neuronal stimulus.  
However, there should be little or no initial MR signal enhancement prior to the neuronal stimulus in order to achieve optimal T1-contrast 
enhancement.  Although the administration protocol used in this study has been employed by others,3 the time period between BBB 
opening and Mn2+ administration was longer (approximately 15 minutes) than that used in this study (two minutes).  Using the current 
administration protocol, significant initial T1-enhancement would obscure T1-contrast changes arising from any subsequent neuronal 
stimulus; thus precluding the use of this particular dosing regimen for such studies.  However, this Mn2+ administration method is quite 
effective in visualizing the region of BBB opening under these circumstances.  The strong T1-contrast enhancement observed in these 
experiments suggests a large accumulation of intracellular Mn2+ immediately following osmotically-induced BBB opening; assuming 
that the mechanism of contrast change is similar to that observed following neuronal stimulation or for white-matter-tract tracing.  
However, because of the dramatic changes in cell volume that occur under these circumstances, Mn2+ sequestered in the extracellular 
space may also be a contributing factor.  In spite of this uncertainty, we observed (data not shown) that regions of T1 contrast did not 
change significantly over time (3 hours) with respect to 1) spatial position, 2) region size, or 3) level of enhancement.  These 
observations are consistent with the intracellular uptake of Mn2+, where signal-enhancement levels have been shown to be maintained for 
several hours because of intracellular Mn2+ sequestration following neuronal stimulation.1  However, an extracellular contribution to the 
T1-contrast enhancement cannot be ruled out, since closure of the BBB following osmotic shock could also trap a significant 
concentration of Mn2+ in the extracellular space, preventing its subsequent washout over time.  Finally, this administration protocol may 
be a useful alternative for imaging experimental BBB disruption.     
 
Figure 2: T1-weighted MEMRI following 
administration of 30 mM MnCl2. Images 
acquired with TR = 300 and TE =  7 ms 
(A) and 20 ms (B). Signal loss due to 
T2 and T2* effects on the image suggest 
high concentrations of intracellular 
manganese.4 (C) MR signal intensity in 
cortical ROIs as a function of TE (TR = 
300 ms).   
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Manganese-Enhanced MRI (MEMRI) and Diffusion-Weighted MRI Mismatch in the Absence of a Specific Neuronal Stimulus 
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Introduction: Manganese (Mn2+) has proven to be a useful MR contrast agent for 
functional imaging1 and neuronal tract tracing2. The paramagnetic properties of Mn2+ 
provide localized contrast on a T1-weighted (T1W) MR image after cellular 
sequestration via voltage-gated calcium channels1. Many MEMRI experiments rely on 
the delivery of a significant volume of Mn2+ to the brain parenchyma via an 
osmotically-disrupted blood-brain barrier (BBB). Neuronal activity associated with 
stroke3 and cortical spreading depression4 can also result in localized T1-enhancement. 
For example, in an effort to detect ischemic brain regions using MEMRI Aoki et al.3 
coined the term “MEMRI-DWI mismatch” to categorize the difference between T1-
enhanced brain regions and regions with an ADC below 0.5x10-3 mm2/s after 
permanent occlusion of the middle cerebral artery in the rat. The T1-enhanced regions 
in Aoki’s study were suggested to represent stroke core. However, mechanisms other 
than stroke, such as brain edema and the paramagnetic effects of manganese, were not 
discussed with respect to ADC deficits in the hemisphere of interest. Here, using an 
experimental protocol similar to that of Aoki et al.3, we show significant ADC 
reductions in brain regions infused with hyperosmotic solution, manganese chloride, 
and Evans Blue as well as non-specific T1-enhancement and DWI contrast due to Mn2+ 
accumulation. Additionally, 2,3,5-triphenyltetrazolium hydrochloride (TTC) staining 
showed signs of tissue injury in areas with significant ADC deficit. These studies 
suggest that when MnCl2 is delivered via an osmotically-disrupted BBB, careful 
assessment of baseline MEMRI-DWI mismatch regions should be performed prior to 
any subsequent neuronal stimulus or ischemic intervention. 
Methods: Eight male Sprague-Dawley rats (280-350 g) were anesthetized with 2.0% 
isoflurane mixed with breathing-quality air during surgery. Five minutes prior to 
hyperosmotic BBB-opening, rats were switched to 2% isoflurane mixed with 100% 
O2. Prior to each injection, the external carotid (ECA) and pterygopalatine artery were 
ligated and the common carotid (CCA) was temporarily clamped (~10 minutes) during 
catheterization of the ECA with PE-10 tubing. 1.6M arabinose solution (5 ml/kg; 
Sigma) was infused into the internal carotid artery over 55 seconds using an infusion 
pump (Harvard Apparatus, Model PHD2000). The CCA was immediately unclamped 
after securing the ECA catheter. During the arabinose infusion, the CCA was clamped 
to ensure flow towards the brain. Immediately after arabinose infusion the CCA clamp 
was removed and the rat was switched back to 2% isoflurane mixed with breathing 
quality air. Two (N=3) and ten (N=4) minutes after arabinose infusion manganese 
chloride (MnCl2 · 4H2O, MW = 198; Sigma), dissolved to 10 mM in isotonic saline, 
and Evans Blue (EB, Sigma), dissolved to 2% in MnCl2 solution (MnCl2+EB = 2 
ml/kg), was infused into the internal carotid artery at 4.5 ml/hr. MnCl2+EB and 
arabinose solutions were filtered with 0.45 µm syringe filters (Nalgene). MR images 
were acquired using a Bruker Biospin 2.0T/45 cm imaging spectrometer operating at 
85.56 MHz for 1H and equipped with ±20G/cm self-shielded gradients. DW images 
were acquired with six b-values (23, 92, 207, 828, 1126, and 1471 s/mm2), 64x64 
matrix zero-filled to 128x128 before Fourier transformation, FOV=3x3cm, six 2-mm 
slices, TR/TE = 2000/51.0ms, ∆= 6.0ms, δ = 24.31ms, and NEX=8. T1W MRI was 
performed as follows: TR/TE = 500/10.8ms, FOV = 3x3cm, matrix = 128x128, six 2-
mm slices with 0.1mm gap and NEX = 8. Slice profiles of DW- and T1W images were 
commonly referenced to the rhinal fissure at the olfactory bulb boundary. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Timeline of infusions, imaging and histological staining. 
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Discussion: Many MEMRI experiments rely on the delivery of Mn2+ to the brain 
parenchyma via an osmotically-disrupted BBB prior to specific neuronal stimulus1,3,4. 
For these studies, non-specific T1-enhancement and DWI contrast is undesirable and 
may obscure the expected T1-contrast and ADC changes. Although ischemic 
conditions were not intentionally induced in these experiments, our data suggests that 
hyperosmotic shock itself can give rise to non-specific brain T1 and ADC changes 
(permanent, Figure 2B) under these conditions.  These observations are consistent 
with previous studies that provided evidence for brain cell and endothelial cell injury 
after hyperosmotic shock5,6,7 and for ADC changes as a result of brain edema8,9. Our 
data does not, however, permit us to rule out T1-enhancement, DWI contrast and 
edema formation by an anesthetic effect. Isoflurane, specifically, has been shown to 
increase blood plasma glutamate levels in humans10 and exacerbate brain edema in 
brain-injured rats11. Although we did not use a combined non-volatile and volatile 
anesthetic regimen as described by Aoki et al.3, this approach may be helpful in 
reducing or eliminating any non-specific T1-enhancement under these conditions.  
While insufficient anesthetic depth may contribute to non-specific T1-enhancement, 
the MEMRI-DWI mismatched regions shown here may also reflect a brain response 
(functional, volumetric, or both) to the hyperosmotic disruption of the BBB alone. 
The results of these experiments stress the need for careful assessment of baseline 
MEMRI-DWI mismatch prior to any subsequent neuronal stimulus or ischemic 
intervention; in order to ensure that the osmotic disruption of the BBB itself does not 
contribute significantly to any non-specific brain T1 or ADC changes.  
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Figure 2: Averaged signal intensity of DW images acquired in x,y, and z directions 
(b=1126 s/mm2) , average ADC map, T1W, EB, and TTC images from three animals. 
MR images are from animals infused with MnCl2+EB A) 2 minutes and B), C) 10 
minutes after arabinose bolus. Red arrows in A) and B) point to regions of MEMRI-
DWI mismatch and EB staining and tissue damage suggestive of low blood flow to 
these regions possibly due to severe edema. C) One animal infused with 5ml/kg 1.6M 
arabinose at 50 ml/hr shows an almost complete MEMRI-DWI mismatch in this slice. 
MR slice in C) is 4mm ventral to MR slices in A) and B). ADC deficit and apparent 
hemispheric volume changes (EB and TTC slices) in C) suggests severe edema which 
may explain lack of T1-enhancement and EB stain in this slice. 
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MEMRI-DWI mismatch size was defined as the area of ADC deficit within regions 
without T1-enhancement compared to the area of the entire hemisphere. Calculations 
and regions of interest were made using imageJ (NIH). 
Results: Animals infused with MnCl2+EB 2 minutes after arabinose showed a T1W 
signal increase of 38.7±7.9% covering 43.1±7.2% of each infused hemisphere. Animals 
infused with MnCl2+EB 10 minutes after arabinose showed a T1W signal increase of 
40±4% covering 50±19% of each infused hemisphere. Figure 2 shows images from three 
animals that include the average signal intensity of DW images, corresponding ADC 
maps, T1W images, EB and TTC stains. Images were acquired according to Figure 1. 
Figure 2A and 2B show regions of bright T1-enhancement corresponding to regions with 
dark EB staining (white arrows). Figure 2A and 2B also show regions of DW 
hypointensity due to Mn2+ accumulation (white arrow 2A, center of hemisphere in DW 
image 2B). Regions of MEMRI-DWI mismatch (red arrows in 2A,2B, whole hemisphere 
in 2C) do not show correlated (gross) EB staining but do correspond to areas of tissue 
injury as verified by TTC stains (2A,2B). Data shown in Figure 2C are from an animal 
infused with 1.6M arabinose at 50 ml/hr (MnCl2+EB 10 minutes after arabinose) to 
control for brain edema and non-specific T1-enhancement due to infusion rate of 
arabinose. For the slice shown, brain water changes are apparent and may reflect severe 
edema due to hyperosmotic shock. Brain edema may be responsible for reducing blood 
flow and delivery of MnCl2+EB to this region. Figure 3 shows percent area of non-T1-
enhanced regions with ADC deficit, percentage ADC deficit in non-T1-enhanced regions 
and percent area of the MnCl2+EB-infused hemisphere with a MEMRI-DWI mismatch. 
T1-enhancement was defined as voxels in infused hemisphere whose signal intensity 
exceeded the mean +2 SDs in the non-infused hemisphere. ADC deficit was defined as 
voxels in the infused hemisphere with ADC values less than the mean plus 2 SDs in the 
non-infused hemisphere. 
Time (min) 
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Introduction. Tissue inter-compartmental equilibrium water exchange can significantly affect the quantitative analysis of various in 
vivo MR parameters.  One method for investigating equilibrium-water-exchange effects is NMR Relaxography,1 which can employ an 
MR contrast agent to selectively modify the T1 relaxation time of one tissue compartment relative to the other.  In the absence of a 
contrast agent, the inter-compartmental water exchange rate is significantly faster than the difference in longitudinal relaxation rates 
(R1 = 1/T1) in each compartment. In this case, a mono-exponential T1 relaxation time would be measured.  However, selective addition 
of an MR contrast agent (of sufficient concentration) to one compartment can increase the T1-relaxation-rate difference between the 
two compartments (relative to the inter-compartmental exchange rate; which remains constant); potentially moving the system into an 
intermediate- or slow-exchange regime.  If the slow-exchange regime can be achieved, then the MR signal contributions from each 
compartment can be separated on the basis of their T1 relaxation time differences.  In the simplest case, a bi-exponential T1 relaxation 
time would be measured. One impediment to achieving the slow-exchange regime in vivo has been the difficulty in attaining the 
necessary contrast-agent concentration in one of the tissue compartments.  In previous in vivo attempts in rat skeletal muscle using 
Gd-DTPA, only the intermediate-exchange regime could be achieved.2  In this study, manganese-enhanced MRI (MEMRI) has been 
investigated as a method for separating and identifying the MR signals from intra- and extracellular water compartment in rat skeletal 
muscle in vivo.     
Materials and Methods. The experiments were performed on a GE CSI-II 2.0T/45-cm imaging spectrometer operating at a 1H 
frequency of 85.56 MHz. A 22 mm (ID), 4-turn solenoid RF coil was placed around the right thigh of male Sprague-Dawley rats. In 
order to prevent the RF field from extending outside the longitudinal edges of the coil, a doughnut-shaped piece of copper foil was 
placed at each end. This made it possible to perform localized spectroscopy using only the RF-field profile of the coil itself. MnCl2 
was infused through a catheter inserted in the femoral vein. Five rats, with an average weight of 320 g, were studied at six different 
[Mn2+] (20, 30, 40, 50, 60 and 70 mM); each infused successively over periods of 32 min at a flow rate of 0.0266mL/min. The total 
accumulated dose was 0.715 mmol/kg Mn2+ after 192 min. During infusion, T1 was measured over 6-min intervals using a standard 
Inversion Recovery (IR) pulse sequence with an adiabatic inversion pulse. The data were analyzed by Inverse Laplace Transform 
(ILT); which, when performed on the IR data, yields the distribution 
of T1 relaxation times in the sample.
1 
 Results. A typical series of T1 distributions, as a function of 
infused [Mn2+], over time is shown in the Figure (Exp. No 5). At 
low [Mn2+] only one peak (located around 1170 ms) is observed.  
This is indicative of the fast-exchange regime, where the difference 
in the T1 relaxation rates (∆R1) between the two compartments is 
small relative to the inter-compartmental equilibrium water 
exchange rate.  However, as the administered [Mn2+] increases over 
time, the mean of the single distribution shifts to lower T1 values.  
At a certain  [Mn2+] in this case, a second distribution appears. If 
there is no significant transport of Mn2+ into the skeletal-muscle 
intracellular (IC) space over the experimental time course, then the 
fast T1 component can be assumed to arise from water in contact with Mn
2+ in the extracellular (EC) space (as well as in equilibrium 
with the vascular water). The appearance of two T1 distributions also heralds the onset of the slow-exchange regime. The means of the 
T1 distributions (and the fractional population, p1, of the short-T1 component; p2 = 1.0 – p1) at the highest (final) infused [Mn
2+] are 
given in the Table and were similar for all experiments. The fraction of the shortest component (p1) corresponds well to values for the 
skeletal muscle EC fraction reported in the literature.3 
 
Discussion and Conclusions. A similar study using Gd(DTPA) was 
not able to separate the water signals from the two compartments in rat 
skeletal muscle.2 A shoulder was observed at highest [Gd(DTPA)]; 
perhaps indicating the approach of the slow-exchange regime.  In the 
Gd(DTPA) study, the shortest T1 value attained was ~600 ms at the 
highest dose.  In our study, a value of ~350 ms was observed at the 
onset of peak separation, indicating a significantly higher [Mn2+] and/or 
relaxivity for Mn2+ the EC space. Mn2+ bound to macromolecules in the plasma and interstitial space can result in a 5-fold increase in 
relaxivity vs. Mn2+ in water.4 The enhanced relaxivity, in combination with [Mn2+], appears to be sufficient to achieve the slow-
exchange regime; allowing separation of the EC and IC water signals. By contrast, the relaxivity of Gd(DTPA) is the same in water 
and plasma,3 which may explain why only the intermediate-exchange regime was attained in (2), even at plasma [Gd(DTPA)] as high 
as 10 mmol/L. The ability to differentiate between IC and EC water compartments in vivo using MEMRI would have important 
implications for studying inter-compartmental equilibrium water exchange in skeletal muscle under a variety of circumstances as well 
as other applications.  
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Exp. no T1 initial T1-1 final  T1-2 final p1 final 
1 1197 134 539 0.25 
2 1175 155 616 0.24 
3 1230 138 530 0.27 
4 1152 130 480 0.26 
5 1170 95 473 0.24 
Overall (SD) 1185 (30) 130 (22) 528 (57) 0.25 (0.01) 
